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Ischaemic stroke is a major cause of adult death and disability and is one of the most 
expensive neurological conditions. Currently, thrombolysis by rtPA is the only 
pharmacotherapy for hyperacute ischaemic stroke, and in routine practice it must be 
administered within 4.5 hours of symptom onset. Consequently, most patients with 
unknown onset time are precluded from thrombolytic therapy, despite the possibility of still 
being within the 4.5 hour treatment window. Unknown onset time, therefore, poses a 
substantial challenge in the management of hyperacute stroke patients.  
 
Multiparametric quantitative magnetic resonance imaging (qMRI) is a potential tool for 
estimating stroke onset time due to its sensitivity to hydrodynamic and haemodynamic 
changes in the ischaemic brain. This thesis explores the potential abilities of MRI based 
stroke timing methods in a preclinical rat model of ischaemia and hyperacute ischaemic 
stroke patients. Both the preclinical and clinical results suggest that quantifying the change 
in the T2 relaxation time is a more accurate and reliable method for onset time estimation 
than measuring the intensities of signals represented in the T2-based weighted images 
typically acquired in clinics. Results also suggest that T2 distributional information within 
grey matter lesions may provide a reference-independent stroke timing method.  
 
The translation of preclinical methods and MRI findings to stroke patients demonstrated 
in the thesis highlights the importance of preclinical research in identifying MRI biomarkers 
that could aid treatment decisions. Clinical MRI scanners can transform conventional 
weighted magnetic resonance images that are usually acquired and assessed visually (e.g., 
T2 weighted), into their ‘absolute’ parametric counterparts (e.g., T2 relaxometry maps). 
Exploiting this ability will enable ischaemia to be identified and onset time estimated more 
accurately and reliably. Ultimately, the encouraging results from this thesis warrant further 
investigation into the quantification of T2 for informing treatment decisions regarding 
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Introduction 
 An introduction to the problem of unknown onset 
time in hyperacute ischaemic stroke treatment 
Stroke is defined as the neurological deficit that results from a focal injury of the 
central nervous system by a vascular cause (Sacco et al., 2013). Worldwide, stroke 
is the second leading cause of death and a major cause of adult disability (Johnson 
et al., 2019). Stroke is one of the most expensive neurological conditions for 
healthcare in Western countries due to treatment and post-stroke care related costs 
(Rajsic et al., 2019). A recent projection (Norrving et al., 2018) showed that due 
to an ageing population the number of strokes and therefore the associated health 
care and non-healthcare costs are expected to rise considerably and thus the need 
to minimise the impact of stroke is now more urgent than ever.  
 
Ischaemic strokes are the most prevalent, accounting for 84% of strokes globally 
(Johnson et al., 2019). The occlusion of a cerebral artery with thrombotic or embolic 
material results in the abrupt and sustained reduction of blood flow to the 
surrounding area, causing rapid cell death and permanent brain damage and 
consequently, a variety of neurological deficits (Meschia & Brott, 2018; Saver, 
2006). The narrowing of an artery due to atherosclerosis can also result in severely 
reduced blood flow, but the disruption is not abrupt. The main therapeutic aim for 
ischaemic stroke is to restore blood flow as quickly as possible, to prevent further 




brain damage. The primary reperfusion-based intervention for hyperacute 
ischaemic stroke is intravenous (IV) administration of the thrombolytic agent, 
recombinant tissue plasminogen activator (rtPA) (referred to as alteplase or 
thrombolysis) (Powers et al., 2018) which is hoped to restore blood flow by actively 
dissolving the occluding clot.  The safety, efficacy and benefit of rtPA when 
administered intravenously within 4.5 hours of symptom onset, is well established 
(Hacke et al., 2008; Lees et al., 2016; Sandercock et al., 2012). rtPA has also been 
shown to be safe and effective when administered intraarterially (IA) to patients 
with anterior circulation stroke, presenting within six hours of symptom onset 
(Berkhemer et al., 2015). Patients with a large vessel occlusion, presenting within 
24 hours of symptom onset can also be considered for mechanical thrombectomy 
where reperfusion is achieved by physically removing the clot with an intravascular 
catheter (Nogueira et al., 2018; Powers et al., 2018). However, both IA rtPA and 
mechanical thrombectomy are not yet practised routinely (Fiehler et al., 2016; 
Powers et al., 2018). 
 
Currently, rtPA is the only licensed pharmacotherapy for acute ischaemic stroke 
(Powers et al., 2018) but only 7.3% of acute ischaemic patients receive it (Aguiar 
de Sousa et al., 2019). One of the main reasons for such a low treatment rate is 
that time is the dictating factor as to whether a patient can be considered for IV 
rtPA (Powers et al., 2018). In most countries, to be eligible, the first neurological 
symptoms must have happened within 4.5 hours of the patient arriving at the 
emergency department (Fiehler et al., 2016; Powers et al., 2018). IV rtPA after this 
time point is associated with a severely increased risk of symptomatic intracranial 
haemorrhage and other clinically adverse events because the tissue is already dead 
(Hacke et al., 2008). This time limitation poses a significant barrier to the 
treatment of acute ischaemic stroke. A multitude of neuroprotective agents 
targeting different pathophysiological mechanisms and alternative reperfusion 
strategies have shown potency in preclinical models but have failed in clinical trials 
(O’Collins et al., 2006). Alternative therapies without a time-window restriction 
such as those that modulate the adaptive immune response by administration of 




stem-cells are an active and promising area of investigation, but at present are far 
from a clinical application (Hess et al., 2017; Malone et al., 2019).  
 
A fundamental consequence of the 4.5 hour treatment window is that almost one-
third of ischaemic stroke patients are automatically precluded from thrombolytic 
therapy because the time of symptom onset is not known (Dekker et al., 2017). 
Reasons for unknown onset time include; the patient was unable to communicate 
time of onset, symptoms were not noticed by the patient or not witnessed by others, 
or the time could not be pinpointed by a witness (Dekker et al., 2017). ‘Wake-up 
stroke’, where the ischaemic event occurred during sleep, and the patient woke with 
neurological symptoms, is one of the most common reasons for unknown onset time 
(Thomalla et al., 2017). However, there is accumulating evidence from studies on 
circadian-rhythms (e.g., Elliott, 1998) and imaging (e.g., Thomalla et al., 2017) 
that suggest many wake-up stroke patients may still be within the 4.5 hour rtPA 
treatment window upon awakening. If clinicians had a method or tool that 
identified patients that may benefit for reperfusion therapies, patients with 
unknown onset time could be considered for rtPA, which would ultimately minimise 
the impact of stroke to the individual and society.  
 
Neuroimaging methods, such as computerised tomography (CT) or magnetic 
resonance imaging (MRI) have been proposed as potential tools for reducing the 
problem of unknown onset time in the treatment of hyperacute ischaemic stroke 
patients (e.g., Jokivarsi et al., 2010; Mair et al., 2017; Minnerup et al., 2016; 
Thomalla et al., 2011). This is because, as a standard of care, all suspected stroke 
patients must receive some form of imaging on arrival to the emergency department 
(Fiehler et al., 2016; Powers et al., 2018) and these imaging modalities are sensitive 
to the hydrodynamic and haemodynamic changes in the ischaemic brain 
(Dzialowski et al., 2004; Kauppinen, 2014; Mair et al., 2017; Siemund et al., 2009). 
Typically, non-contrast CT (NCCT) is the preferred imaging modality for stroke 
in the United Kingdom (UK), as it is widely available, inexpensive and fast and is 




used to rule out haemorrhage as a cause of neurological symptoms (Birenbaum et 
al., 2011; Mair & Wardlaw, 2014). Unlike MRI, NCCT is also better tolerated by 
unstable and claustrophobic patients (Mair & Wardlaw, 2014) and is safe for 
patients that have metallic implants (e.g., pacemaker, joint replacement).  
 
MRI, however, is more sensitive to early ischaemia than NCCT and so, unlike 
NCCT, can be used to diagnose ischaemic stroke (Chalela et al., 2007; Fiebach et 
al., 2002). MRI also offers the advantage of being multiparametric, in that different 
sequences are sensitive to different pathophysiological changes in the ischaemic 
brain (Kauppinen, 2014). This diversity would provide clinicians with much more 
information for which to base treatment decisions. It is therefore not surprising 
that MRI is becoming more commonplace as the first-line imaging modality for 
suspected stroke in specialised stroke centres, most European (Li et al., 2019) and 
United States hospitals (Burke et al., 2012) and some UK National Health Service 
(NHS) hospitals (Wardlaw et al., 2014). Multiparametric MRI data can also be 
acquired within a matter of minutes, with the application of magnetic resonance 
fingerprinting (MRF) (Ma et al., 2013), which has recently been applied successfully 
in a clinical study of hyperacute ischaemic stroke patients (Duchaussoy et al., 
2019).  
 
There are two potential imaging approaches to overcoming the problem of unknown 
onset time in hyperacute ischaemic stroke treatment (Biggs et al., 2019; Etherton 
et al., 2018). One of these is to use imaging as a tissue clock, where the decision to 
treat with thrombolysis would depend on the extent of potentially salvageable 
tissue evident on the patient’s scans (Biggs et al., 2019; Etherton et al., 2018). This 
approach is referred to as the infarct core-perfusion mismatch approach which 
involves quantifying the extent of irreversibly damaged tissue (infarct core) relative 
to the amount of hypoxic, potentially salvageable tissue (Etherton et al., 2018), 
usually identified via contrast agent enhanced CT perfusion or MRI perfusion 
imaging techniques (Demeestere et al., 2020). If there is a mismatch, where there 




is more hypoxic tissue (tissue at risk) than infarct core (irreversibly damaged), the 
patient could be considered for reperfusion-based therapy regardless of onset time 
(Etherton et al., 2018).  
 
The benefit of the tissue clock approach is that treatment decisions would be made 
on a patient-specific basis and so accounts for the fact that each patient will tolerate 
ischaemia differently due to individual differences such as age, collateral status, 
cerebral reserve and the presence of pre-existing systemic diseases (Wang and 
Wang, 2019). However, for both perfusion-based CT and MRI infarct core-
perfusion-mismatch approaches, there is no consensus on the specific thresholds 
that should be used to differentiate between irreparably damaged and potentially 
salvageable brain tissue, due to high inter-vendor variability in MRI scanner 
hardware and software (Dani et al., 2011; González et al., 2013) and incomplete 
standardisation of image interpretation (Demeestere et al., 2020). Additionally, at 
the time the studies in this thesis were conducted, the efficacy of treating based on 
the infarct core perfusion mismatch with perfusion CT or perfusion MRI had not 
been demonstrated, and a positive phase three clinical trial that would warrant 
incorporation of the tissue clock approach into clinical guidelines did not exist  
(Etherton et al., 2018; Powers et al., 2018). Chronological time remained a barrier 
to treatment with rtPA (Biggs et al., 2019), and was, therefore, the main 
motivation for the studies in this thesis. However, as will be discussed in the 
General Discussion (Chapter 9), since this thesis was written, the field has moved 
on, with more clinical evidence supporting the adoption of the tissue clock approach 
to treatment decisions of acute ischaemic stroke patients.  
 
The other imaging-based approach to overcoming the problem of unknown onset 
time in the treatment of acute ischaemic stroke is to use imaging as a chronological 
clock and estimate how long ago the stroke started (Biggs et al., 2019; Etherton et 
al., 2018).  According to this time-based approach, if the estimated time from onset 
is less than 4.5 hours, the patient with unknown onset could be considered for IV 




thrombolysis as per clinical routine (Thomalla et al., 2011). The appeal of this time-
based approach is that it is in accordance with current treatment guidelines and 
compliments the tissue clock approach because time is a proxy for tissue viability 
(Hacke et al., 2008). Patients presenting after 4.5 hours from symptom onset are 
unlikely to have enough salvageable tissue to benefit from rtPA safely and the risk 
for iatrogenic haemorrhage increases (Hacke et al., 2008). Unlike the tissue clock 
approach outlined above, the size of the ischaemic region is not considered in the 
decision to consider a patient for thrombolysis, as the time from symptom onset is 
considered to be the most important factor. As will be expanded upon in Chapter 
4 (Section 4.4) according to this time-based approach, unknown onset can be 
treated as a binary classification problem, where imaging is used to classify a 
patient as within or beyond 4.5 hours of symptom onset. For example, the visual 
MRI based method, the DWI/FLAIR mismatch, classifies a patient as within the 
treatment window if ischaemic tissue is identifiable on DWI but not FLAIR scans, 
and beyond the treatment window if ischaemic tissue is identifiable on both 
(Thomalla et al., 2011). Alternatively, the amount of time passed since the first 
ischaemic event could be estimated by quantifying the difference in image 
intensities of ischaemic and non-ischaemic regions on NCCT (e.g., Mair et al. 2017) 
or MRI scans (e.g., Siemonsen et al., 2009; Song et al., 2012).  
 
 Aims of this thesis 
At the start of this PhD (September 2015), the WAKE-UP trial, which aimed to 
investigate the safety and efficacy of treating patients with unknown onset time 
according to the visual-based DWI/FLAIR mismatch criteria was underway 
(Thomalla et al., 2014). Other studies had investigated various quantitative MRI 
(qMRI) based approaches, some just in preclinical animal models of ischaemia (e.g., 
Jokivarsi et al., 2010; Rogers et al., 2014) and some in both preclinical (e.g., Rogers 
et al., 2014; Xu et al., 2014) and clinical patient studies (e.g., Madai et al., 2016; 
Siemonsen et al., 2009; Song et al., 2012). Reported accuracies of these approaches 
were variable across studies, and imaging approaches had not been compared 




directly. It was therefore unclear which, if any, imaging methods would serve as 
the most reliable chronological clock for stroke onset time estimation.  
 
This thesis, therefore, explores the ability of potential MRI based methods at 
estimating stroke onset time, with the overall goal of identifying which 
parameter(/s) should be studied further in larger-scale clinical studies. MRI was 
chosen as the imaging method to study because of its multiparametric abilities 
(Kauppinen, 2014) and its availability in most clinical settings worldwide (OECD, 
2018). It is recognised that a variety of other MRI based techniques have been 
recommended for onset time estimation, such as magnetic resonance spectroscopy 
(e.g., Wang et al., 2000), perfusion-weighted imaging (PWI) (e.g., Roldan-Valadez 
et al., 2012) and diffusion tensor imaging (DTI) (e.g., Puig et al., 2013). However, 
the MRI parameters researched in this thesis were chosen because they are already 
part of recommended stroke protocols (e.g., Mair & Wardlaw, 2014) and are easy 
to acquire and analyse quantitatively in clinical settings. This is important because 
radiographers and clinicians involved in scanning stroke patients would be familiar 
with the pulse sequences used, and there would be no extra effort involved in setting 
up the MRI scanner. Additionally whilst the focus was on onset time estimation, 
to fit in with the clinical guidelines at the time, as will become evident throughout 
the course of the thesis and discussed in Chapter 9, the results of the research 
studies are also relevant to the patient-specific tissue clock approach, which 
throughout the course of 2015 to early 2020, gained more attention in clinical stroke 
literature.   
 
The purpose of Chapters 2, 3 and 4 is to provide the reader with a background 
understanding of acute ischaemic stroke and MRI. Chapter 2 provides an essential 
overview of the pathophysiological changes that occur in the hyperacute ischaemic 
brain in order to contextualise the changes seen in the MRI parameters studied in 
this thesis.   




Chapter 3 introduces the reader to MRI as a medical imaging technique, including 
the setup of the MR equipment, how MRI works, how images are acquired, and 
the different types of contrast MR images can have. The Chapter ends with an 
introduction to the main quantitative approaches to MR image analysis (qMRI), 
which differs from the standard qualitative approach used in hospitals and are the 
main methods of analysis used in the studies of this thesis.  
 
Chapter 4 draws Chapters 2 and 3 together by providing an overview of what the 
different MRI contrasts studied in this thesis reveal about ischaemia and why they 
are potentially informative of stroke onset time. This is followed by a description 
of time-based MRI approaches that have been proposed for overcoming the problem 
of unknown onset time. Results from previous studies that have adopted these 
methods are described and explained in this Section as well as the introductions 
and discussions of the relevant research Chapters in this thesis. 
 
Chapters 5, 7 and 8 are the main research studies. These Chapters were written for 
publication and so are structured as they would appear in a journal with separate 
abstracts, introductions, methods, results and discussions. 
 
Chapter 5 is a preclinical study involving rat models of ischaemia that compared 
the accuracy, sensitivity and specificity of qMRI parameters for stroke timing. 
Using rats enabled qMRI parameters to be studied under controlled conditions that 
would not be possible to emulate in patient studies. The purpose of the study was 
to inform which qMRI parameters should be studied in hyperacute stroke patients. 
 
Chapter 6 introduces the reader to some of the advantages and limitations of 
preclinical research to study cerebral ischaemia and outlines how the results from 




the preclinical study in Chapter 5 and previous clinical studies informed the design 
of the studies of hyperacute ischaemic stroke patients in Chapters 7 and 8.  
 
Chapters 7 and 8 are pilot studies that explored the potential ability of qMRI 
parameters to estimate stroke onset time in a cohort of hyperacute ischaemic stroke 
patients. The overall purpose of these studies was to identify MRI based parameters 
that would be suited to more rigorous investigation in more extensive clinical 
studies. The aim of Chapter 7 was specifically to compare the ability of visual and 
quantitative MRI based methods for stroke timing. The aim of Chapter 8 was to 
study the potential heterogeneity of the ischaemic lesion by means of T2 relaxation 
time histograms and the ability of T2 distribution characteristics to time from 
ischaemia onset. 
 
The final Chapter summarises the results and conclusions of the three research 
Chapters and the questions that emerged from them. The conclusions are drawn 
together to form the main conclusion, followed by discussions outlining the original 
contributions of this thesis and how the conclusions fit in with up-to-date stroke 
timing literature (up to February 2020). Limitations of the research studies are also 
addressed, and the Chapter ends with recommendations for further work. 
  












                           
Acute Ischaemic Stroke 
  Introduction 
An ischaemic stroke is defined as an episode of neurological dysfunction caused by 
focal cerebral infarction (Sacco et al., 2013). The occlusion of a cerebral artery with 
thrombotic or embolic material results in the abrupt cessation of focal blood supply, 
and severe reduction in blood flow to surrounding brain parenchyma (Toole, 1999). 
The narrowing of an artery due to atherosclerosis can also result in severely reduced 
blood flow, but disruption is not abrupt.  In the hypoxic state, the brain can initially 
engage in compensatory mechanisms, by increasing cerebral blood volume (CBV) 
to increase oxygen extraction (Muir et al., 2006) and converting to anaerobic 
glycolysis if glucose is available (Hossmann, 1989). However, once cerebral blood 
flow (CBF) below the critical threshold for energy metabolism (from the normal 
average of ~ 50 mL/100g/min to ~ 20 mL/100g/min) oxygen supply is hindered, 
causing normal physiological processes to cease, which prompts a cascade of 
pathophysiological events that ultimately contribute to cell death and irreversible 
brain damage (Heiss & Rossner, 1983; Huang et al., 2019).  
 
The pathophysiological changes that take place in the ischaemic brain and the 
mechanisms for which they contribute to cell death are highly complex, and it is 
beyond the scope of this thesis to provide a detailed account of all potential events. 




Therefore, the purpose of this Chapter is to provide an essential overview of the 
ischaemic changes that are directly relevant to the MRI studies in this thesis. As 
MRI probes changes in tissue water, the focus of this Chapter is mainly on 
components of the ischaemic cascade related to hydrodynamic changes in the acute 
ischaemic brain. For more detailed accounts of the pathobiology of ischaemic 
stroke, the reader is referred to excellent reviews by Dirnagl et al. (1999) and 
Simard et al. (2007). This Chapter and many previous reviews on the 
pathophysiology of ischaemia are mainly informed by preclinical animal studies 
(Muir et al., 2006), which contributes to the theme throughout this thesis of the 
importance of animal studies in informing clinical research of disease states such as 
ischaemic stroke.   
 
 The three-zone core-penumbra-oligaemia model 
The ischaemic brain parenchyma can be broadly summarised into three main zones 
that reflect the spatial gradient of hypoxia, including the ischaemic core, the 
penumbra, and the oligaemia (Hossmann, 1994; Simard et al., 2007). The ischaemic 
core corresponds to the tissue within the immediate vicinity of the occluded artery, 
where CBF has already dropped below the critical threshold for energy metabolism, 
and brain tissue is irreversibly damaged (Hossman, 1994). Surrounding the core is 
the ischaemic penumbra, which is the hypoperfused, potentially viable tissue 
(Hossmasn, 1994). Outside of the penumbra is the oligaemia which is characterised 
by small reductions in CBF but in principle, should survive (Muir et al., 2006). 
These zones and their development over time after ischaemia onset are 
schematically illustrated in Figure 2.1, and the relevant pathophysiological 
mechanisms that take place within them are summarised in the Sections that 
follow. 
  






2.2.1 The ischaemic core 
In the ischaemic core, CBF is below 6 mL/100 g/ min, which results in functional 
and structural impairment within minutes of onset, due to a number of 
pathophysiological mechanisms that result from membrane pump failure (Astrup, 
1977; Heiss & Rosner, 1983; Jones et al., 1981). The severe energy deprivation that 
results from lack of oxygen causes a failure of the energy dependent 
sodium/potassium pumps (Na+/K+ ATPase pump, ATP: adenosine triphosphate) 
and thus collapse in membrane function.  This anoxic depolarisation causes the 
death of neural cells as the oxygen and glucose deprivation means they cannot 
survive the energy demands of repolarisation and has been described as a “wave of 
Figure 2.1 Schematic illustration of the three-zone core-penumbra-oligaemia model 
representing the progression of tissue damage due to ischaemia. Unless reperfusion takes 
place, the ischaemic penumbra becomes incorporated into the irreversibly damaged 
ischaemic core. The figure is a recreation of a figure by Dirnagl et al. (1999) which is 
reproduced from McGarry (2015). 
 




electrical silence propagating across the neocortex” (Anderson et al. 2005, p. 
963).  Cerebral oedema is one of the main consequences of membrane pump failure, 
for which there are three main types, cytotoxic, ionic and vasogenic, which are 
schematically illustrated in Figure 2.2 and described in further detail in this Section.  
 
Cytotoxic oedema  
Normally, Na+ concentrations within serum and extracellular space are the same 
and higher than in the neural cells (Figure 2.2-part A) (Simard, 2007). However, 
failure of membrane function causes opening of the non-selective cation channel 
(NCCA-ATP channel), which results in the efflux of potassium (K+) from the cell 
into extracellular space  and an influx of sodium (Na+), chloride (Cl-) and calcium 
(Ca2+) from extracellular space, into the cell (Figure 2.2-part B) (Astrup et al. 
1977; Hansen & Zeuthen, 1981; Simard 2007). This change in intra and extracellular 
concentrations results in cytotoxic oedema, where osmotically obliged water from 
extracellular space, follows Na+ into ischaemic neural cells (Astrup et al., 1981; 
Klatzo, 1967; Simard et al., 2007). This redistribution of water causes the cells to 
swell and lose structure (Astrup et al., 1981; Klatzo, 1967; Simard et al., 2007). At 
this stage, the total tissue water content does not change; only the distribution of 
water. The ischaemic tissue is therefore still potentially salvageable as the blood-
brain barrier remains intact. However, the swollen cells eventually lose structure, 
resulting in oncotic death of the neuronal cells (Figure 2.2-part C) (Astrup et al., 
1981; Klatzo, 1967; Simard et al., 2007). 
 
Ionic oedema 
Ionic oedema results from the cytotoxic oedema of endothelial cells (Simard, 2007). 
The influx of Na+ and water into cells results in less Na+ and water in extracellular 
space, which in turn causes a Na+ gradient that draws the fluid from capillaries 
into extracellular space (Figure 2.2-part D) (Simard et al., 2007). This fluid shift is 




the first time in the ischaemic process which leads to a net increase in water and 
transition to irreversible tissue damage (Simard et al., 2007).  
 
Vasogenic oedema 
Over subsequent hours, the endothelial junctions of the blood-brain barrier start to 
break down marking the start of vasogenic oedema where water and 
macromolecules such as albumin and plasma proteins leak into extracellular space 
followed by even more water uptake, causing further cell damage (Figure 2.2-part 
E)  (Huang et al., 2019; Klatzo, 1967; Simard et al., 2007). As a result of the blood-
brain barrier break down, inflammatory leukocytes in the blood transfer to brain 
tissue which also contributes to cell death as they can block microvasculature, 
causing further reduction in CBF, and production of toxic mediators (Durukan & 
Tatlisumak, 2007). The increase in extracellular water can also cause an increase 
in brain volume, which increases intracranial pressure and can result in further 
ischaemia due to compression of other cerebral arteries (Rosenberg, 1999).  
 
Further causes of cell death in the core  
The Na+/K+ ATPase pump failure results in other pathophysiological events that 
contribute to cell death in addition to the progression of oedema. For example, the 
increase in intracellular Ca2+ facilitates the production of free radicals that damage 
membrane, mitochondria and DNA (Dirnagl et al. 1999). Additionally, 
excitotoxicity, which is the action by excitatory neurotransmitters (i.e., glutamate 
on N-methyl-D-aspartate (NMDA) receptors) followed by a cascade of destructive 
ionic and enzymatic events, is an additional contributor to cell death (Dirnagl et 
al., 1999). The depolarisation of neurons and glia causes an extracellular 
accumulation of excitatory amino acids such as glutamate and aspartate, resulting 
in prolonged stimulation of NMDA and AMPA (a-amino-3-hydroxy-5-methyl-4-
isoxazole propionic acid) receptors (Dirnagl et al., 1999). The over prolonged 
stimulation of AMPA receptors promotes further depolarisation and release of the 




NMDA magnesium block (Mg2+) causing a further influx of Ca2+ (Dirnagl et al., 
1999; Doyle et al., 2008). The prolonged stimulation of NMDA receptors 
exacerbates cytotoxic oedema as it causes a further influx of Na+, Ca2+ and water 




Figure 2.2 Displayed on the right-hand side. Schematic diagram illustrating the types of 
oedema during ischaemia. 
 
A. Normal capillary and neuron:  Na+ concentrations are higher in extracellular space 
and K+ is higher intracellularly. 
 
B.  Cytotoxic oedema: when the Na+/ K+ pumps fail due to severe energy deprivation, 
Na+ enters into the ischaemic neuron / neural cell, which depletes extracellular Na+, which 
sets up an ionic gradient between intravascular and extracellular compartments, causing 
osmotically obliged water from extracellular space to follow Na+ into cells causing them 
to swell.  
 
C. Oncotic death: eventually the swollen cells lose structure, resulting in oncotic death 
of the neural cell. 
 
D. Ionic oedema: the cytotoxic oedema of endothelial cells and Na+ gradient that draws 
the fluid from capillaries into extracellular space.  
 
E. Vasogenic oedema: the blood brain barrier breaks down and water and 
macromolecules leak into extracellular space.  
 
Reproduced from The Lancet Neurology, Vol 6, Simard et al., Brain oedema in focal 
ischaemia: molecular pathophysiology and theoretical implications. P 258-68., Copyright 
(2007), with permission from Elsevier (Appendix D). 









2.2.2 The ischaemic penumbra 
The ischaemic penumbra is the hypoperfused tissue immediately surrounding the 
ischaemic core. In this region, CBF is between an upper threshold of 15 mL /100 
g/ min between and the critical threshold for energy metabolism of 6 mL/100 g / 
min (Astrup, 1977; Heiss & Rosner, 1983; Jones et al., 1981). The CBF is less 
reduced than in the core because other surrounding arterial channels supply the 
affected region with blood (Hossmann, 1994; Huang et al., 2019).  Due to the 
reduction in blood supply, neural cells in the penumbra are functionally impaired, 
which contributes to neurological symptoms, but their structural integrity is 
maintained (Hossmann, 1989). The penumbra is electrically silent, but unlike the 
core, the cells are still polarised, so there is no anoxic depolarisation (Hossmann, 
1989). Thus, in the first minutes and hours of ischaemia, the penumbral tissue is 
potentially salvageable and thus is the target in treating ischaemic stroke (Muir et 
al., 2006). If reperfusion happens quickly enough, either spontaneously (i.e., a 
transient ischaemic attack) or therapeutically (e.g., IV or IA thrombolysis, 
mechanical thrombectomy) there is potential for penumbral tissue to recover 
(Huang et al., 2019).  
 
If CBF is not restored, over subsequent hours of ischaemia, the ischaemic core 
expands into penumbral tissue (Hossman, 1994). This expansion is thought to be 
partly due to repetitive peri-infarct depolarisations, referred to as, spreading 
depression, where cells are in a constant state of depolarisation and repolarisation, 
as the elevated K+ concentrations and glutamate release causes cells to depolarise, 
but the remaining energy supplies enable repolarisation (Hossmann, 1996). The 
constant depolarisations and repolarisations completely deplete energy supplies 
over time, and so the cell death that happens in the core also happens in penumbral 
tissue (Hossmann, 1996). Additional factors that are responsible for the growth of 
the ischaemic core into penumbral regions include ongoing excitotoxicity, free 
radical formation and tissue acidosis caused by anaerobic glycolysis (Dirnagl et al., 
1999; Rehncrona et al., 1985). Within days and weeks of the first ischaemic event, 




cells eventually break down, and all that is left is a fluid-filled cavity (Hossmann, 
1989). 
 
2.2.3 The oligaemia 
The oligaemia represents tissue with very small reductions in CBF, between the 
normal average of 50 mL/100 g/min and the critical threshold for energy 
metabolism of 20 mL/100g/min (Muir, 2006). In this region, functional integrity is 
maintained for a long time, and tissue is unlikely to proceed to infarction. However, 
secondary events that reduce cerebral perfusion pressure may push the oligaemia 
into a penumbral state, and therefore, potentially the core (Muir, 2006). Examples 
of such secondary events include vasogenic oedema, systemic hypotension, 
hypoglycaemia and pyrexia (Baron, 2001; Muir, 2006).  
 
 Concluding comment 
It is important to note, that although the progression of ischaemia can be simplified 
into this three-zone, core-perfusion-oligaemia model, the pathogenesis of ischaemia 
is a highly dynamic and heterogeneous process (Meschia & Brott, 2018). 
Compensatory and pathophysiological mechanisms described in this Chapter occur 
in both the core and the penumbra but at different rates, due to differences in 
collateral blood supply (Muir et al., 2006). Ultimately, the survival of the 
penumbral tissue overall depends on the collateral circulation. For example, 
patients with better collaterals have been shown to have better outcomes (Maas et 
al., 2009) and smaller infarcts (Iwasawa et al., 2016). Other patient-specific factors 
such as the location of the infarct, age and pre-existing disease states (e.g., diabetes, 
hypertension) will also contribute to how well ischaemia is tolerated and how fast 
it progresses (Macrae, 1992; Wang & Wang, 2019).  












                       
Magnetic Resonance Imaging  
 
 Introduction 
Magnetic resonance imaging (MRI) is a non-invasive medical imaging technique 
that uses strong magnetic fields and radio waves to generate signals that are 
transformed into detailed images of the body’s physiology and anatomy. 1H 
Magnetic Resonance (MR) was the chosen imaging modality for studies in this 
thesis, because compared to non-contrast CT (NCCT), its multiparametric 
capabilities and sensitivity to different pathophysiological changes in the brain, 
means it has the potential to provide more information about ischaemic tissue, 
without exposing the patient to ionising radiation, or injecting a contrast agent (as 
with perfusion CT). The purpose of this Chapter is to contextualise the MRI signals 
studied in this thesis for stroke onset time estimation. To this end, the MR 
equipment and nuclear magnetic resonance (NMR) phenomenon are described, 
followed by an outline of how the NMR signals are acquired and the different types 
of image contrasts that can be generated. The Chapter ends with an introduction 
to the main method of analysis used in this thesis, quantitative MRI (qMRI), and 
an explanation of how it differs from the conventional qualitative approach 
traditionally used in hospitals.   
 




  The MR equipment 
An example of a typical clinical MR system and patient set up is shown in Figure 
3.1 and further described in the caption. The MR scanner (without the console) is 
situated in an isolated room protected by a Faraday cage, which is a copper-lined 
barrier that ensures potential sources of electromagnetic noise are kept out, and its 
own electromagnetic fields are kept in (Currie et al., 2013).  After correctly 
positioning the patient within the scanner, the radiographer (Figure 3.1-part A) 
operates the MR scanner from a separate control room via a computer interface. 
In the control room the radiographer can select an appropriate MR protocol (pre-
set or user-determined) and view the images which are reconstructed by the 
computer from the signals produced by the MR system.   
 
The MR system contains 360° concentrically arranged coils around the magnet bore 
(Figure 3.1-part C), including the main superconducting energised coils (Figure 3.1-
part B), three gradient coils (Figure 3.1-part D), radiofrequency (RF) coils (Figure 
3.1-part E) and shim coils (Figure 3.1-part G) (Currie et al., 2013). The 
arrangement of these coils is schematically illustrated over a picture of a clinical 
MRI scanner in Figure 3.1. Chapter 5 of this thesis is a preclinical MRI study.  
MRI scanners for preclinical animal research have similar hardware arrangement 
to that of a clinical scanner; however, the magnet bore is much smaller. A 
photograph of one of the preclinical MRI systems used in Chapter 5 is shown in 
Figure 3.2. 
  







Figure 3.1 An example of a clinical 3T Siemens Magnetom Skyra MRI scanner. The 
radiographer (A.) ensures the subject is comfortable on the patient table with elevated legs 
and a blanket if needed. The subject is given earplugs to protect hearing.  The patient’s 
head is positioned comfortably within the head coil (F.) with foam padding. For brain 
imaging, a separate radio frequency receiver coil (not shown) is placed in front of the 
subject’s face to improve the signal to noise ratio. The subject is asked to lie as still as 
possible during the scan to reduce movement artefacts. The subject is also given an alarm 
button (not shown) to hold during the scan to alert the radiographer if needed.  Once in 
place, the radiographer slides the patient table into the magnet bore (C.) using control 
buttons on the side of the scanner and will return to the separate operating room to set up 
the MR experiment. The concentric arrangement of the 360° degree RF (E.), gradient (D.) 
and shim (G.) coils are schematically illustrated by the blue, green and red arcs. The X, Y 
and Z axis is also shown to illustrate the direction of the main magnetic field (B0) and the 
X, Y planes.  





Figure 3.2 The 9.4T animal MRI scanner used in the preclinical study in Chapter 5. The 
animal is positioned securely on the animal handling table (A.) before being slid into the 
magnet bore (B.). As with the clinical setting, the MR equipment is operated in a separate 
control room using the MRI console (C.). The magnetic coils are organised around the bore 
in the same way as the clinical MRI scanner in Figure 3.1. X, Y and Z axis are also shown 
to illustrate the direction of the main magnetic field (B0) and the X, Y planes. 
  




 Main magnetic coils 
The main magnetic coils (Figure 3.1-part B) are superconducting energised coils 
which are hyper-cooled close to absolute zero (~ 4 K / ~ -269 °C) using cryogenic 
liquid helium. A strong electric current in these coils generates a strong homogenous 
external magnetic field (B0) in the bore of the machine (Figure 3.1-part C) along 
the Z-axis, which is in the head-foot direction (Currie et al., 2013). The strength of 
the external magnetic field is measured in units of Tesla (T), which is 
approximately 20,000 times larger than the earth’s magnetic field (Currie et al., 
2013; Plewes & Kucharczyk, 2012). Most MRI scanners in a hospital setting are 
1.5T or 3T (used in Chapter 7 and Chapter 8). MR systems with higher field 
strengths (e.g., 4.7T, 7T, and 9.4T) offer higher signal to noise ratio (SNR) but are 
mainly used in preclinical (e.g., Chapter 5) and human imaging research (mainly 
7T).  
 
3.3.1 Shim coils 
In order to correctly localise the MR signal, the main B0 field needs to be as uniform 
as possible (Currie et al., 2013). However, simply placing an object within the main 
magnetic field will reduce the homogeneity of B0 due to magnetic susceptibility 
effects (Currie et al., 2013). Magnetic susceptibility is the extent a substance is 
magnetised in the presence of an external magnetic field (Currie et al., 2013). Some 
substances will increase the local external magnetic field by a few parts per million 
(ppm), and others will decrease it (Plewes & Kucharczyk, 2012; Schneck, 1996). 
For example, human tissue and bone are diamagnetic, so will reduce the B0 field, 
whereas iron is paramagnetic and will increase the B0 field (Juchem & de Graaf, 
2017). Therefore, when a patient is positioned in the scanner, they will generate 
small field variations in B0. Shim coils situated close to the magnet bore (Figure 
3.1-part G) are necessary to optimise B0 homogeneity (Sprawls, 2000). This can be 
achieved by adjusting the electrical currents induced by the shim coils on a patient-
specific basis via the computer, or when the magnet is serviced (Sprawls, 2000). It 




is important to note here, that despite shimming, B0 will never be perfectly 
homogenous, and so will always influence the MR signal to some extent. This B0 
inhomogeneity is an important factor to remember when reading this thesis, as the 
main quantitative MR imaging parameter (T2 relaxation time introduced in Section 
3.4.3 of this Chapter) and proposed for the study of stroke pathophysiology and 
stroke timing (Chapter 4) is not impacted by B0 inhomogeneities.  
 
3.3.2 Gradient coils 
During the imaging process, the external magnetic field is distorted with gradients, 
which is achieved with gradient coils (Figure 3.1-part D) (Sprawls, 2000). Gradients 
are magnetic fields where the strength of the magnetic field varies depending on 
the spatial position (Currie et al., 2013). In the MR system, an X-Y-Z coordinate 
system is used to define the direction of the main magnetic field (as shown in 
Figures 3.1, 3.2 and 3.3.). A gradient applied in the X direction, for example, will 
modify the magnetic field strength in that direction. Gradients are important for 
producing an echo event and signal (introduced later in this Chapter, Section 3.4) 
and are necessary for localising the MR signal (Plewes & Kucharczyk, 2012; 
Sprawls, 2000). In the MR system, there are three gradient coils (position shown 
in Figure 3.1-part D), which represent the three orthogonal directions (X, Y and 
Z) and lie concentric to each other within the main magnet (Currie et al., 2013). 
These coils alter the strength of B0 along the direction of the applied gradient field 
(X, Y or Z direction) (Currie et al., 2013). In addition to the X, Y and Z directions, 
gradients can be produced in any desired direction by using two or more of the 
gradient coils together (Sprawls, 2000).  
 
3.3.3 Radiofrequency coils 
The RF coils are positioned within the gradient coils (Figure 3.1-part D) and 
generate electromagnetic fields (known as the RF field, RF pulse or B1 field), but 




at much lower power (in the MHz range) than the main magnetic field (Tesla).  RF 
coils are similar to an antenna, whereby they transmit RF energy to the tissue of 
interest, as well as receive the induced RF signal from that same tissue (Currie et 
al., 2013). Some MR scanners are fitted with RF coils that perform both transmit 
and receive functions, whereas others have separate coils for transmitting and 
receiving (Currie et al., 2013). In neuroimaging, a separate receive coil is commonly 
used, which is positioned around the patient’s head (Figure 3.1-part F) to maximise 
the signal to noise ratio (Currie et al., 2013). When switched on, the RF pulse 
combines with the main external magnetic field to produce the MR signals that are 
spatially localised and encoded by the gradient magnetic fields (Currie et al., 2013).  
 
 Nuclear magnetic resonance phenomenon 
The vast majority of MRI used in clinics today is based on imaging the hydrogen 
(1H) nucleus because of the high abundance of water in the body. 1H nuclei, hence, 
Nuclear Magnetic Resonance (NMR), behave like tiny bar magnets with a north 
and a south pole (Plewes & Kucharczyk, 2012). 1H nuclei have a single, positively 
charged proton and possess the quantum property, angular momentum, or spin, 
and are referred to as spins (Plewes & Kucharczyk, 2012). The interactions between 
applied magnetic fields and spins enable spatial encoding of hydrogen atoms within 
different water-based tissues, to produce the images that are used in the clinic 
(Brown & Semelka, 2011). 
 
3.4.1 Net magnetisation 
In MRI, the magnetic field that is generated by the main magnet coils gives rise to 
net magnetisation along the longitudinal axis (MZ) which in the direction of B0 (Z 
direction, shown in Figure 3.1, Figure 3.2 and Figure 3.3). As there are billions of 
1H spins in a typical voxel, net magnetisation, refers to the sum of magnetisation 
of these spins (Wolbarst et al., 2013) and is illustrated by the large red arrow in 




part A of Figure 3.3 (Brown & Semelka, 2011). MZ is also referred to as longitudinal 
magnetisation (Brown & Semelka, 2011). In the presence of the magnetic field, the 
spins precess around their axes at a constant frequency known as the Larmor or 
resonant frequency, which is linearly proportional to the gyromagnetic ratio of the 
nuclei being observed (42.58 MHz/ T) for hydrogen) and the strength of B0 (e.g., 
3T) (Currie et al., 2013). At this stage, the NMR signal is not detected simply by 
placing the object into the magnet bore. Instead, more elaborate hardware and 
software are required (Plewes & Kucharczyk, 2012).  
 
In the absence of a magnetic field, spins are aligned nearly randomly with respect 
to each other (Brown & Semelka, 2011). As illustrated in Figure 3.3 (part A), where 
black arrows represent individual spins, in the presence of an external magnetic 
field, the majority of spins align parallel to the direction of the magnetic field (low 
energy state) and slightly less align anti-parallel to the external magnetic field (high 
energy state) (Brown & Semelka, 2011). This population difference in the energy 
state of spins is predicted by the Boltzmann distribution function (Brown & 
Semelka, 2011). 
Figure 3.3 Longitudinal and transverse magnetisation. A. When the subject is placed in 
the magnet bore the majority of spins align parallel to the magnetic field, in the Z / head-
foot direction, termed longitudinal magnetisation (Mz). B. The signal is produced by 
tipping net magnetisation into the transverse plane (X-Y axis), termed transverse 
magnetisation (MXY). There are billions of spins within each voxel, and so net 
magnetisation is the sum of the magnetisation of these spins. 
 




3.4.2 Disturbance of net magnetisation 
In order to produce the signal that is used to form an image, net magnetisation 
must be tipped from the longitudinal axis into the transverse plane, which is 
orthogonal to the direction of the B0 field (Figure 3.3-part B.) (Plewes & 
Kucharczyk, 2012). Therefore, a second magnetic field, at the Larmor frequency 
referred to as the radio frequency pulse (RF pulse) and B1 field, is introduced by 
the transmit RF coils (Plewes & Kucharczyk, 2012). The spins that were aligned 
parallel to B0 absorb energy from the RF pulse and tilt away from the Z-axis, into 
the transverse plane (Plewes & Kucharczyk, 2012). The spins that were aligned 
anti-parallel to B0 release energy and start to align parallel to B0 (Plewes & 
Kucharczyk, 2012). As a result, the spins precess in synchrony, or in-phase with 
each other, causing the net magnetisation to rotate 90° away from the longitudinal 
Z-axis, into the transverse X-Y plane (Figure 3.3-part B). The net magnetisation 
in this plane is referred to as transverse magnetisation and MXY (Plewes & 
Kucharczyk, 2012). In accordance with Faraday’s law of induction, where a 
changing magnetic field induces a voltage in a nearby conductor, it is the precession 
of net magnetisation during resonance that induces a small electrical current in the 
receiver coil, which forms the MR signal that is collected and reconstructed by the 
MR system’s computer to form the MR image (Hahn 1953; Sprawls, 2000). 
 
3.4.3 Relaxation processes 
The NMR signal resulting from the application of the RF pulse decays due to two 
simultaneously occurring, but independent relaxation processes, transverse 
relaxation (T2) and longitudinal relaxation (T1) (Currie et al., 2013). These 
processes are caused both by dipolar and non-dipolar effects by fluctuating 
magnetic fields, spin-spin interaction, and energy exchange between the spin and 
the molecular lattice (Bloembergen et al., 1948). Both T1 and T2 relaxations are 
central to forming contrast in images and are the key MR parameters studied for 
stroke timing in this thesis.   





Longitudinal relaxation or T1 relaxation is how rapidly the net magnetisation 
regrows along the longitudinal axis in the direction of B0 and is described by the 
time constant T1, which is the time (in milliseconds) for the net magnetisation to 
return to 63% of its original magnitude in a single exponential system (Plewes & 
Kucharczyk, 2012). Longitudinal relaxation occurs due to spins emitting the energy 
that was absorbed by the RF pulse to the surrounding molecular lattice (spin-
lattice interaction) (Deoni, 2010). Longitudinal relaxation is modelled as an 
exponential growth curve with the time constant T1, shown in Figure 3.4 and given 
by: 
𝑀 = 𝑀#	(1 − 𝑒)*/,-) 
 
Where M = magnetisation, M0 = longitudinal magnetisation, t = time and T1 is 
T1 relaxation time (ms).  
 
  
Figure 3.4 T1 recovery curve. 





Transverse relaxation or T2 relaxation is the loss of net magnetisation in the 
transverse plane due to dephasing of spins and is described by the time constant, 
T2, which is in milliseconds, the time in which transverse magnetisation drops to 
37% of its original size in a single exponential system (Plewes & Kucharczyk, 2012). 
Transverse relaxation is a random process and occurs due to the exchange of energy 
between neighbouring spins (spin-spin interaction, a dipolar effect) as well as non-
dipolar effects, such as exchange and diffusion. Individual spins move about and so 
experience small variations in their magnetic fields due to the presence of other 
spins, which causes slight differences in precessional frequencies, causing spins to 
fall out of phase (Deoni, 2010). Transverse relaxation is modelled by a simple 
exponential decay with a time constant T2, shown in Figure 3.5 and is given by:  
 
𝑀/0 = 𝑀#𝑒)*/,1 
 
Where M = magnetisation, M0 = longitudinal magnetisation, t = time and T2 is 
T2 relaxation time (ms).  
 
As discussed earlier in this Chapter (Section 3.3.1 on shim coils), the B0 field will 
never be perfectly homogenous due to susceptibility effects, and so the magnetic 
field strength will vary very slightly from one point of the body to another (Currie 
et al., 2013). These macroscopic magnetic field inhomogeneities cause further 
dephasing of spins, as the spins experience slightly different precessional frequencies 
with respect to each other. This dephasing of spins due to magnetic field 
inhomogeneities is sometimes referred to as T2 prime (T2’) but is usually 
acknowledged as T2* which is the combined dephasing due to T2 and T2’. T2* is 
always shorter or equal to T2 because it is the combined effects of natural effects 
(spin-spin interaction) and magnetic field variations (Figure 3.5) (Boulby & Gunn, 
2003; Deoni, 2010). Unlike T2, T2’ decay is not random and is potentially reversible 




(Currie et al., 2013). T2 is measured by the spin-echo method (Hahn, 1950), whereas 
T2* is measured by the gradient-echo method (Currie et al., 2013; Hahn 1960), 
which are outlined in Section 3.5 of this Chapter.  
 
 
As T1 and T2 relaxations result from molecular motion and interactions between 
spins, the rates of T1 and T2 are different for tissues with different densities (e.g., 
water content and mobility) (Deoni, 2010). For example, T1 is longer in tissues 
containing more free fluid because the spins move too rapidly for energy to be 
transferred back into the surroundings (McRobbie et al., 2006). The T2 relaxation 
rate depends on how much time an individual spin spends near neighbouring spins 
(Currie et al., 2013). For example, T2 is also longer in free fluids because spins 
continually move and interact with each other (Currie et al., 2013). It is these 
differences in T1 and T2 relaxation times between different tissue types that provide 
the contrast of the final image (see Section 3.6 of this Chapter) (McRobbie et al., 
2006). T1 is approximately five times longer than T2 in biological tissues, with the 
respective relaxation times ranging between 300-2000 ms and 30-150 ms at the 
typical clinical B0 (Currie et al., 2013).  
Figure 3.5 T2 decay curve. 




3.4.4 Free induction decay  
A radiofrequency signal (the NMR signal) is produced whenever there is transverse 
magnetisation (Sprawls, 2000). Immediately after the RF pulse, the free induction 
decay (FID) signal is produced, and its intensity is proportional to the extent of 
transverse magnetisation, which is greatest immediately after the RF pulse 
(Sprawls, 2000). As a result of dephasing, the detectable signal diminishes (Sprawls, 
2000). The FID has a constant frequency, and so takes the form of a sinewave 
which rapidly decays as both T1, and T2 relaxation processes occur (Figure 3.6) 
(Currie et al., 2013).  The FID is generated in the time-domain but is Fourier 
transformed to give a spectrum in the frequency-domain (Tofts & Waldman, 2003). 
The FID is not usually measured in MRI as it is disrupted by the magnetic field 
gradients used to localise and encode the MR signal (Currie et al., 2013). Therefore, 
the MR signal is usually generated and measured as a spin-echo (Hahn, 1950) or a 
gradient-echo (Hahn, 1960) and either spin-echo and gradient-echo pulse sequences, 
which are described in Section 3.5 of this Chapter, are the basis for most MRI pulse 
sequences (Elster, 1993).  
 
Figure 3.6 Free induction decay (FID). The transverse magnetisation is at its greatest following the 
90° RF pulse. As spins begin to lose phase coherence, its amplitude, along with the signal intensity 
decreases. The decay in the signal is the FID.  The Figure is reproduced from ‘Understanding MRI: 
basic MR physics for physicians’, Currie et al., volume 89, page 214, 2013, with permission from 
BMJ Publishing Group Ltd. (see Appendix D for permissions). 




 Pulse sequences 
Pulse sequences involve repeated cycles of a long list of RF pulses (for spin-echo) 
or gradient pulses (for gradient-echo), activation of gradients, and the collection of 
spin-echo and/or gradient-echo signals (Sprawls, 2000; Tofts, 2005). Different pulse 
sequences can be used to generate different strengths of signals and therefore, 
different types of MR image contrast (introduced in Section 3.6) depending on the 
purpose of the examination and tissue of interest. The resulting image depends on 
which RF pulses and gradients are applied, and when they are applied (Sprawls, 
2000). The main parameters that can be altered in a pulse sequence, include: 
 
- The excitation flip-angle (FA) which is the amount of rotation experienced 
by the net magnetic field in relation to the direction of B0 after application 
of the RF pulse (not to be confused with fractional anisotropy, which is also 
abbreviated as FA in MR research, but is a different concept). The size of 
the FA is determined by the strength and duration of the RF pulse 
(Sprawls, 2000). Most imaging methods use both 90° and 180° FAs, 
however, any size FA can be set (Sprawls, 2000). 
- The repetition time (TR), which is the amount of time in milliseconds 
between the application of two consecutive RF pulses and therefore the 
amount of time allowed for T1 relaxation to occur (Hendrick, 2005). 
- The echo time (TE) which is the amount of time in milliseconds between 
the middle of the RF pulse and the middle of the spin-echo and so is the 
amount of time that is allowed for T2 relaxation to occur (Hendrick, 2005). 
 
The pulse sequences used in the research Chapters are mainly based on spin-echo, 
but a combined gradient and spin-echo pulse sequence (GRASE) is also used in 
Chapters 7 and 8. Therefore, the spin-echo and gradient-echo pulse sequences are 
briefly outlined next. 




3.5.1  The spin-echo pulse sequence  
The spin-echo pulse sequence, which is illustrated in Figure 3.7, involves applying 
an additional 180° RF pulse after the initial 90° RF pulse, to refocus the spins and 
flip the net magnetisation back into the transverse plane (Plewes & Kucharczyk, 
2012). In the spin-echo pulse sequence, the magnetisation at the transverse plane 
is refocused by the 180° pulse to generate the spin-echo (Hahn, 1950). The signal 
is maximum when the spins are aligned, and signal loss occurs when the spins are 
dephased (Brown & Semelka, 2011).  
 
The refocusing pulses can be repeated several times after a single 90° RF pulse, in 
a multi-echo sequence, which involves repeated 180° RF pulses after a single 90° 
RF pulse (Figure 3.7) (Brown & Semelka, 2011). Each time the spins in the 
transverse plane are refocused, the signal from the spin-echo is always less than the 
previous spin-echo because the RF pulse only refocuses the dephasing due to 
magnetic field inhomogeneities (T2’) (Currie et al., 2013). The dephasing of spins 
due to spin-spin interaction is not refocused because it is an intrinsically irreversible 
process (Currie et al., 2013). 
 
There are different variations of the spin-echo sequences, depending on the scanner 
vendor, the imaging purposes, and the time allocated for scanning patients (Deoni, 
2010). The multi-echo T2 sequence is one of the main pulse sequences used in the 
research studies of the thesis. Generally, multi-echo sequences involve acquiring 
several weighted images from echoes produced at different user defined TE values 
with a static TR to give each image a different T2 weighting (Hendrick, 2005). 
  








Figure 3.7 T1, T2 and T2* relaxation. a. T1 recovery curve: plot of the recovery of 
longitudinal magnetisation overtime after the RF pulse is switched off. b. T2 recovery curve: 
a 180° RF pulse rephases spins, resulting in a temporary gain in signal intensity at time 
echo time (TE) termed spin-echo. A sequence of 180° RF pulses results in a chain of spin-
echoes. Each subsequent echo will be of lower intensity due to spin-spin interactions. The 
curve connecting the spin-echo intensities is the T2 decay curve. c. The T2* curve results 
when 180° RF pulses are not used, and the signal decays due to magnetic field 
inhomogeneities. The Figure is reproduced from ‘Understanding MRI: basic MR physics for 
physicians’, Currie et al., volume 89, page 213, 2013, with permission from BMJ Publishing 
Group Ltd. (see Appendix D for permissions). 
 
  




3.5.2 The gradient-echo pulse sequence 
Like the spin-echo pulse sequence, the gradient-echo pulse sequence also involves 
refocusing spins (Elster, 1993). However, instead of RF pulses, magnetic field 
gradients are applied to generate the echoes (Elster, 1993). In a spin-echo sequence 
the RF pulse is applied to rephase spins after being dephased by magnetic field 
inhomogeneities (T2’) and spin-spin interactions (T2) (described by T2*), whereas 
in a gradient-echo sequence, the spins are purposefully dephased by turning on the 
gradient, and then rephased by reversing the direction of the gradient (Sprawls, 
2000). When applied, the magnetic field gradient only refocuses spins that have 
been rephased by the gradient and not spins that are dephased by magnetic field 
inhomogeneity (Elster, 1993). Therefore, the signal in gradient-echo images is also 
influenced by T2* (Elster, 1993).  
 
In the patient studies in Chapter 7 and Chapter 8, one of the sequences used for 
the acquisition of T2 weighted images is the multi-echo GRASE sequence. The 
GRASE method (Gradient and Spin-Echo) is a combination of the gradient and 
spin-echo methods, which involves a train of 180° RF pulses to generate spin-
echoes, and for each spin-echo, there are additional gradient-echoes which are 
generated by rapidly switching the readout gradient polarity (Caruthers et al., 
1998). 
 
3.5.3 Localising the signal 
In order to map the signal to a spatial position, the origin of the signal must be 
isolated in three dimensions (X, Y, Z), using three separate magnetic field gradients 
for slice-selection, phase-encoding and frequency-encoding (Currie et al., 2013). 
Applying magnetic field gradients in the X, Y and Z directions in the same pulse 
sequence will mean that each voxel contains spins with different combinations of 
frequency, amplitude and phase, resulting in the spatial encoding of NMR signals 




(Westbrook & Roth, 2011). Ultimately, the signal echoes that are generated are 
digitised and stored in k-space, which is a 2D or 3D raw data matrix. A Fourier 
transform is applied to k-space to convert the signal information into an image 
(Currie, 2013; Plewes & Kucharczyk, 2012) 
. 
 MR image contrasts  
The NMR signals and the contrast of the resulting MR images are directly related.  
The MR image is a display of the NMR signal emitted from the tissue, where the 
brightness of the image indicates the strength of the signal (i.e., level of 
magnetisation) (Sprawls, 2000). The strength of the MR signal and therefore, the 
contrast in the resulting image, depends on the physical characteristics of the tissue 
being imaged, which influences the extent of magnetisation experienced (Sprawls, 
2000). The soft tissue contrast on conventional MR images arises from differences 
in the T1 and T2 relaxation properties and the number of detectable spins in the 
voxel, referred to as proton-density (PD) (Deoni, 2010). The contrast can be 
manipulated by altering the pulse sequence acquisition parameters outlined in 
Section 3.5 of this Chapter (Hendrick, 2005). The relationships between tissue 
properties (PD, T1 relaxation rate, T2 relaxation rate), MR signal intensity (i.e., 
extent of magnetisation experienced by the tissue) and resulting image contrast is 
summarised in Figure 3.8 (Sprawls, 2000).  
 
By selecting the appropriate pulse sequences and parameters, images can be 
weighted toward T1 or T2 relaxation times or PD (Elster, 1988), which means the 
primary contributor to the signal for PD weighted (Section 3.6.1), T1 weighted 
(Section 3.6.2) and T2 weighted (Section 3.6.3) will either be PD, T1 relaxation, or 
T2 relaxation respectively. However, it is important to note that although the 
contrast of images can be selectively weighted, T1, T2 and PD contribute to the 
signal of all weighted images to some extent (Deoni, 2010; Elster, 1988). For 
example, the signal obtained in a T2 sequence will predominantly be determined by 




the T2 relaxation time, and therefore contrast on T2 weighted images will reflect 
the relative T2 relaxation of tissue types; however, the signal that is produced is 
also partly influenced by T1 relaxation, and PD (Deoni, 2010; Elster, 1988). As will 
become evident throughout the course of this thesis, the combined influence of these 
intrinsic properties to the signals is one of the main (and often underappreciated) 
factors that contribute to variability in results across quantitative MRI based 
stroke timing studies (Rogers, McGarry et al., 2014; McGarry et al., 2016a).  
 
 
Figure 3.8 Summary of the relationships between signal intensities and the brightness of 
image contrast. Image is reproduced from Sprawls (2000). 
  




3.6.1 Proton-density weighted images 
In proton-density (PD) weighted images (Figure 3.9), the tissue contrast is 
dominated by the number of detectable spins/protons in the voxel. The tissues with 
the highest density of spins/protons produce the strongest signal and therefore 
appear brighter on the resulting image. Images that are PD weighted are collected 
with a short TE to minimise T2 contribution and a long TR to minimise T1 
contribution (McRobbie et al., 2006). PD images are not typically used in stroke 










3.6.2 T1 weighted images 
In T1 weighted (T1w) images (Figure 3.10), the T1 relaxation rate is the 
predominant contributor to the signal and therefore, the predominant source of 
tissue contrast. Tissues with a short T1 have the highest level of magnetisation, 
which produces a higher signal, and translates to brighter contrast in the resulting 
image (Sprawls, 2000). For example, grey and white matter have a shorter T1 
compared to CSF and appear bright on T1 weighted images. As CSF is a fluid, it 
has a long T1 and so the signal recovery slowly, resulting in fast signal loss and 
therefore dark appearance in T1 weighted images (Plewes & Kucharczyk, 2012).  
Figure 3.9 Example of a proton-density 
weighted image. 






T1w images are usually obtained with a spin-echo inversion recovery pulse sequence 
or a saturation recovery pulse sequence. The spin-echo inversion recovery sequence 
begins with a 180° inversion pulse to invert steady-state longitudinal magnetisation 
in the direction of the minus Z-axis, followed by the typical spin-echo sequence 
starting with a 90° pulse (Brown & Semelka, 2011). Saturation recovery sequences 
such as FLASH T1 (used in Chapter 5), involve multiple RF pulses so that 
magnetisation does not fully recover before the next pulse, hence saturation (Haase, 
1990). T1 weighting is achieved by setting a short TE to minimise the contribution 
of T2 to the signal. Also, by setting a TR that is short enough to capture the signal 
difference due to T1 relaxation before longitudinal magnetisation recovers fully 
(Plewes & Kucharczyk, 2012). The short TR ensures there is a low signal from 
regions with a long T1 relative to those with a short T1 (Plewes & Kucharczyk, 
2012). As will be explained in Chapter 4, Section 4.2.3, T1w images are not typically 
acquired for the assessment of acute ischaemic stroke patient, but they were 
acquired in Chapter 7 and Chapter 8 to aid with image processing.   
  
Figure 3.10 Example of T1 weighted images, in the axial, 
sagittal and coronal planes. 




3.6.3 T2 weighted images 
T2 weighted (T2w) images (e.g., Figure 3.11) can be acquired with spin-echo or 
gradient-echo pulse sequences. A long TE is used to ensure T2 is the predominant 
contributor to the signal. In the GRASE sequence, the weighting is mainly T2, but 
T2* also has some contribution (discussed in Section 3.5.2), which is an important 
factor in the interpretation of the results of Chapter 8. T2w images, where the signal 
and therefore, image contrast, is predominantly influenced by the T2 relaxation 
time, are obtained by setting a long TE and long TR (McRobbie et al., 2006). The 
contribution of T1 is minimised by setting a long TR to ensure magnetisation 
recovers fully (McRobbie et al., 2006). Additionally, the longer transverse 
magnetisation persists, the stronger the signal will be, resulting in brighter contrast 
(McRobbie et al., 2006). Thus, setting a long TE ensures the T2 decay of different 
tissue types is captured (McRobbie et al., 2006). Fluids, such as cerebrospinal fluid 
(CSF) have a long T2, and so have a stronger signal, which appears bright on T2 w 
images (McRobbie et al., 2006). Grey and white matter, which have a shorter T2 
appear darker on T2w images due to signal loss (McRobbie et al., 2006). T2* 
weighted images can be produced by using a gradient-echo sequence with relatively 
long TE (Plewes & Kucharczyk, 2012). 
 
Figure 3.11 Example of a T2 weighted image. 
 




3.6.4 T2 weighted FLAIR images 
T2w images can also be acquired where the signal from CSF is suppressed, in order 
to improve the contrast of other fluids. CSF suppression is achieved with a T2w 
fluid attenuated inversion recovery (T2w FLAIR) sequence (Hajnal et al., 1992), 
which has a long inversion time to null the signal from CSF (which has a long T1) 
as well as a long TE to give the image a T2 weighting. The T2 weighting and no 
signal from CSF result in images greater anatomical detail and lesion signal 
intensity than standard T2w images (Hajnal et al., 1992) and is, therefore, the 
preferred T2w sequence for imaging stroke patients. An example of a T2w FLAIR 
image is shown in Figure 3.12. 
 
 
3.6.5 Diffusion weighted images 
Diffusion weighted images (DWI) are arguably one of the most important MR 
images for studying acute ischaemic stroke as they reveal regions of the brain 
affected by ischaemia within minutes of stroke onset (Moseley, 1990). The reasons 
for which will be explained in Chapter 4 Section 4.2.1. An example of a diffusion-
weighted image from an acute ischaemic stroke patient is shown in Figure 3.13.  
Figure 3.12 Example of a T2 weighted 
FLAIR image. 
 




The contrast of diffusion-weighted images predominantly reflects the relative 
amount of diffusion (random thermal motion) of water molecules within the voxels 
(Hendrick, 2005). The diffusion-weighted pulse sequence (Stejskal & Tanner, 1965) 
first involves obtaining a T2w image with a spin-echo sequence with no diffusion 
weighting (b0, not to be confused with B0). This is followed by applying the pulsed 
gradient method which is a spin-echo sequence where two magnetic field gradients 
of the same magnitude but in opposing directions, are applied either side of the 
180° RF pulse (Baird & Warach, 1998). The first gradient causes spins to lose 
phase-coherence, and the second gradient causes spins to re-gain phase-coherence, 
provided that they are stationary during the time between the gradients (Baird & 





If water molecules are mobile, for example, in CSF, spins do not rephase due to 
fast translational motion, resulting in large signal loss, and therefore dark 
appearance on the resulting image (Baird & Warach, 1998). When water molecules 
are less mobile, such as in white matter, the signal is only slightly reduced, and 
contrast, therefore, appears bright on the image (Baird & Warach, 1998). The 
Figure 3.13 Example of a diffusion weighted 
image from an acute ischaemic stroke 
patient. 
 




diffusion-sensitising gradients are applied in one or more directions (e.g., X/Y/Z) 
to produce source images, which are averaged to produce the diffusion-weighted 
images used for clinical diagnosis (Baird & Warach, 1998). The strength and timing 
of the gradients in the pulse sequence are given by the b-value (secs/mm2). The b-
values can be set to produce optimal diffusion weighting for the tissue of interest, 
where higher b-values give more diffusion weighting, but also low signal to noise 
ratio (SNR) (Kingsley & Monahan, 2004). However, due to a relatively long TE 
needed to include diffusion gradients into the pulse sequence, diffusion-weighted 
images also have some T2 weighting, termed T2 shine through (Burdette et al., 
1999). Therefore bright contrast on the image could also reflect the presence of 
fluid, rather than decreased diffusion.  
 
 Quantitative MRI 
In a clinical setting, the assessment of the MR signal in weighted images (i.e., DWI, 
T1, T2, in Section 3.6) is almost always qualitative, and images are produced 
according to the scanner settings. Routinely, the radiographer or clinician will 
visually assess the images and can measure the volume of lesions or anatomical 
regions that are defined by the image contrast but will not extract information 
about the tissue properties from standard weighted images (Tofts, 2005). However, 
the MRI scanner is capable of providing much more information (Tofts, 2005). The 
concept of quantitative MRI (qMRI) merges the traditional visual assessment of 
MRI with the scientific process of measurement, where MRI is not only a ‘picture-
taking tool’ but also a scientific instrument (Tofts, 2005). qMRI is the main method 
of analysis used in the research Chapters of this thesis.  
 
The purpose of the quantitative approach to MRI, especially when informing 
clinical decisions, is to reduce problems of bias and low-interrater reliability which 
is often encountered when images are assessed visually (e.g., Galinovic et al., 2014). 
The goal of qMRI is, therefore, to transform MRI into a reliable, reproducible form 




of measurement that requires minimum human training or intervention (Tofts, 
2005). In any image acquired with MRI, each voxel is represented by a number, 
and as with any other area of scientific enquiry, qMRI, therefore, involves recording 
and measuring these numbers in the region of interest, to identify changes from the 
normal ranges (Tofts, 2005).  
 
The strength of the MR signal is influenced by PD, and T1 and T2 relaxation times 
of the imaged tissue. Due to differences in water content and paramagnetic 
properties, different tissues have distinct relaxation characteristics, which are 
altered differently by pathology (Deoni, 2010). Thus, by measuring the changes in 
the MR signal caused by changes in relaxation properties, pathologies such as 
ischaemic stroke can be identified, investigated, diagnosed and monitored (Deoni, 
2010). In stroke timing literature, many have adopted the quantitative approach 
to analysing MRI data (e.g., Cheng et al., 2013; Jokivarsi et al., 2010; Madai et al., 
2016; Siemonsen et al., 2009; Song et al., 2012) but these have taken two different 
forms.  
 
The first form is the quantitative analysis of the signal intensities represented in 
weighted images (Section 3.7.1) and the second, is the parametric approach to qMRI 
(Section 3.7.2), which involves mathematically parameterising MR signal intensities 
before measuring them and transforming them into parametric images/maps. In 
MRI stroke timing research, both quantitative approaches involve measuring 
changes in values obtained from MR images of ischaemic stroke patients, but, as 
will become apparent in the following Sections and remainder of the thesis, these 
approaches differ fundamentally in terms of what is being measured, and how 
informative and reliable they are. 
 




3.7.1 Quantitative analysis of signal intensities represented in 
weighted images  
In standard weighted imaging, each voxel has a signal value, which is an arbitrary 
number that represents the strength of the MR signal and determines the contrast 
of the final weighted image (Tofts, 2005). Voxels with strong signal have higher 
numbers than voxels with comparatively lower signal (Tofts, 2005). For example, 
in a T2w sequence, the signal of CSF is stronger than the signal of white matter 
(WM); therefore, voxels containing CSF will have comparatively higher numbers 
than voxels containing WM. CSF voxels will therefore appear hyperintense on the 
resulting weighted image. In weighted imaging, the values that are measured are 
referred to as the signal intensities as they are proportional to the signal voltage 
induced in the RF coil. By extension, signal intensities are also referred to as image 
intensities, as it is the intensity of the MR signal that determines the contrast of 
the image that is constructed from the signal data (Sprawls, 2000). 
 
The quantitative analysis of signal intensities, therefore, involves measuring the 
strength of the signal in a given voxel of weighted images (such as those shown in 
Section 3.6), where the measured signal is influenced by a combination of intrinsic 
tissue properties (PD, T1, T2) and factors related to MR hardware (e.g., B1, B0). 
As will be introduced in Chapter 4, these MR signal values increase in weighted 
images of ischaemic stroke patients due to hydrodynamic changes caused by 
ischaemia. Thus, a popular approach in clinical stroke research literature is to 
measure the changes in the MR signals displayed in the weighted images that would 
usually be used in the visual assessment of strokes, such as DWI, T2w, and T2w 
FLAIR images (e.g., Madai et al., 2016; Cheng et al., 2013; Song et al., 2012).  
 
A limitation of quantifying the signal intensities represented in weighted images is 
that the voxels of weighted images do not have a fixed tissue-specific numerical 
value (Rizzo et al., 2018). Even if the same patient is scanned in the same position, 
with the same pulse sequence in different sessions, the resulting image will appear 




identical, but the voxel intensity values will be different (Madabhushi & Udupa, 
2005; Rizzo et al., 2018). Having different voxel intensity values is not problematic 
when assessing the MR image visually. For example, when identifying the location 
of ischaemic tissue, the number assigned to each voxel is not important, so long as 
the affected region is visible to the viewer. However, arbitrary voxel values are 
problematic if the purpose of the MR scan is to objectively measure and quantify 
the physical changes caused by disease. If the voxel intensity values are different 
in the same patient on different occasions, then it would not be clear whether the 
measured difference was biological in origin, or due to hardware issues of the MR 
system.  
 
Arbitrary voxel values also have implications for clinical research. If different 
studies used MR systems with different hardware and software, the performance of 
the different qMRI parameters cannot be cross-compared, which makes it difficult 
to draw meaningful conclusions across studies. As will be pointed out in Chapter 4 
and the introduction of Chapter 5, one of the main problems in stroke timing 
research at present, is that there are many studies that have quantified MR signal 
intensities, but because they were performed at different sites with different MR 
hardware and software, results are not directly comparable. Therefore, identifying 
which approach is most appropriate for clinical use becomes extremely difficult.   
 
Furthermore, when developing a quantitative method for studying cerebral 
ischaemia, whether the purpose is onset time estimation (i.e., the chronological 
clock approach outlined in  Chapter 1) or evaluation of tissue status (i.e., the tissue 
clock approach outlined in Chapter 1), the thresholds used to identify ischaemia, 
and the diagnostic software that is developed, would need to be tailored for the 
specific MR system if signal intensities are used for onset time estimation. This is 
the current issue with the core-perfusion-mismatch methods for the tissue clock 
approach (highlighted in Chapter 1 and raised in further detail by Dani et al., 2011 
and Demeestere et al. 2020). From a clinical and research perspective, it would be 




more practical for methods and software to be universally applicable. For reasons 
that will be highlighted in the following Section, this may be more achievable if the 
parametric approach to quantitative MRI is adopted instead.    
 
3.7.2 The parametric approach to quantitative MRI 
The second qMRI based approach, also involves measuring voxel values of MR 
data, but first involves mathematically removing factors that contribute to the 
signal that are not of interest. For example, removing the influence of PD and T1 
relaxation from the signal of a T2w sequence, or removing the influence of T2 
relaxation from diffusion-weighted signals to eliminate the T2 shine through effect. 
The parametric approach to qMRI involves transforming signals that are obtained 
in weighted imaging sequences (e.g., DWI, T1, T2) into data that is parametric 
(Tofts, 2005). Thus, instead of measuring the arbitrary values associated with NMR 
signals (as explained in Section 3.7.1), tissue-specific properties can be measured 
(Deoni, 2010; Tofts, 2005). 
 
Converting MR signal data into parametric data involves fitting the signal 
intensities acquired during a weighted imaging sequence to equations that describe 
the parameter of interest (described later in this Section). The main parameters 
that are computed and measured in stroke research include the average T1 
relaxation time (measured in ms) and the average T2 relaxation time (ms). As well 
as the average diffusion rate of spins in the voxel, referred to as the apparent 
diffusion coefficient (ADC) which is typically measured in µm2/ms (Le Bihan et 
al., 1992). The computed parameters can also be used to construct parametric 
images or maps, which have the same anatomical distinctions as weighted images 
but are conceptually different (Tofts, 2005). As with weighted images, each voxel 
has a number, but for T1 maps, these numbers are in ms, representing the estimated 
average T1 of spins within the voxel, for T2 maps, the numbers obtained are the 




estimated average T2 of spins within the voxel, and for ADC maps, the numbers 
represent the average diffusion rate of spins within the voxel.  
 
The parametric approach to quantitative MRI overcomes the problems associated 
with the quantitative analysis of the signal intensities represented in weighted 
images (Section 3.7.1) but has received comparatively less attention in clinical 
stroke imaging, perhaps due to clinicians and researchers being unaware of good 
practice in the quantification of MRI images (Tofts, 2005). By computing 
parametric maps, the contributions of PD, T1, T2 and extraneous sources of signal 
such as magnetic field inhomogeneities, and variability in the scanner 
manufacturer’s RF hardware and pulse sequences, are separated out (Deoni, 2010). 
The parametric data and the maps that are produced are, therefore, essentially a 
purer form of their weighted counterparts (Deoni, 2019).  
 
This purer form of data has a number of advantages. The ability to separate all 
extraneous factors from the parameter of interest enables a more explicit 
interpretation of changes in the image intensities of the MRI data in relation to all 
physiology including normal and pathological factors (Deoni, 2010). As the MR 
relaxometric properties are sensitive to the local tissue and biochemical 
environments, measuring changes in these individual parameters, provides richer 
and more detailed information than the measurements of signal intensities from 
weighted images (Deoni, 2010). A further advantage is the consistency of 
parametric data (Deoni, 2010). Unlike the quantitative analysis of weighted images, 
parameterising MR signal data enables unbiased comparison of MRI data from 
different patients and imaging centres when identical acquisition methods are used 
(Deoni et al., 2008). This consistency between sites would be better for longitudinal 
studies as well as large scale clinical studies, where data from multiple sites are 
combined, as it would remove the need for complex, sophisticated normalisation 
techniques (Deoni, 2019). Consistency is also especially important for the clinical 
research Chapters in this thesis (Chapter 7 and Chapter 8) as the patient data was 
acquired from three different hospitals with different MR systems.   




Computation of T1 maps  
The computation of T1 relaxation times from MR signal data involves fitting signal 
intensity values obtained in a T1w sequence using different flip-angles (e.g., Deoni 
et al., 2004) or inversion times (e.g., Nekolla et al., 1992) on a voxel-wise basis to 
the respective T1 equations. For example, the traditional computation of T1 maps 
using T1w images with different inversion times involves fitting the signal data to 
the expression below: 
𝑆(𝑇𝐼) = 𝑆#	(1 − 2	𝑒
),6,-	) 
 
Where S(TI) is the signal measured at time TI (inversion time) which is 
proportional to the Z magnetisation at the time, S0 is the signal that would be 
acquired from the equilibrium longitudinal magnetisation (M0) (Gowland and 
Stevenson, 2003).  
 
By converting voxel values into T1 relaxation times, T1 maps or images can be 
constructed. These parametric maps are not the same as T1w images. Voxels in a 
T1 map represent the average estimated T1 relaxation time of spins within that 
voxel, independent of PD and T2 relaxation (Deoni, 2010). In T1w images, regions 
with long T1 have a dark contrast because of the signal loss and regions with a 
short T1 have bright contrast because of the stronger signal. Whereas in T1 maps, 
the contrast is opposite because it is determined by the measured values in ms. 
Thus fluids, which have a long T1 relaxation time, appear bright on T1 maps. 
Voxels with a short T1 appear dark. Examples of a T1 map and a T1w image are 
shown alongside each other in Figures 3.14 and 3.15 (respectively) to demonstrate 
the difference in contrast.    













Figure 3.14 Example of a T1 relaxation time 
map. 
Figure 3.15 Example of a T1 weighted image. 




Computation of T2 maps 
In order to quantify the T2 relaxation time, and compute a T2 map, the signal 
values acquired with different TEs (from the multi-echo T2 sequence, see Section 
3.5) and static TR are fitted on a voxel-wise basis typically to a single exponential 
function (Deoni, 2010; Tofts, 2005):  
 
𝑆(𝑇𝐸) = 𝑆#	𝑒),8/,1 
 
Where S0 is the proton-density, and TE is the echo time (Milford et al., 2015).  
 
By converting voxel values into T2 relaxation times, T2 maps or images can be 
constructed (Figure 3.16). As with T2 weighted images, fluids, such as CSF have a 
long T2 relaxation time and so appear bright on T2 maps. Although the tissue 
contrast is similar, T2 maps are parametric and are not the same as T2w images. 
Voxels in a T2 map represent the average estimated T2 relaxation time of spins 
within that voxel, independent of PD, T1 relaxation and magnetic field 
inhomogeneities (Deoni, 2010). 
 
Figure 3.16 Example of a T2 relaxation 
time map. 




Computation of apparent diffusion coefficient maps  
The parametric approach can also be applied to diffusion data. Apparent diffusion 
coefficient (ADC) maps are the parametric images that are computed from the 
signal values obtained from a diffusion-weighted sequence which is achieved by 
performing a voxel-wise fit of at least two diffusion-weighted images with different 
b-values (b, high and low). The ADC map can be computed by dividing the signal 
from the diffusion-weighted image (SDWI) by the signal (S0) from the corresponding 
points on the b0 image and taking the logarithms (Schaefer et al., 2000), where: 
 







ADC maps, or images, are not the same as diffusion-weighted images. In DWI, 
restricted diffusion is represented by higher signal values, and so regions with 
decreased diffusion, such as ischaemic tissue appears bright (Figure 3.17). Whereas 
voxels in an ADC map correspond to the mean estimated diffusion rate, commonly 
given in µm2/ms. Thus, in contrast to DWI, as regions with restricted diffusion 
have low ADC values, they appear dark on ADC maps (Figure 3.18). Fluids have 
high diffusion and therefore high ADC values, which appear bright on ADC maps 
(Le Bihan et al., 1992). By computing the ADC maps, T2 shine through is 
effectively eliminated as the contribution of T2 to the signal is removed (Le Bihan 
et al., 1992). Therefore, ADC images reflect only the diffusivity of different tissue 
types (Le Bihan et al., 1992). 
 





Figure 3.17 Example of a diffusion weighted image 
from an acute ischaemic stroke patient. 
 
Figure 3.18 Example of an ADC map from the 
same acute ischaemic stroke patient in Figure 
3.17. 




3.7.3 Magnetic resonance fingerprinting (MRF) 
Throughout this thesis, an MR acquisition technique, termed magnetic resonance 
fingerprinting (MRF) (Ma et al., 2013, Siemens Healthcare Limited, 2020) is often 
referred to. Most clinical MRI scanners can compute parametric maps 
automatically, but MRF enables these parametric maps to be obtained 
simultaneously, which reduces the total scan time to a few minutes (Ma et al., 
2013). MRF involves under sampled acquisition with varying FAs, TRs and TEs, 
to extract multiple quantitative tissue parameters from a single scan (Siemens 
Healthcare Limited, 2020). This acquisition approach causes tissues to make unique 
signal patterns of data that are recorded as fingerprints, whicch reflect the tissue 
composition (Siemens Healthcare Limited, 2020). These fingerprints are matched 
to an existing library or database of possible fingerprints using pattern recognition 
and when there is a match, the matching tissue properties are identified and given 
in a parametric map (Siemens Healthcare Limited, 2020). Using MRF there is no 
need to fit an exponential curve (as described in Section 3.7.2 of this Chapter) and 
multiple types of quantitative data (e.g., T1 relaxation, T2 relaxation, ADC) can 
be acquired at the same time. This fast acquisition makes MRF as quick as NCCT 
and therefore tolerable for unstable acute ischaemic stroke patients. Currently MRF 
is for research use only (Siemens Healthcare Limited, 2020), but if eventually 
incorporated into hospital MRI scanners, MRF would enable clinicians to utilise 
the benefits of qMRI parameters (such as those that are studied in this thesis) to 
aid their diagnoses and treatment decisions.  
 
 Summary and clarification of qMRI terminology  
In the stroke timing literature that is reviewed over the course of the remaining 
Chapters, there is a lack of consensus over terminology in the context of qMRI.  
The purpose of this Section is to provide some clarification over the terminology 
used throughout this thesis.  
 




As outlined in Section 3.7. of this Chapter, generally, the term quantitative MRI is 
used as an overarching term for two different quantitative approaches to MR data 
analysis. One popular approach is to measure the signal intensities of voxels that 
are represented in weighted images that would typically be used in the visual 
assessment of stroke (Section 3.7.1). The other approach, which has received 
comparatively less attention in stroke timing literature, involves parametrising the 
MR signal data so that parameters of interest such as diffusion, T1 relaxation and 
T2 relaxation can be measured separately (Section 3.7.2). Both approaches involve 
measuring voxel values, which are either arbitrary numbers that represent the 
intensity of the MR signal, or separate properties of the MR signal (i.e., relaxation 
or diffusion).  
 
The terminology associated with the of the type of data that is quantified in stroke 
timing literature can also be confusing and misleading. Both quantitative 
approaches do not require an image for the analysis, because it is the numbers 
associated with each voxel that are being studied (i.e., signal intensity value or 
relaxation time in ms). However, the signal data is loosely represented by the 
contrast of the reconstructed images (i.e., weighted image or parametric map). As 
clinical MRI traditionally involves looking at images, the quantitative values that 
are measured in both approaches are often referred to in the context of the images 
that represent them. For example, the image intensity values of weighted images 
or the image intensity values of T2 relaxation time images/maps. 
 
For consistency, the term image intensity value is used in this thesis to refer to 
signal intensity values that are represented in weighted images, as well as the 
relaxation times and ADC values obtained from relaxometry and ADC maps 
respectively. The term qMRI parameters is also used to refer to the different types 
of image intensity values, for example, T2w image intensities, or T2 relaxation time 
intensities. The reference to images in the context of qMRI also highlights the 
importance of MR images in studying stroke. qMRI is beneficial because it allows 
us to delve deeper into the changes in the brain caused by ischaemia and to measure 




the changes that are not visible by eye (Deoni, 2010; Tofts, 2005), however, the 
images are still important for contextualising and anatomically locating these 











                           
MRI for the Imaging of Acute 
Ischaemic Stroke  
 
 Introduction 
The purpose of this Chapter is to show how MRI can be used to study the 
pathophysiology of cerebral ischaemia and to contextualise the research studies in 
this thesis. The Chapter is split into two Sections. The first Section relates the 
different MR images and qMRI parameters to different aspects of stroke 
pathophysiology. The second Section explains the main approaches to timing the 
ischaemic stroke using MRI, with a brief overview of the relevant research and the 
rationale for the approaches studied in this thesis. The summary of previous 
research is kept brief because the stroke timing research is also considered in the 
introductions and discussions of the research Chapters (5, 7 and 8). The Chapter 
ends with an explanation of the rationale for the methods studied in this thesis, 
and recognition of potential alternative methods for applying qMRI to the problem 
of unknown onset time. 
  




 MRI and stroke pathophysiology 
Different MRI pulse sequences can be used to capture different aspects of stroke 
pathophysiology (Kauppinen, 2014). There is a consensus that in the clinical stroke 
centres where MRI is used, at the very least, diffusion-weighted (DWI), T2 weighted 
(T2w), T2w fluid-attenuated inversion recovery (T2w FLAIR) images and T2* 
weighted images (for identification of haemorrhage) should be obtained (Mair & 
Wardlaw, 2014). Therefore, except for T2*, these images were acquired for the 
studies of this thesis, with the addition of T1 weighted images (T1w), and the 
parametric counterparts of the weighted images, including the apparent diffusion 
coefficient (ADC) maps, T2 relaxometry maps (Chapters 5, 7 and 8) and T1 
relaxometry maps (Chapter 5). Throughout this Section, the reader is referred to 
Figure 4.9, which illustrates how the stages of ischaemia and the different forms of 
oedema relate to different MR images.  
 
4.2.1  Diffusion images 
As outlined in Chapter 3 (Section 3.6.5), diffusion is the random thermal motion 
of free water molecules within tissue (Le Bihan et al., 1992) and images acquired 
using diffusion sequences portray the diffusivity of water in the parenchyma in the 
imaged voxel (Le Bihan et al., 1992). Two types of diffusion images are used in the 
assessment of acute ischaemic stroke and studied in this thesis, diffusion-weighted 
images (Section 3.6.5) and the parametric counterpart, the apparent diffusion 
coefficient (ADC) maps (Section 3.7.2). Diffusion based images are essential in the 
MRI protocol for ischaemic stroke patients because they reveal the affected regions, 
that would not otherwise be identifiable on non-diffusion images, within minutes of 
ischaemia onset (Moseley et al., 1990). Diffusion images are, therefore, sensitive 
diagnostic tools for acute ischaemic stroke (Moseley et al., 1990).  
 
 




Diffusion weighted images (DWI) 
Figure 4.1 is an example of a diffusion weighted image of a hyperacute ischaemic 
stroke patient. Within minutes of ischaemia onset, the DWI signal increases, due 
to the decreased diffusion that is attributed to cytotoxic oedema (i.e. shift of 
extracellular water into the intracellular space, Figure 4.9-partA) (Moseley et al., 
1990). As fluid shifts from extracellular to intracellular space, the extracellular 
space becomes smaller, which reduces the mobility of total tissue water (Moseley 
et al., 1990) (Figure 4.1-part A). However, unless considered alongside T2 w images 
or ADC maps, the pathological underpinnings of hyperintensities on DWI images 
are difficult to separate from each other due to T2 shine through (i.e. whether 




The apparent diffusion coefficient maps (ADC) 
Figure 4.2 shows the ADC map of the same ischaemic stroke patient in Figure 4.1 
The ADC map is the parametric counterpart of the diffusion weighted image and 
as outlined in Chapter 3 (Section 3.7.2), is computed from the values obtained from 
the diffusion weighted sequence. As with DWI images, ADC maps are useful for 
Figure 4.1 Example of a diffusion weighted 
image from an acute ischaemic stroke patient. 




the diagnosis of ischaemic stroke as the ADC value decreases within minutes of 
ischaemia onset (Hoehn-berlarge et al., 1995). The contrast of ADC maps is 
determined by the ADC values of the tissue. Therefore, ischaemic regions are visible 
as hypointensities on ADC maps, where voxels have low ADC values due to 




As discussed in Chapter 3 (Section 3.7.2), ADC is a purer measure of diffusion than 
diffusion weighted sequences as by computing ADC maps, the contribution of T2 
shine through is eliminated. Therefore, regions with low ADC values mainly reflect 
cytotoxic oedema and therefore, potentially salvageable tissue (Fiehler et al., 2002; 
McGarry et al., 2016a, Rogers, McGarry et al., 2014). The main benefit of 
computing ADC maps is that ischaemia can be consistently and automatically 
identified. The ADC values of hyperacute ischaemic tissue typically fall within the 
range of 0.14 – 0.50 µm2/ms compared to 0.74 – 0.84 µm2/ms in healthy tissue. 
These values are independent of field strength and scanner characteristics (Sener, 
2001) and so can be used detect ischaemia automatically using thresholding 
techniques (e.g., Knight, Damion, McGarry et al., 2019; Straka et al., 2010). 
 
Figure 4.2 Example of an ADC map from an 
acute ischaemic stroke patient. 




4.2.2 Images based on T2 relaxation contrast  
There are three different types of T2 images that can be acquired for assessment of 
ischaemic stroke; including T2w images (Section 3.6.3), T2w FLAIR images (Section 
3.6.4) and T2 relaxation time maps (Section 3.7.2). The T2 relaxation time is the 
main contributor to the contrast of T2w images and T2w FLAIR images and the 
only contributor to the contrast of T2 relaxation time maps. T2 is particularly 
sensitive to ischaemic stroke, as it changes concomitantly with changes in water 
content, and therefore changes in T2 reflect both ionic and vasogenic oedema.   
 
Preclinical animal research has shown that the T2 relaxation time changes almost 
instantaneously after the onset of ischaemia, showing an initial shortening due to 
the negative blood oxygen level-dependent (BOLD) effect, whereby the 
compensatory increase of oxygen extraction from the blood due to graded CBF 
reduction, causes higher concentrations of deoxyhaemoglobin (Gröhn et al., 1998). 
The paramagnetic properties of iron in deoxyhaemoglobin cause faster T2 decay 
(Gröhn et al., 1998; Thulborn et al., 1982). The T2 shortening is followed by a 
pseudo-normalisation of T2 as oedema advances, and a subsequent linear increase 
over time due to the accumulation of water from vasogenic oedema  (Gröhn et al., 
1998) accompanied by the breakdown of cytoplasmic macromolecules, explained by 
the cytotoxic oedema – dissociation model (CED model)(Knight, McGarry, et al., 
2016). Regions with an increase in T2, therefore, reflects either tissue that is at risk 
(cytotoxic oedema) or that is irreversibly damaged (vasogenic oedema) (Gröhn et 
al., 1998; Kato et al., 1985). As will be explained in Section 4.4 of this Chapter, the 
linear increase of T2 relaxation times with time from ischaemia onset, also makes 
it a suitable parameter for estimating stroke onset time (Jokivarsi et al., 2010; 
Siemonsen et al., 2009).  
  




T2 weighted images (T2w) 
As described in Chapter 3, Section 3.6.3, T2w images are acquired using a spin-
echo pulse sequence, with a relatively long TE and the T2 relaxation time is the 
predominant contributor to the signal. Visually, T2w images are insensitive to early 
ischaemic changes, and changes caused by stroke may not be visible for many hours 
after onset. For example, the T2w scan in Figure 4.3 is of a patient who was scanned 
seven hours after symptom onset. This patient had a confirmed ischaemic stroke 
(visible in the DWI and ADC images of the same patient in Figures 4.1 and 4.2 
respectively and Figure 4.9-part C), but there are no visible changes in the 




As will be seen in Chapter 8, the insensitivity of T2w images to early ischaemia is 
useful for segmenting ADC defined ischaemic regions so that ischaemic grey and 
white matter can be studied separately. Additionally, Knight, Damion, McGarry 
et al. (2019) have recently shown that the intensity of T2w images is useful for 
estimating pre-ischaemic T2 relaxation time values, which, as will become apparent 
throughout the course of this thesis, is an important component of MRI based 
methods for stroke timing. Eventually, in much later hours or days after onset, 
Figure 4.3 Example of a T2 weighted image 
from an acute ischaemic stroke patient. 




hyperintensities on T2w images reveal regions with long T2 due to increased water 
content and therefore show regions affected by vasogenic oedema (Figure 4.9-part 
C). Typically, the clinical purpose of T2w images is to identify and determine the 
extent of irreversibly damaged tissue in the days following stroke onset (Burgess & 
Kidwell, 2011).  
 
T2 weighted FLAIR (T2w FLAIR)  
An example of a T2w FLAIR image, from the same patient as Figures 4.1, 4.2 and 
4.3 is shown in Figure 4.4. The T2w FLAIR sequence nulls the signal from CSF in 
order to produce greater anatomical detail and lesion signal intensity than standard 
T2w images (Hajnal et al., 1992). This is evident by comparing the FLAIR and 
T2w images in Figure 4.9-part C. T2w FLAIR is, therefore, the preferred T2w 
sequence for imaging stroke patients. T2w FLAIR image hyperintensities are 
commonly considered to reveal irreversibly damaged tissue due to increased water 
content caused by ionic oedema (subtle hyperintensities) and vasogenic oedema 
(clear hyperintensities) (Thomalla et al., 2011). As will be introduced in Section 
4.4.2 of this Chapter, T2w FLAIR images can be assessed visually alongside DWI 
images to identify patients that may be within the 4.5 hour thrombolysis treatment 
window (Thomalla et al., 2011). 
Figure 4.4 Example of a T2 weighted FLAIR 
image from an acute ischaemic stroke patient. 




T2 relaxation time parametric maps  
As discussed in Chapter 3, Section 3.7.2, T2 relaxometry maps are not the same as 
T2w images. Figure 4.5 is an example of a T2 map from the same ischaemic stroke 
patient in Figures 4.1, 4.2, 4.3 and 4.4. T2 relaxation time maps are parametric, 
and so voxels in a T2 map represent T2 relaxation times, independent of proton-
density and T1 relaxation (Deoni, 2010). Due to the small dynamic range of T2 
relaxation times across the brain (Wansapura et al., 1999), the changes in T2 are 
not generally visible on standard T2 maps in the early hours of ischaemia (see 
Figure 4.9-parts A, B and C) (Rogers, McGarry et al. 2014). Therefore, to detect 
these early changes, the ischaemic region must first be identified with a diffusion-
based image (i.e., DWI or ADC). T2 relaxation time maps are not currently used 
in clinical settings; however, all scanner vendors can produce these automatically 












Figure 4.5 Example of a T2 relaxation time 
map from an acute ischaemic stroke patient. 




4.2.3 Images based on T1 relaxation contrast  
The T1 relaxation time is the main contributor to the contrast of T1w images and 
the only contributor to the contrast of T1 relaxation time maps. Preclinical studies 
have shown T1 relaxation times increase within minutes of ischaemia onset 
(Calamante et al., 1999; Kettunen et al., 2000) due to factors such as compromised 
CBF (Kettunen et al., 2000), water accumulation (Barbier et al., 2005; Kato et al., 
1985) and temperature drop (Kauppinen, 2014). T1 shows a two-phase response to 
ischaemia which involves a rapid increase followed by a steadier increase over time 
(Calamante et al., 1999; Kettunen et al., 2000). 
 
T1 relaxation time parametric maps  
As with T2 relaxometry maps, changes in T1 relaxation times in the early hours of 
ischaemia are not visible on relaxometry maps (Figure 4.6), and so ischaemic 
regions must first be identified with a diffusion-based image (DWI or ADC). T1 
relaxometry maps are not currently used in the assessment of acute ischaemic 
stroke, but as will be discussed in Chapter 5, preclinical studies suggest the T1 
relaxation times may be informative of stroke onset time and tissue status 
(Kauppinen, 2014; McGarry et al., 2016a; Rogers, McGarry et al., 2014).  
 
In this thesis, T1 relaxation time maps were computed in the preclinical study in 
Chapter 5 but were not acquired in the patient studies in Chapter 7 and Chapter 
8, due to previous difficulties accurately computing T1 maps from patient scans 
(McGarry, 2015). Figure 4.6 is an example of a T1 map computed from T1w images 
acquired at multiple flip angles, from an ischaemic stroke patient scanned five hours 









Figure 4.7 Example of a T1 relaxation 
time map from an acute ischaemic stroke 
patient. 
Figure 4.6 Example of a T1 weighted 
image from an acute ischaemic stroke 
patient. 




T1 weighted images (T1w) 
An example of a T1w image is shown in Figure 4.7. Ischaemic tissue is typically 
isointense on T1w images within the first six hours of ischaemia onset (e.g., Figure 
4.9-parts A, B and C) but will become visible as hypointensities (e.g., Figure 4.9-
part D) within sixteen hours due to the signal loss caused by the long T1 relaxation 
of the accumulated fluid (i.e., vasogenic oedema) (Allen et al., 2012). Therefore, 
T1w images are commonly considered not to be useful in the assessment of 
hyperacute ischaemic stroke (Wardlaw et al., 2013). However, isotropic volumetric 
3D T1w images are recommended for research purposes as sequences such as 
MPRAGE (magnetisation-prepared rapid gradient-echo) (Mugler & Brookeman, 
1991) produce images with clear anatomical distinctions (e.g., Figure 4.8), that can 
be used to co-register other images to and determine precise locations of interest 
(Wardlaw et al., 2013).  
Figure 4.8 Example of a T1 weighted image acquired with 3D MPRAGE. The Figure 
illustrates the great anatomical detail that can be acquired with a T1 weighted sequence. 
  




   Summary of the relationships between 
pathophysiological and MR changes during acute 
ischaemic stroke  
Figure 4.9 provides an illustrative summary of the relationship between different 
stages of oedema in the ischaemic brain and how they appear on MR images. This 
Figure and the following summary are intended as a rough guide to the 
relationships between changes in different MR signals and the pathophysiological 
changes in the ischaemic brain. It must be noted that there are no definitive time 
points for each specific stage of oedema, as the rate of development is a highly 
heterogeneous process which is specific to each patient. Therefore each stage, 
marked by different coloured boxes, is a rough indication of what the different 
stages oedema may look like and the approximate time frame in which the changes 
on the different images become visible. Each coloured box contains a set of MR 
images from a different ischaemic stroke patient at different times from symptom 
onset.   
 
A. DWI and ADC reveal cytotoxic oedema: within minutes of stroke onset, 
ischaemic brain tissue undergoes cytotoxic oedema. The cellular swelling associated 
with cytotoxic oedema, means fluid in the tissue becomes less diffuse than normal. 
Thus when a diffusion-weighted sequence is used, the MR signal from the ischaemic 
tissue is high, and so appears bright on diffusion-weighted images. ADC values of 
ischaemic tissue are lower than normal brain tissue, and so ischaemic regions 
undergoing cytotoxic oedema are displayed as dark in ADC maps. Because there is 
not yet an increase in tissue water content, there are no visible changes in 
corresponding T2w images, T2w FLAIR images, T2 relaxation time maps or T1w 
images. The images in section A. are from a 49-year-old male patient with lacunar 
stroke (LACS), who was not thrombolysed and was scanned two hours and 55 
minutes after symptom onset.   
 




B. Over subsequent hours, ionic oedema develops: at this stage, water is 
still less diffuse than normal, but there begins to be a subtle increase in total tissue 
water content due to ionic oedema. As fluids have long T2 relaxation times, these 
regions have a stronger signal, and therefore start to become subtly visible on T2w 
images and T2 relaxometry maps. These changes are not yet visible on T1w images. 
The images in this section are from a 73-year-old male ischaemic stroke patient 
scanned five hours and 34 minutes after symptom onset, with partial anterior 
circulation stroke (PACS), who had been thrombolysed prior to the MRI scan.  
 
C. After approximately 4.5 hours, vasogenic oedema develops: the blood-
brain barrier breaks down, causing an increase in tissue water content. 4.5 hours is 
given in brackets as this is a rough estimate, and it is difficult to give precise 
timings. In the scans of the patient shown, the increase in water content is not 
visible on the T2w images, but is distinctly visible on the FLAIR image, 
demonstrating why T2w FLAIR images are prefered over standard T2w images 
when examining acute ischaemic stroke patients. The changes are also not visible 
on the T2 map or T1w images. The images in this section are from 56-year-old male 
ischaemic stroke patient with PACS, scanned six hours and 50 minutes after 
symptom onset and had received thrombolysis before MRI.  
 
D. Within days and weeks following ischaemia onset a fluid-filled cavity 
remains: this is visible on diffusion-weighted images as hyperintensities due to T2 
shine through. In contrast to the acute stages, the affected region is also 
hyperintense on the ADC image, reflecting the high diffusivity of water. The 
affected region is also visible as hyperintense on T2w images and T2 maps. A FLAIR 
scan was not available for this patient. The images in this section are from a male 
acute ischaemic stroke patient (age not recorded) with LACS, scanned three days 
after symptom onset and who had received thrombolysis as part of their treatment.  

























































































































































































 Estimating stroke onset time with MRI 
The purpose of this Section is to contextualise the research Chapters of this thesis. 
The Section begins by introducing the supervised machine learning approaches that 
are used followed by an outline of the qualitative and quantitative MRI (qMRI) 
based stroke timing methods that have been proposed in the stroke imaging 
literature and the relevant studies. Next, a schematic illustration and further 
description of the two main quantitative approaches are provided to show how they 
relate to each other. This Section ends with an explanation of the rationale for the 
methods studied in this thesis, and recognition of potential alternative methods for 
applying qMRI to the problem of unknown onset time.  
 
4.4.1 Supervised machine learning and stroke timing  
The study of stroke onset time estimation using qMRI has predominantly taken a 
supervised machine learning approach, which is also adopted in the research 
Chapters of this thesis. Supervised machine learning involves developing algorithms 
that computers can use to extract patterns from existing data to generate predictive 
models that can be applied to new data (Kelleher & Tierney, 2018). Stroke timing 
studies, therefore, involve collecting MRI data from acute ischaemic stroke patients 
with a known time of symptom onset in order to develop a predictive model that 
estimates whether a patient with unknown onset time is within the rtPA treatment 
window.  
 
Within the stroke timing literature, there are two main approaches to estimating 
stroke onset time using supervised machine learning. The method that has mainly 
been adopted in clinical research studies is to regard unknown onset time as a 
binary classification problem (e.g. Madai et al., 2016; McGarry et al., 2016b; Song 
et al., 2012; Thomalla et al., 2009; 2011). The binary approach aims to predict 
whether the patient is in one of two classes, either within or beyond the 4.5 hour 




rtPA treatment window. This binary approach has been adopted for both visual 
(Thomalla et al., 2009; 2011) and quantitative based MRI methods (e.g. Madai et 
al., 2016; McGarry et al., 2016b; Song et al., 2012) which are discussed in Sections 
4.4.2 and 4.4.3  of this Chapter respectively (note, the visual based binary method 
is not a machine learning technique as no computation is involved, but the same 
principles apply). The overall ability of binary approaches is typically assessed by 
calculating levels of specificity and sensitivity (described in Appendix A). A binary 
classification model with high specificity is essential to identify patients that are 
beyond the treatment window and would, therefore be at greater risk of harm by 
thrombolysis. High sensitivity is also imperative to identify as many patients as 
possible that could be eligible for thrombolytic therapy.  
 
The second supervised machine learning approach, which has mainly been adopted 
in the preclinical research context, has involved developing predictive regression 
models that could estimate the time in minutes since ischaemia onset by inserting 
a measured qMRI parameter into the predictive model (Jokivarsi et al., 2010; 
McGarry et al., 2016a; Rogers, McGarry, et al., 2014). The overall ability of 
regression models for estimating stroke onset time can be evaluated by comparing 
the strength of the relationship between the qMRI parameter and time from 
ischaemia onset (R2) and calculating the root mean square error (RMSE), which 
indicates the uncertainty of onset time estimations in ± minutes.  
 
Both the binary and regression-based approaches rely on the observations that the 
MR signals in ischaemic tissue increase in a time-dependent manner (e.g., Jokivarsi 
et al., 2010; Madai et al., 2016; Rogers, McGarry & McGarry, 2014).  For example, 
the T2 relaxation time, which is the main contributor to signal in T2w images, and 
a measurable parameter in T2 maps has been shown to increase linearly with time 
from ischaemia onset in rats (e.g., Gröhn et al., 1998; Jokivarsi et al., 2010). In 
principle, a patient would be eligible to be considered for IV rtPA if they are 
classified as within the 4.5 hour treatment window, or if the estimated time from 
stroke onset is less than 270 minutes. Both the binary and regression-based 




approaches to estimating stroke onset time are studied in the research Chapters of 
this thesis.  
 
4.4.2 The visual based DWI/FLAIR mismatch method for stroke 
timing   
Clinical studies investigating MRI for timing the ischaemic stroke have mainly 
focused on the binary, visual based DWI/FLAIR mismatch approach (Thomalla et 
al., 2009; 2011). The DWI/FLAIR mismatch is in keeping with the traditional 
approach to MRI, where the radiographer or clinician visually assesses the images 
and is not a machine learning approach as it does not involve computer based 
predictive modelling. According to the DWI/FLAIR mismatch approach, a patient 
is classified as within the 4.5 hour treatment window if they have a DWI/FLAIR 
mismatch, where ischaemic tissue is visible on diffusion weighted images (DWI +) 
but is isointense on T2w FLAIR images (FLAIR -) (Thomalla et al., 2011). A 
patient is classified as beyond the treatment window if they have a DWI/FLAIR 
match, where ischaemic tissue is hyperintense on both DWI and FLAIR scans (DWI 
+ and FLAIR +) (Thomalla et al., 2009, 2011). Examples of match and mismatch 
cases are shown in Figure 4.10.  
 
The mismatch indicates tissue has undergone cytotoxic oedema due to hyperintense 
DWI but may still be salvageable because it has not evolved into vasogenic oedema, 
due to isointense FLAIR signal in the same region (Thomalla et al., 2009, 2011). 
The match indicates that the ischaemic tissue that is hyperintense on the DWI 
scan has undergone irreversible damage, because it is also hyperintense on the T2w 
FLAIR scan (Thomalla et al., 2009, 2011). The reflection of the mismatch criteria 
for the indication of tissue salvageability and short ischaemia duration is supported 
by histological studies (Baird & Warach, 1998).  
 




The DWI/FLAIR mismatch approach to stroke timing is appealing for clinical 
settings because of its perceived simplicity. The method involves viewing the images 
and does not require post-processing or mathematical calculations (Wouters et al., 
2014). The DWI/FLAIR mismatch has also consistently been shown to have high 
specificity, and so successfully identifies the majority of patients that are beyond 
the treatment window (Etherton et al., 2018; Wouters et al., 2014). Recently, the 
WAKE-UP trial revealed patients with unknown onset given IV rtPA on the basis 
of the DWI/FLAIR mismatch showed improved outcome compared to those given 
placebo (Thomalla et al., 2018). This result suggests that DWI/FLAIR mismatch 
is a promising method for reducing the problem of unknown onset time (Thomalla 
et al., 2018).  
 
Figure 4.10 The qualitative, visual based DWI/FLAIR mismatch approach to onset time 
estimation. A. The patient is classified as within the 4.5 hour treatment window for IV 
thrombolysis if they show a DWI/FLAIR mismatch, where ischaemic tissue (indicated by 
yellow arrows) is visible on the diffusion weighted image (DWI +), but is not visible in the 
same region on the FLAIR image (FLAIR -). B. The patient is classified as beyond the 4.5 
hour treatment window for IV thrombolysis if they show a DWI/FLAIR match (where 
ischaemic tissue (indicated by orange arrows) is visible on DWI (DWI +) and FLAIR 
(FLAIR +). 




Although encouraging, the results of the WAKE-UP trial are not necessarily 
translatable to all clinical settings and presentations of stroke (Bunney & Ireland, 
2019). The WAKE-UP trial was conducted in specialised and experienced stroke 
centres (with readily available diagnostic pathways and MRI) and only 37% of the 
patients screened for the WAKE-UP trial met the intervention criteria (Bunney & 
Ireland, 2019). Many patients excluded from the study did not have visible 
hyperintensities on DWI images, suggesting that they had had a transient ischaemic 
attack or stroke mimic (Bunney & Ireland, 2019). Smaller hospitals with less 
experience and equipment may struggle to effectively screen these more difficult 
patients (Bunney & Ireland, 2019).  
 
Another predominant disadvantage of the DWI/FLAIR mismatch is that it has 
repeatedly been found to have low sensitivity, causing patients within the treatment 
window to be missed (Etherton et al., 2018; Wouters et al., 2014). A meta-analysis 
of DWI/FLAIR mismatch studies revealed a combined sensitivity of 0.62 (min: 
0.38, max: 0.62) and specificity of 0.81 (min: 0.78, max: 0.89) for identifying 
patients scanned within 4.5 hours of symptom onset (Wouters et al., 2014). Low 
sensitivity is likely due to the high inter-rater and intra-rater variability (Wouters 
et al., 2014) and that many patients within 4.5 hours of symptom onset have visible 
FLAIR lesions (Emeriau et al., 2013). This high variability suggests that the 
DWI/FLAIR mismatch is not as simple as it appears on the outset.  
 
Attempts to improve inter-rater agreement have been made. For example, one 
study colour coded FLAIR images to make subtle FLAIR hyperintensities more 
obvious, which improved inter-rater agreement (Kim et al., 2014). Although this 
finding suggests colour coding FLAIR images could improve the ability of the 
DWI/FLAIR mismatch to correctly classify patients, it also highlights the difficulty 
with relying on the visual assessment of MR images for onset time estimation. If 
interpretation can easily be influenced by how the image is perceived, then 
DWI/FLAIR mismatch cannot be considered a reliable method for which to base 
treatment decisions on. This point is especially important as the contrast and 




quality of the images, and the experience of the rater in detecting changes on MR 
images, will vary between hospitals (Cheng et al., 2013; Galvonic et al., 2014). 
 
4.4.3 Quantitative MRI based methods for stroke onset time 
estimation  
The quantitative based approach for stroke onset time estimation is the main 
approach investigated in this thesis and for which machine learning methods are 
applicable. As discussed in Chapter 3 (Section 3.7) there are two main approaches 
in the stroke timing literature that come under the category of qMRI. The first is 
the quantitative analysis of the signal intensities represented in weighted images 
(Section 3.7.1) and the second, is the parametric approach to qMRI (Section 3.7.2) 
which involves mathematically parameterising MR signal intensities, before 
measuring them and transforming them into parametric images.  
 
For both quantitative approaches, stroke timing involves quantifying the change in 
image intensities (i.e., signals present in weighted images, or the relaxation times 
of voxels in a parametric image, see Section 3.8) caused by ischaemia, by comparing 
intensities in the ischaemic region with intensities of the homologous tissue in the 
contralateral hemisphere. This comparison can be achieved by calculating the 
difference in image intensities (e.g., Siemonsen et al., 2009), calculating the 
ischaemic vs non-ischaemic image intensity ratio (e.g., Madai et al., 2016; McGarry 
et al., 2016b; Song et al., 2012) or computing the absolute percentage difference 
(e.g., McGarry et al., 2016a; Rogers, McGarry et al., 2014). As will be discussed in 
Chapter 8, the purpose of the contralateral hemisphere is to provide an 
approximation of the pre-ischaemic image intensity values. Both quantitative 
approaches are based on the finding that image intensities in ischaemic regions 
increase linearly with time from ischaemia onset (e.g., Jokivarsi et al., 2010; Cheng 
et al., 2013; Song et al., 2012). The goal of the binary approach to onset time 
estimation using qMRI is to identify a specific image intensity ratio threshold that 




distinguishes between patients that are within and beyond the 4.5 hour rtPA 
treatment window. The regression based approach involves measuring the image 
intensity ratio at a given time point and inserting it into a regression equation in 
order to work back and estimate how long ago the stroke started in minutes. 
 
Estimating stroke onset time by quantifying signal intensities 
represented in weighted images 
In an initial attempt to increase the sensitivity associated with the DWI/FLAIR 
mismatch and avoid low inter-rater and low intra-rater agreement altogether, the 
quantitative analysis of the signal intensities represented in the DWI or FLAIR 
images was proposed as a potentially more accurate approach to estimating onset 
time (Petkova et al., 2010; Song et al., 2012). However clinical studies have shown 
varying results, no consensus of the threshold that should be used, and little to no 
improvement on sensitivity compared to the visual DWI/FLAIR mismatch (e.g., 
Galinovic et al., 2014). For example, Song et al. (2012) reported a sensitivity of 
0.78 and specificity of 0.67 for distinguishing between patients scanned before and 
after 4.5 hours from symptom onset using a FLAIR image intensity ratio. Petkova 
et al. (2010) reported the highest overall ability of the FLAIR image intensity ratio, 
but for the old treatment window of three hours, with sensitivity and specificity 
levels of 0.90 and 0.97 respectively. Madai et al. (2016), also reported high 
sensitivity and specificity levels for the 4.5 hour treatment window, with of 0.78 
specificity and 0.75 sensitivity for DWI and 0.79 sensitivity and 0.89 specificity for 
FLAIR.  
 
Other studies found less promising results for quantification of DWI and FLAIR 
image intensities. For example, Cheng et al. (2013) reported a moderate linear 
relationship of the FLAIR image intensity ratio with time from symptom onset and 
identified a threshold that distinguished between patients scanned before and after 
4.5 hours from symptom onset with 0.85 specificity and 0.47 sensitivity and with 
no overall improvement on the ability of the visual DWI/FLAIR mismatch where 




specificity was 0.78, and sensitivity was 0.58. Ebinger et al. (2010) did not find a 
relationship between FLAIR image intensity ratios and time from symptom onset 
and so could not identify a threshold to distinguish between patients within and 
beyond the thrombolysis treatment widow. In another attempt to improve the 
visual based DWI/FLAIR mismatch method, one study adopted a semi-
quantitative method which involved quantitative measurements of FLAIR image 
intensities to support visual assessments (Galinovic et al., 2014). The semi-
quantitative measure did not improve inter-rater agreement indicating that a 
quantitative analysis of T2w FLAIR MR signals specifically would not be useful for 
estimating stroke onset time (Galvonic et al., 2014). This indication is supported 
by the results of Chapter 5 and Chapter 7 of this thesis.  
 
Estimating stroke onset time with the parametric approach to 
qMRI 
At the start of this PhD (2015), only one clinical paper, by Siemonsen et al. (2009) 
had recognised the potential application of the parametric approach to qMRI for 
timing the ischaemic stroke as an alternative to the quantitative analysis of the 
signal intensities represented in weighted images. Much of the work on the 
parametric approach to qMRI for stroke timing was conducted in preclinical 
settings, dating back to the 1980s (e.g. Kato et al., 1985). 
 
In their study of acute ischaemic stroke patients, Siemonsen et al. (2009) reported 
high accuracy of the T2 relaxation time for identifying patients within the previous 
thrombolysis treatment window of three hours but did not test for the 4.5 hour 
window. In 2019, Knight, Damion and McGarry et al. (2019) reported higher 
accuracy of the T2 relaxation time compared to T2w image intensities for identifying 
stroke patients within the 4.5 hour treatment window, but sensitivity and 
specificity were not reported. The primary focus of the Knight, Damion and 
McGarry et al. (2019) paper was to demonstrate a potentially clinically applicable 
method for identifying elevated T2 relaxation times in hyperacute ischaemic stroke 




patients and was a side project involving the patient data analysed in this thesis. 
Therefore, the ability of T2 based parameters for onset time estimation was not 
further investigated, as this analysis was reserved for Chapter 7 of this thesis (and 
its future publication).   
 
The research adopting the regression based approach to stroke timing was mainly 
carried out in rat models of ischaemia, using hemispheric differences in qMRI 
parameters obtained from weighted and parametric images as well as distributional 
information as predictive parameters (discussed further in Chapter 5 and Chapter 
8) (Jokivarsi et al., 2010; McGarry et al. 2016a; Rogers, McGarry et al., 2014). For 
example, in rat models of ischaemia, Jokivarsi et al. (2010) identified predictive 
linear regression models for the hemispheric difference in the T2 relaxation time 
that could be used to estimate time from ischaemia onset in minutes. Further 
studies in rat models of ischaemia showed stronger relationships of relaxation time-
based parameters with time from stroke onset, compared to image intensity ratios 
from weighted images (McGarry et al., 2016a; Rogers, McGarry et al., 2014). A 
relationship between hemispheric differences in T2 and time from symptom onset 
had been reported in patients (Siemonsen et al., 2009) but a regression model was 
not used to assess its predictive ability. Since then, Duchaussoy et al. (2019) also 
reported a linear relationship between T2 relaxation times and time from symptom 
onset in patients, but with no evaluation on performance.  
  




4.4.4 Summary of qMRI based stroke timing methods  
In the following summary of qMRI approaches to estimating stroke onset time, the 
reader is referred to the schematic illustration in Figure 4.11. 
 
Part A: qMRI based approaches to timing the ischaemic stroke involves 
quantifying the difference in image intensities (i.e., the signal from weighted images, 
or the relaxation time from parametric maps) between the ischaemic region (shown 
as by the red region) and the homologous region in the non-ischaemic hemisphere 
(shown by the yellow region). The most common approach is to calculate the image 
intensity ratio, which is the mean voxel values of the ischaemic region, divided by 
the mean value in the non-ischaemic region.   
Part B: The main approaches to onset time estimation are binary and regression 
based. Both are based on the underlying assumption that image intensity ratios of 
qMRI parameters increase linearly with time from stroke onset, which is illustrated 
by the dark blue trendline. This assumption has been based on extensive preclinical 
research, that the relaxation times which influence the signal intensities associated 
with weighted images, and are measured with the parametric approach to qMRI, 
increase linearly with time from onset (e.g., Calamante et al., 1999; Gröhn et al., 
1998; Jokivarsi et al., 2010; Kettunen et al., 2000; Rogers, McGarry et al., 2014) 
Part C: The binary approach involves identifying an optimal image intensity ratio 
that distinguishes between patients that are within and beyond the 4.5 hour 
treatment window. Patients whose image intensity ratio falls below the identified 
cut-off that corresponds to 4.5 hours, would be within the treatment window 
(indicated by shaded blue area). Patient’s whose image intensity ratio exceeds the 
optimal ratio would be regarded as beyond the treatment window.  
Part D: The regression based approach involves by measuring the image intensity 
ratio at a given time point and inserting it into a regression equation in order to 
work back and estimate how long ago the stroke started in minutes. 
  



























































Figure 4.11 Schematic illustration of the binary and regression-based qMRI methods for 
estimating stroke onset time. Based on the assumption that the image intensity ratio 
has a linear relationship with time from stroke onset (D.), stroke onset time can be 
estimated by identifying an optimal image intensity ratio cut-off (A.) that distinguishes 
between scans performed before and after 4.5 hours from onset. A ratio below this 
threshold would indicate the patient is within the treatment window (C.). Alternatively, 
by measuring the image intensity ratio at a given time point, it can be inserted into the 
regression equation (D.) to work back and estimate how long ago the stroke started in 
minutes. 




 The rationale for the stroke timing methods studied 
in this thesis  
The studies in this thesis focus primarily on quantitative approaches to onset time 
estimation and specifically establishing a linear relationship with qMRI parameters 
and time from ischaemia onset. The traditional visual based qMRI approach of the 
DWI/FLAIR mismatch was also studied as, despite its limitations (addressed 
Section 4.4.2), it is an active area of stroke timing research (e.g., Thomalla et al., 
2018). The main motivation for studying the potential utility of linear relationships 
of qMRI parameters with time from stroke onset time was to keep in line with 
existing work and publications. At the start of the PhD, much of the previous 
preclinical and clinical stroke timing studies had focused on linear models. It had 
taken a long time to get the linear relationships of qMRI parameters that were 
observed in preclinical studies (e.g., Gröhn et al., 1998; Jokivarsi et al., 2010) to be 
investigated in clinical settings (e.g., Siemonsen et al., 2009; Song et al., 2012). It 
was therefore considered appropriate to continue this investigation in this thesis.  
 
A further motivation for studying linear relationships was the simplicity of a linear 
model, which, in a clinical setting, is important. If a linear model for estimating 
onset time works well enough to successfully identify patients potentially eligible 
for rtPA, it would be unnecessary to overcomplicate the method by pursuing more 
complex models. Additionally, when applying machine learning to support clinical 
decisions, there is the issue of “the black box”, where clinicians may be reluctant to 
incorporate a predictive model into their clinical practice if they do not know how 
it works (Zihni, Madai et al., 2020). Linear models and binary classification 
problems are familiar territories for researchers and clinicians alike, and therefore 
linear regression based models and binary classifiers may be more readily accepted 
into clinical practice. Indeed, a recent study by Zihni, Madai et al. (2020) showed 
traditional regression based machine learning methods performed comparably to 
more complex and advanced machine learning methods (tree boosting and 
multilayer perceptron) when using clinical parameters to predict stroke outcome. 
Although this would need to be tested in the context of stroke MRI, it suggests 




that despite the limitations of simple models, they may be sufficient for clinical 
needs.  
 
Despite the above advantages of seeking to establish a linear relationship, it is also 
recognised that qMRI stroke timing research should not be restricted to fitting 
linear models, especially as ischaemia is such a complex and heterogeneous disease 
state. Throughout the course of this PhD, it became evident that there may be 
more to the relationship of qMRI parameters and time from stroke onset, than a 
strictly linear one. qMRI studies in rats (Knight, McGarry et al., 2016; Norton et 
al., 2017), which are discussed in Chapter 8, highlighted the possibility of a non-
linear relationship of the T2 relaxation time with time from ischaemia onset. The 
possibility of a non-linear relationship of qMRI parameters was thus investigated 
in Chapter 8, by evaluating the predictive ability of polynomial regression models 
for onset time estimation. This involved including squared and cubed terms of the 
predictive variables in the original linear models, in order to accommodate non-
linear relationships in the data (James et al., 2013).  
 
It is also recognised that there are other machine learning methods that could be 
utilised in the study of onset time and acute ischaemic stroke. With the rapid 
advance of artificial intelligence in healthcare, the possibilities of machine learning 
approaches to support clinical decision making are endless (Zihni, Madai et al., 
2020). The potential utility of other machine learning methods in stroke timing 
research was recognised during the data analysis of Chapter 7, and so Chapter 7 
incorporates two additional supervised machine learning methods of analysis that 
had not previously been applied to qMRI stroke timing data, including logistic 
regression and precision-recall-gain (Flach & Kull, 2015).  
 
Other approaches that are beyond the scope of this thesis, but would be worth 
investigating in future,  include other supervised machine learning methods such as 
artificial neural networks and ensemble models such as and tree boosting, which 




have been shown to perform better than traditional linear and logistic regression 
methods in other areas of predictive modelling in stroke related health care (Zihni 
& Madai et al., 2020). Also, if taking the tissue clock approach, rather than the 
time-based approach to reducing the problem of unknown onset time (outlined in 
Chapter 1), unsupervised machine learning techniques, such as principal 
components analysis or deep learning approaches, may also be informative when 
applied to qMRI data. This is because unsupervised approaches do not have a 
target attribute but seek to discover complex patterns in data sets and relationships 
between them that would otherwise be unknown, but maybe informative 
(Lundervold & Lundervold, 2019).  
  
Chapter 5 | Determining stroke onset time using quantitative relaxometric MRI: A study 







                     
Determining stroke onset time 
using quantitative relaxometric 
MRI: A study on accuracy, 
sensitivity and specificity in a 
rat model of focal permanent 
cerebral ischaemia  
  
Chapter 5 | Determining stroke onset time using quantitative relaxometric MRI: A study 






Chapter 5 | Determining stroke onset time using quantitative relaxometric MRI: A study 





Many ischaemic stroke patients are ineligible for thrombolytic therapy due to 
unknown time of symptom onset. Quantitative MRI (qMRI) has been proposed as 
a potential surrogate for stroke timing. In this study, rats were subjected to 
permanent middle cerebral artery occlusion (MCAo), and qMRI parameters were 
measured at hourly intervals at 4.7T and 9.4T for up to seven hours post MCAo. 
qMRI parameters included, image intensity ratios from the apparent diffusion 
coefficient maps (ADC), T2 weighted images (T2w), T1 and T2 relaxation time maps, 
as well as parameters representing the distribution of high T1 or T2 relaxation times 
(f1, f2 respectively) and both high T1 and high T2 relaxation times (Voverlap) within 
the ADC defined ischaemic region. The T2 image intensity ratio, f2 and Voverlap 
qMRI parameters showed the strongest relationship with time from MCAo. 
Receiver operating characteristic (ROC) curves and areas under the ROC curves 
(AUC) showed the T2 image intensity ratio, f2 and Voverlap were also the most 
successful at differentiating between scans performed before and after three hours 
from ischaemia onset (AUC > 90%). At a specificity of 1, sensitivity was highest 
for Voverlap (0.90) and f2 (0.80). Overall results are promising for the potential use 
of qMRI indices based on relaxation times for the clinical assessment of stroke onset 
time.   
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Ischaemic stroke patients are ineligible for thrombolytic treatment if the time of 
symptom onset is unknown (Powers et al., 2018). Common reasons include lack of 
a witness, being unaware of symptoms or wake-up stroke (Dekker et al., 2017; 
Thomalla et al., 2017). MRI is sensitive to hydrodynamic changes in brain 
parenchyma caused by ischaemia (Kauppinen, 2014). A growing body of evidence 
suggests quantitative data from these changes could be informative of tissue status 
and stroke onset time and therefore potentially aid decision-making for clinical 
treatment (e.g., Jokivarsi et al., 2010; Kauppinen, 2014; McGarry et al., 2016a, 
2016b). Low sensitivity and ambiguity associated with relying on visual assessment 
of magnetic resonance (MR) images (e.g., DWI/FLAIR mismatch, Thomalla et al. 
2009, 2011) prompted the investigation into the potential utility of quantitative 
MRI (qMRI) for clinical needs (e.g., Song et al., 2012).  
 
Hemispheric differences in qMRI parameters including the apparent diffusion 
coefficient (ADC)(Petkova et al., 2010), signal intensities of T2 weighted images 
(T2w) with and without FLAIR (e.g., Madai et al., 2016; Petkova et al., 2010; 
Rogers, McGarry et al., 2014; Xu et al., 2014), the T1 relaxation time (McGarry et 
al., 2016a) and the T2 relaxation time (Jokivarsi et al., 2010; McGarry et al., 2016a; 
Rogers, McGarry et al., 2014; Siemonsen et al., 2009) have been shown to correlate 
with time from stroke onset, enabling onset time to be estimated with varying levels 
of accuracy. The relationships between these qMRI parameters and time from 
stroke onset are attributed to changes in tissue-water dynamics due to cytotoxic 
and vasogenic oedema (Chapter 3.2 and Kauppinen, 2014).  
 
The time-dependency of the T1 relaxation time in the ischaemic brain is less well 
characterised than for the T2 relaxation time (McGarry et al., 2016a). T1 increases 
gradually over time from stroke onset within regions of decreased diffusion 
(Calamante et al., 1999; Hoehn-berlarge et al., 1995; Kettunen et al., 2000). 
Pathophysiological mechanisms thought to underlie this T1 increase are similar to 
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the increase in the T2 relaxation time, including altered water dynamics and content 
in ischaemic tissue (Barbier et al., 2005; Kato et al., 1985; Kauppinen, 2014). The 
T1 relaxation time is additionally influenced by the cerebral blood flow (CBF) and 
cerebral blood volume (CBV) (Calamante et al., 1999; Kettunen et al., 2000), 
temperature (Youl et al., 1992), pH (Kettunen et al., 2002) and tissue oxygen 
tension (Calamante et al., 1999). Thus, by combining data from the time courses 
of T1 and T2 in the ADC defined ischaemic region, one would expect to obtain a 
fuller picture of ischaemic pathology in brain tissue, which may aid in the 
estimation of stroke onset time and assessment of tissue viability (McGarry et al., 
2016a).  
 
Previous stroke timing studies in rat focal ischaemia also suggest that the 
distribution of relaxation times within the ischaemic region may serve as a proxy 
for stroke onset time (McGarry et al., 2016a, 2017; Rogers, McGarry et al., 2014). 
For example, the spatial distribution of elevated T2 relaxation times (Rogers, 
McGarry et al., 2014) and volume of tissue with high T1 or T2 relaxation times 
(McGarry et al. 2016a) was initially smaller than the volume of total ischaemia 
delineated by ischaemic ADC but increased with ischaemia duration (McGarry et 
al., 2016a; Rogers, McGarry et al. 2014). Figure 5.1, reproduced and adapted from 
McGarry et al. (2016a), illustrates these changes and demonstrates how the 
heterogeneity of relaxation times within the ischaemic region, decreases over time. 
Based on these observations, qMRI surrogates for stroke timing were proposed, 
including f1, f2 (Knight, McGarry, et al., 2016a, 2017) and Voverlap (McGarry et al., 
2016a, 2017). f1 and f2 are the volumes of tissue with high T1 or T2 relaxation times 
as a percentage of total ischaemia volume, respectively and Voverlap is the volume 
with both high T1 and T2 normalised by the whole-brain volume (McGarry et al., 
2016a, 2017). Time from ischaemia onset time could be estimated in rats with 
uncertainties of ± 25 minutes, ± 34 minutes, ± 47 minutes using Voverlap, f2 and f1, 
respectively (McGarry et al., 2016a).  
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From a clinical perspective, a method for estimating stroke onset time must have 
high specificity to minimise potential adverse events of thrombolysis. High 
sensitivity is also essential to stratify as many patients as possible for thrombolysis. 
The abilities of the change in the ADC, T2w, T1 relaxation and T2 relaxation times 
and the f1, f2 and Voverlap parameters in estimating stroke onset time have been 
reported in preclinical (e.g., Jokivarsi et al., 2010; McGarry et al., 2016a, 2017; Xu 
et al., 2014) and clinical settings (e.g., Madai et al., 2016; Siemonsen et al., 2009) 
but performance of these parameters have not been compared. The objective of this 
study (McGarry et al.,2016b) was to compare the overall ability of these qMRI 
parameters as stroke timers in a defined rat model of ischaemic stroke. 
Figure 5.1 The spatial distribution of elevated relaxation times within the 1/ADC defined 
ischaemic lesion, at hourly intervals post MCAo. Bright voxels indicate decreased ADC 
values. Images in the Y direction are from the same rat at different scan times.  The image 
remains the same from left to right. Images are a central slice from 1/ADC maps from a 
representative rat, overlaid with colour coded regions depicting regions with high relaxation 
times. Red regions indicate reduced ADC and therefore ischaemic tissue. Columns: A. 
1/ADC map where hyperintense regions indicate ischaemia. B. Red voxels are the 1/ADC 
defined ischaemic regions of interest. C. Blue voxels represent reduced ADC and high T2 
relaxation times. D. Pink voxels represent reduced ADC and high T1 relaxation times. E. 
Yellow voxels represent voxels with reduced ADC and voxels with both high T1 and T2 
relaxation times. Relaxation times were identified as high if they exceeded the median 
relaxation time of the non-ischaemic VOI by more than one half-width at half maximum 
(see McGarry et al., 2016a). Figure reproduced and adapted from McGarry et al. (2016a). 
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The multi-parametric MRI images from previous rat stroke studies using 4.7T 
(Jokivarsi et al., 2010; Rogers, McGarry et al., 2014) and 9.4T MRI systems 
(Knight, McGarry et al., 2016; McGarry et al., 2016a, 2017) were combined and 
used in the data analyses of this study (McGarry et al., 2016b). Both studies were 
conducted on separate occasions at the A.I. Virtanen Institute for Molecular 
Sciences, Department of Neurobiology, the University of Eastern Finland, Kuopio. 
The 4.7T data was acquired by Dr Kimmo Jokivarsi and colleagues in 2008 
(Jokivarsi et al., 2010) and the 9.4T data was acquired by Dr Kimmo Jokivarsi, 
Bryony McGarry and Harriet Rogers in 2014 (McGarry et al., 2016a, 2016b). The 
methods given for the animal model, MRI protocol and image processing are 
therefore identical to the methods described in the publications by Jokivarsi et al., 
(2010), Rogers, McGarry et al. (2014), Knight, McGarry et al.  (2016) and McGarry 
et al. (2016a, 2016b, 2017). The methods employed in this study are also available 
in a video publication with a supporting manuscript (McGarry et al., 2017), which 
is accessible via: [https://www.jove.com/video/55277/a-magnetic-resonance-






Although T1 and T2 relaxation times scale with magnetic field strength, combining 
data from 4.7T and 9.4T was not considered problematic as the net magnitude of 
T1 and T2 change due to ischaemia is independent of field strength during the first 
hours of stroke (McGarry et al., 2016a). For example, a previous study found that 
after ten minutes of ischemia, the change in the T1 relaxation time was twofold 
greater at 9.4T than at 4.7T (Kettunen et al., 2000). However, at three hours post 
MCAo a change in T1 at similar magnitudes has been determined, where at 4.7T, 
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T1 increased by 9% (Moonen et al., 1991) and at 9.4T the increase was 6% 
(McGarry et al., 2016a). For T2, at three hours post MCAo, the increase was 5% 
at both 4.7T (Jokivarsi et al., 2010) and 9.4T (McGarry et al., 2016a). These 
observations indicate that while the polarity of early changes and time-dependent 
kinetics of T1 and T2 relaxation times differ in ischaemic tissue, the increases in 
both relaxation times at clinically relevant time points are comparable and 
independent of magnetic field strength (McGarry et al., 2016a).  
 
5.3.1 Animal model 
Animal procedures were conducted according to European Community Council 
Directives 86/609/EEC guidelines and approved by the Animal Care and Use 
Committee of the University of Eastern Finland. Twelve male Wistar rats (300-
400g) underwent permanent middle cerebral artery occlusion (MCAo) to induce 
focal ischaemia using the intraluminal thread model (Longa et al., 1989) where a 
nylon thread was advanced along the internal carotid artery until it blocked the 
blood flow from the middle cerebral artery (see McGarry et al., 2017 for a video 
demonstration). All rats were anaesthetised with isoflurane through a facemask 
(maintained at 1.5 – 2.4%) for the duration of the operation and MRI.  Before 
MRI, arterial blood gases and pH were analysed (i-Stat CO, East Windsor, NJ). 
Breathing rate and rectal temperature were monitored, and core temperature 
maintained at 37°C with a water heating-pad under the torso. After MRI, rats were 
sacrificed via decapitation in deep isoflurane anaesthesia (McGarry et al. 2016a; 
2017) or injection of saturated potassium chloride (KCl) (Jokivarsi et al., 2010, 
Rogers, McGarry et al., 2014).  
 
5.3.2 MRI protocol 
Multi-parametric MRI images were acquired using a horizontal 4.7T Magnex 
Scientific Inc (Yarnton, UK) magnet interfaced to a Varian Inova console (Palo 
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Alto, California), with a volume coil transmit/quadrature half-volume receive set 
up (Rapid Biomedical GmbH, Rimpar Germany) (Jokivarsi et al. 2010) and a 9.4T 
Agilent horizontal magnet (Agilent, Palo Alto, CA, USA) interfaced to a Varian 
direct drive system and equipped with an actively decoupled linear volume 
transmitter and quadrature receiver coil pair (RAPID Biomedical, GmbH, Rimpar 
Germany) (McGarry et al. 2016a, 2017).  
 
The 4.7T MRI protocol included a spin-echo diffusion MRI sequence for 
quantification of ADC (TR = 1500ms, TE = 55ms, incorporating four bipolar 
gradients and four b-values 0 – 1370 mm-2 s) and fast-spin multi-echo T2 for 
quantification of T2 relaxation times (5 echoes with 10ms inter-echo spacing 
starting at 10ms, TR = 2500ms). For both sequences, the images that were acquired 
were single slice, and field of view (FOV) was 2.56 cm x 2.56 cm covered by 64 x 
128 points. This protocol was 24 minutes and for each rat (n = 7), was repeated 
every 30-60 minutes post MCAo. Therefore, maximum total imaging time for each 
rat was up to seven hours (Jokivarsi et al., 2010; McGarry et al. 2016a, 2017; 
Rogers, McGarry et al., 2014).  
 
The 9.4T MRI protocol included (a) a 2D diffusion-weighted sequence for ADC 
quantification (TE = 36 ms, TR = 4000 ms, incorporating three bipolar gradients 
along each axis (duration of diffusion gradient = 5 ms) with three b-values: 0, 400, 
1040 mm-2 s), (b) the Carr-Purcell-Meiboom-Gill (CPMG) spin-echo multi-echo 
2D T2 sequence for quantification of T2 relaxation times (12 echoes with 10ms inter-
echo spacing starting at 10 ms, TR = 2000 ms) and (c) a 2D fast low angle shot 
(FLASH) T1 (time from inversion to first FLASH sequence, = 7.58 ms, time 
between inversion pulses, = 10 s, TI = 600 ms, TR = 5.5 ms). For all sequences, 
12 slices were acquired, and images were congruently sampled. FOV was 2.56 cm 
x 2.56 cm covered by 128 x 256 points, with 0.5 mm gap and 1 mm slice thickness. 
This protocol was 20 minutes and for each rat (n = 5), was repeated up to four 
times at hourly intervals post MCAo. Therefore, the maximum total imaging time 
for each rat was five hours (McGarry et al. 2016a, 2017).  
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5.3.3 Image processing 
The following image processing steps were carried out using MATLAB release 
2015b (The Mathworks, Natick, MA, USA) using functions written in-house by 
Knight, McGarry et al. (2016), which are available on the University of Bristol 
website (Wearn et al., 2017). 
 
To preserve the signal to noise ratio (SNR), data were first filtered with a squared 
hamming window function in the phase and frequency-encode dimensions (Knight, 
McGarry et al. 2016; McGarry et al. 2016a, 2017). The hamming window is a 
smoothing function which increases SNR at the expense of resolution. It is applied 
to the T2w images so that when the T2 map is calculated, the T2 values have smaller 
uncertainty and are closer to their true values even though the map is slightly 
blurred. The blurring was not considered a problem as it was much smaller than 
the size of the ischaemic region. It was necessary to apply the hamming window to 
the T2w images rather than the T2 maps, as any outlying T2 values would be spread 
across the maps, resulting in inaccurate T2 relaxation times.   
 
Images used for the quantification of T2w image intensities were the sum of 
weighted images acquired at each echo time (4.7T data: five images due to five 
echoes in the multi-echo T2 protocol, and 9.4T data: 12 images due to 12 echoes in 
the multi-echo T2 protocol). Relaxation time maps were computed using a mono-
exponential fit in a logarithmic space. For T2 data, hamming filtering was applied 
in k-space by a point-wise multiplication before inverse Fourier transform (Knight, 
McGarry et al., 2016). For diffusion and T1, image-domain data was used, and 
squared-hamming filtering applied. T1 fitting was performed according to methods 
given by Nekolla et al. (1992) however in order to speed up the process, magnitude 
data was used, and the lowest intensity point whose sign (±) cannot be known 
from the fitting, was excluded (Knight, McGarry et al. 2016; McGarry et al. 2017). 
ADC maps were calculated from diffusion-weighted data by the analytical solution 
to the Stejskal and Tanner (1965) diffusion equation (Knight, Mcarry et al., 2016). 
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To account for the fact that ischaemia causes an increase in T2w image intensities, 
and T1 and T2 relaxation times, but causes ADC to decrease, reciprocal ADC maps 
(1/ADC) were calculated so that change in image intensities were all in the same 
direction.  
 
5.3.4 Data analysis 
Data analysis was performed using the Multi-image Analysis GUI (MANGO, 
Research Imaging Institute, UT Health Science Centre at San Antonio, TX, USA). 
Image intensity ratios of 1/ADC, T2w, T1 relaxation and T2 relaxation times and 
the f1, f2 and Voverlap parameters were computed for each rat at each time point 
available. 
 
Computation of image intensity ratios (McGarry et al., 2016b) 
Ischaemic regions were visually identified as hyperintense areas on 1/ADC images, 
all within the rat striatum. A typical example of the striatal hyperintensities on 
1/ADC images at each time point post MCAo is shown in Figure 5.1. Figure 5.1 is 
adapted from McGarry et al., (2016a) and is of the 9.4T dataset used in this study. 
An example of the striatal hyperintensities in the 4.7T data set is shown in Figure 
5.2. 1/ADC images were used to identify the ischaemic region because the bright 
voxels stand out more than the dark ischaemic voxels on normal ADC images. 
Regions of interest (ROI), 3 mm in diameter, were placed in the ischaemic and 
homologous regions of the non-ischaemic hemisphere and loaded onto corresponding 
weighted and relaxometry images (see Figure 5.2 for example). For 9.4T data, a 
representative central slice from the comparable brain region to the 4.7T data was 
chosen for analysis. Image intensity ratios of 1/ADC, T2w, T1 relaxation time and 
T2 relaxation time images were calculated by dividing the mean value of the 
ischaemic ROI by the mean value in the non-ischaemic ROI. Use of non-ischaemic 
values was to eliminate inter-subject variation so that each rat served as its own 
control. 
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Figure 5.2 Example of 1/ADC map (A.) T2w image (B.) and T2 relaxation time map (C.) 
from a representative rat in the 4.7T data set. These images were acquired two hours after 
MCAo.  The ischaemic region is clearly visible as hyperintensities on the 1/ADC map. The 
red circles are the ischaemic regions of interest (ROIs) the green circles are the non-
ischaemic ROIs, which are the same as the ischaemic ROIs but have been reflected across 





Computation of f1 and f2 
The f parameter was initially introduced by Knight, McGarry et al. (2016) and 
represents the fraction of voxels within the ischaemic volume of interest (VOI) with 
high relaxation times. In this study, f1 and f2 are the number of voxels with high 
T1 or T2 relaxation times (respectively) relative to the number of voxels in the 
ADC defined ischaemic VOI, represented as a percentage (as per McGarry et al., 
2016a, 2017). These parameters could not be computed for the 4.7T dataset as 
unlike the 9.4T data set which was 3D and imaged the whole brain, the 4.7T data 
set was 2D, and only one imaging slice through the ischaemic region was obtained 
per rat. Therefore, an ischaemic volume could not be calculated from the 4.7T 
images.  
 
Computation of f1 and f2 first involved identifying ischaemic tissue and generating 
ischaemic volumes of interest (VOI) by applying Knight and McGarry et al.’s 
(2016) automatic ischaemic region detection method to 1/ADC images acquired for 
each rat at each time point. In brief, this involved identifying voxels with values in 
1/ADC maps (where ischaemic voxels are bright with high values) that were higher 
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than average (one SD above the median) and eliminating voxels with unrealistically 
high T2 voxels (above 200 ms, to exclude CSF) in order to generate binary masks.  
 
The binary masks of the ischaemic region typically contained several distinct 
clusters of non-zero voxels as well as single voxels due to noise in the data. The 
masks were therefore filtered to remove clusters of voxels with a prescribed cluster 
size that were too small to realistically be ischaemic tissue (Knight, McGarry et 
al., 2016). The smallest acceptable cluster size was a user-defined parameter, which 
was set on a case by case basis (Knight, McGarry et al., 2016). In all cases, there 
was no ambiguity as to which voxels of the binary mask were ischaemic and which 
were due to noise, as the MCAo model used typically encompasses most of the rat 
striatum (see hyperintensities on 1/ADC maps in Figures 5.1 and 5.2). Homologous 
regions in the non-ischaemic hemisphere were identified by reflecting ischaemic 
VOIs about the vertical midline axis (see Figure 5.2). 
 
Next, the number of voxels with high T1 or T2 relaxation times within the ischaemic 
VOI was determined by reflecting the ischaemic VOI onto the homologous region 
of the contralateral hemisphere to obtain the median T1 or T2 of the non-ischaemic 
tissue. As before, use of the non-ischaemic values was so that each rat served as its 
own control. A voxel within the ischaemic VOI was considered to have a ‘high’ 
relaxation time if its median value exceeded the median value of the non-ischaemic 
VOI by more than one half-width at half maximum (HWHM) of the distribution 
of relaxation times within the non-ischaemic VOI (Knight, McGarry et al., 2016) 
where HWHM is half of the difference between the two extreme values (full width 
at half maximum) of the independent variable (i.e., relaxation time in ms) when 
the dependent variable (number of voxels) is half of its maximum value. 
 
As relaxation times have also been shown to decrease within the first hour after 
MCAo due to the negative blood oxygen level dependent (BOLD) effect (Gröhn et 
al., 2000; Jokivarsi et al., 2010; Rogers, McGarry et al., 2014) voxels with low 
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relaxation times were also identified (Knight, McGarry et al., 2016). A voxel in the 
ischaemic VOI was considered to have an unusually ‘low’ relaxation time if its 
median value was below the median value of the non-ischaemic VOI by more than 
one HWHM of the distribution of relaxation times within the non-ischaemic VOI 
(Knight, McGarry et al., 2016). The f parameters were calculated as a percentage 
according to the following equation: 
 





Where 𝑥	refers to the relaxation time (T1 or T2), 𝑁QRST	refers to the number of 
‘high’ relaxation time voxels in the ischaemic VOI, 𝑁UVW is the number of ‘low’ 
relaxation time voxels in the ischaemic VOI (Knight, McGarry et al., 2016) and 
𝑁UXYRVZ,	is the total number of voxels within the ischaemic VOI (McGarry et al., 
2016a, 2017). 
 
Computation of Voverlap 
Voverlap is the volume of tissue with both elevated T1 and T2 relaxation times within 
the ischaemic VOI, normalised by the whole brain volume and represented as a 
percentage (McGarry et al., 2016a, 2017). Different from f1 and f2, which shows 
elevated relaxation times within the ADC defined ischaemic region, Voverlap shows 
how much of the overall rat brain has elevated relaxation times. Voverlap was 
calculated for each rat and time-point as follows: 
 




Where 𝑁d_X`abc is the number of voxels within the ADC defined ischaemic region 
with both high T1 and T2 (defined above). 𝑁:TVaX;`bRZ is the total number of voxels 
within the whole rat brain, which was determined by manually creating a VOI 
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around the whole brain on T2 relaxation time maps (McGarry et al., 2016a, 2017). 
Dividing by the whole brain volume was important to control for the fact that the 
brain swells (and therefore increases in size) during ischaemia due to the net 
increase in water content (ionic and vasogenic oedema). This has been 
demonstrated consistently in rat models of ischaemia (e.g., Gerriets et al., 2004).  
 
Signal to noise ratio (SNR) 
SNR, the key image quality characteristic, was computed for the maps and summed 
weighted images using the dual acquisition approach described by Firbank et al., 
(1999). SNR was computed to account for the possibility that better performance 
could be due to better SNR rather than an inherent quality of the parameter 
studied. Also, to check the SNR was the same for scans acquired at the different 
field strengths. Firbank et al.’s (1999) SNR approach involved computing a 
difference image from sequential acquisitions (McGarry et al., 2016b). Here, 
difference images for all rats were computed by subtracting images acquired in the 
second hour post MCAo from images acquired in the first hour.  SNR was computed 





Where S1 is the mean signal intensity from an ROI (6 mm x 6 mm) placed in the 
contralateral hemisphere, SD1-2 is the standard deviation of the signal from the 
same ROI placed in the same region of the difference image. SNR values given in 
the results are averaged across rats.  
 
5.3.5 Statistical analysis 
Statistical analysis was performed using XLSTAT for Microsoft Excel and Prism 
8.03 (GraphPad Software, La Jolla California, USA). Data were assessed for 
normality using the Shapiro-Wilk test (Shapiro & Wilk, 1965). The relationship of 
1/ADC, T2w, T1, T2, f1, f2 and Voverlap with time from ischaemia onset was assessed 
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using Pearson’s correlations for normally distributed data and Spearman’s 
correlations for non-normal data.  
 
For a visual indication of the overall performance of each MRI parameter at 
discriminating between scans performed before and after three hours from 
ischaemia onset, receiver operating characteristic (ROC) curves were plotted (see 
Appendix A for description). Three hours was chosen as the time-point for 
comparison as both the 4.7T and 9.4T datasets contained this time-point and the 
number of scans before and after was similar (21 data points before three hours, 19 
data points after three hours). For a numerical indication of the overall performance 
of MRI parameters, areas under the ROC curves (AUC) and their statistical 
difference from 0.5 (indicating no discriminative ability) were calculated and 
statistically compared using non-parametric methods that control for multiple 
comparisons (DeLong et al., 1988). The sensitivity levels of each parameter at a 
specificity level of 1, were also determined. All statistical tests were two-tailed with 
a significance level of p < .05.  
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SNR was higher for weighted images than relaxation time maps but comparable 
across field strengths (Table 5.1) (McGarry et al., 2016b). Comparable SNR across 
field strength shows that combining data from two different field strengths could 
not have impacted the results.   
 
         Table 5.1 Signal to noise ratio of weighted images and relaxation time maps. 
 Signal to Noise Ratio (SNR) 
Image 4.7 T 9.4 T 
T2w 31.4 (SD = 7.1) 19.1 (SD=3.9) 
T2 relaxation  90.5 (SD = 19.2) 59.2 (SD = 23.0) 
        Note, standard deviation (SD) is given in brackets  
 
Non-normally distributed data included 1/ADC (w = 0.88, p < 0.001) and f1 (w = 
0.90, p = 0.048).  Figure 5.3 shows all parameters correlated significantly with time 
from MCAo and that Voverlap and f2 showed the strongest relationships (Voverlap r = 
0.93, f2 r = 0.91). Figure 5.4 shows the ROC curves and AUC values for all 
parameters. All AUC values were significant, demonstrating all parameters could 
be used to distinguish between scans performed before and after three hours from 
MCAo. Voverlap and f2 demonstrated the highest overall ability, as the AUCs for 
these parameters were comparable to each other (p > 0.05) and were significantly 
higher than the other parameters (p < 0.05) (McGarry et al., 2016b). The T2 
relaxation time ratio had the next highest overall performance, which was 
significantly higher than f1, T2w, T1 and 1/ADC (McGarry et al., 2016b).  
  
The low SNR of relaxation time maps compared to the weighted images (Table 
5.1) shows that the better performance of the relaxation time based parameters 
(given below) was not attributable to higher signal and that despite higher SNR, 
which should boost performance, weighted images still performed poorly. This 
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suggests that the better performance of the relaxation time parameters is an 
inherent quality of these qMRI parameters.  
 
Table 5.2 shows at a specificity of 1, Voverlap and f2 had the highest sensitivity levels 
and the sensitivity of T1, T2, 1/ADC and T2w were low (McGarry et al., 2016b). 
Thresholds for identifying strokes less than or equal to three hours at these 
specificity and sensitivity levels are also shown in Table 5.2. For example, a Voverlap 
measurement of greater than 1.83% indicates that the scan was performed after 
three hours from onset (due to specificity of 1) and most measurements less than 
or equal to 1.83% indicates the scan was performed within three hours of onset. 
However, due to the sensitivity of 0.90, 10% of the measurements that were less 
than 1.83% could have been after three hours. A T2 image intensity ratio (mean 
ischaemic T2 / mean non-ischaemic T2) greater than 0.99 indicates that the scan 
was performed after three hours (due to specificity of 1) and most measurements 
equal to or less than 0.99 indicates the scan was performed within three hours of 
onset. However, due to the sensitivity of 0.39, 61% of the measurements could have 
been after three hours. 
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Table 5.2 Sensitivity of qMRI parameters and corresponding cut-off values when specificity 
is maximum (McGarry et al., 2016b). 
 
Note, CI = 95% confidence interval. Thresholds for f1, f2 and Voverlap are percentages, where 
f1 and f2 are the respective volumes of high T1 or T2 within the ADC defined ischaemic 
region as a percentage of the size of the ischaemic volume. Voverlap is the percentage of 
voxels with both high T1 and high T2 within the ischaemic volume relative to the whole-
brain size. 1/ADC, T2, T2 and T2w thresholds are the image intensity ratios (mean 




Threshold Specificity  
(95% CI) 
Sensitivity 
 (95% CI) 
Voverlap 1.83 % 1 (0.65 – 1) 0.90 (0.57 – 1.00) 
f2 69.71 % 1 (0.65 – 1) 0.80 (0.48 – 0.95) 
f1 84.09 % 1 (0.65 – 1) 0.50 (0.24 – 0.76) 
T2 0.99 1 (0.85 – 1) 0.39 (0.24 – 0.56) 
T2w 1.00 1 (0.85 – 1) 0.29 (0.16 – 0.47) 
T1 0.99 1 (0.65 – 1) 0.10 (0.00 – 0.43) 
1/ADC 0.79 1 (0.77 – 1) 0.00 (0.00 – 0.12) 
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Voverlap = 0.99 (0.99 - 0.99), p < 0.001
f2 = 0.97 (0.97 - 0.97), p < 0.001
T2 = 0.90 (0.83 - 0.97), p < 0.001
T2w = 0.81 (0.70 - 0.92), p < 0.001
f1 = 0.83 (0.69 - 0.98), p < 0.001
T1 = 0.74 (0.55 - 0.94), p = 0.014
1/ADC = 0.68 (0.54 - 0.82), p = 0.014
Figure 5.4 ROC curves and associated AUC values showing the overall ability of qMRI 
parameters for distinguishing between MRI scans performed before and after three hours 
from MCAo in ischaemic rats. AUC values are displayed for each qMRI parameter with 
95% confidence intervals in brackets. Lines closer to the grey dashed 0.5 reference line 
indicate parameters with poor overall ability. Figure adapted from McGarry et al. (2016b). 
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The study compared the overall ability of qMRI parameters for estimating stroke 
onset time in rat models of ischaemia (McGarry et al., 2016b). qMRI parameters 
involving T2 relaxation times had the highest overall ability, as Voverlap, f2, and the 
T2 image intensity ratio demonstrated the strongest relationships with time from 
ischaemia onset. These qMRI parameters also had the highest overall accuracy for 
distinguishing between scans performed before and after three hours from onset 
(McGarry et al., 2016b). The data suggest qMRI is a potential tool for identifying 
ischaemic stroke patients with an unknown onset time that are still within the 
treatment window, which may aid decision making for pharmacotherapy (McGarry 
et al., 2016b).   
 
This study agrees with previous studies that quantitative MR relaxation times are 
more accurate for stroke onset determination than signal intensities in respective 
relaxation-weighted images (Rogers, McGarry et al., 2014; McGarry et al., 2016a). 
The high overall ability of parameters derived from relaxation times in this study 
(demonstrated by high AUCs) is likely due to the fact that fitting signal intensities 
to the MR relaxation equations removes inherent variations caused by technical 
factors such as magnetic field inhomogeneities, and proton-density (McGarry et al., 
2016a, also discussed in Chapter 3 Section 3.7.2). A further benefit of Voverlap, f1 
and f2 is their insensitivity to magnetic field variation within the ischaemic region 
(McGarry et al., 2016a, 2016b). SNR was higher for summed weighted images 
suggesting poor SNR cannot account for the inferior performance of signal 
intensities from weighted images (McGarry et al. 2016b).  
 
The results argue that Voverlap and f2, which represent the distribution of elevated 
relaxation times within ADC defined ischaemic regions, may perform better in onset 
time estimation than relaxation-based image intensity ratios (McGarry et al., 
2016b). The relationship of these distribution-based parameters with time from 
stroke onset, reflects the transition of the ischaemic region from compromised 
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tissue, to irreversible infarction (McGarry et al., 2016a, 2016b). As illustrated in 
Figure 5.1, in the initial hours, the ischaemic region is composed of voxels with 
heterogenous relaxation times. In the absence of reperfusion, the extent of 
irreversible damage, and therefore the number of voxels with elevated relaxation 
times will increase.  
 
Given the different pathophysiological mechanisms reflected by T1 and T2 
(Kauppinen, 2014), Voverlap may also serve as an indicator of tissue viability 
(McGarry et al., 2016a). Where voxels with decreased ADC, high T1 and high T2, 
indicates irreversibly damaged tissue (McGarry et al., 2016a) and voxels with 
decreased ADC and ‘normal’ T1 and T2 indicate potentially viable tissue (McGarry 
et al. 2016a; Rogers, McGarry et al., 2014). This conclusion (McGarry et al., 2016a) 
is supported by the fact that prolonged T1 and T2 relaxation times in the ischaemic 
brain were shown to signify the transition to necrosis by histological methods 
(Calamante et al., 1999). T1 and T2 are influenced by total tissue water content 
(Barbier et al., 2005; Kato et al., 1985), and so, Voverlap may represent tissue with 
irreversible vasogenic oedema (McGarry et al., 2016a).  
 
It is worth noting; however, that quantification of Voverlap and f2 could be 
problematic in a clinical setting. The rat brain is comprised mainly of grey matter 
(GM) (Zhang & Sejnowski, 2000) and so in this study, it was safe to assume that 
an increase in relaxation times relative to the non-ischaemic hemisphere was caused 
by ischaemia. The human brain, however, is a combination of GM and white matter 
(WM), which due to difference in structure, metabolism, haemodynamics and 
electrophysiology, have different baseline T2 relaxation times (Wansapura et al., 
1999), and sensitives to ischaemia (Berner et al., 2016). CBF thresholds for the 
ischaemic core have been shown to be higher in GM than WM in patients (Bristow 
et al., 2005; Chen et al., 2019) and anoxic depolarisation (associated with cytotoxic 
oedema), was shown to decrease faster in GM in ischaemic cats (Kumura et al., 
1999). As these factors both contribute to changes in ADC (Sotak, 2004) and T2 
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relaxation (Knight, McGarry et al., 2016), the criteria for defining ‘high T2’ caused 
by ischaemia will differ between tissue types. 
 
ADC does not differentiate between tissue type (Serner, 2001), therefore applying 
one criterion across the whole ADC defined ischaemic region to identify high and 
low relaxation times as was done in this study, will not be informative. It would 
not be clear whether voxels identified as having high or low T2 represent voxels 
from a different tissue type or voxels that have changed due to ischaemia. Ischaemic 
GM and WM would, therefore, need to be analysed separately in patients 
(addressed in Chapter 8) which may be challenging in a clinical setting. Although 
the methods employed for calculating Voverlap and f2, in this study are not 
necessarily directly translatable to human stroke patients, results suggest that 
examining the distribution of relaxation times within regions of reduced ADC, could 
be informative of stroke onset time and therefore merits further investigation. 
 
Although the T2 ratio demonstrated high overall ability at distinguishing between 
scans performed before and after three hours from ischaemia onset, compared 
to Voverlap and f2, the sensitivity of T2 was low (Table 5.2). Applying the cut-off of 
a T2 ratio greater or less than 0.99, meant all scans performed after three hours 
were identified (ratio > 0.99), but at the expense of only identifying 39% of scans 
performed before three hours (ratio < 0.99). The low sensitivity is likely due to 
including T2 data from early time points. As seen in Figure 5.3, several data points 
had a ratio of less than one, indicating a decrease in T2. This decrease is consistent 
with studies in rat models of ischaemia, where T2 decreased within the first 90 
minutes, before increasing over time (Calamante et al., 1999; Gröhn et al., 2000). 
The T2 shortening is attributed to the negative BOLD effect described in Chapter 
3, Section 3.2.2 (Calamante et al., 1999; Gröhn et al., 2000). The subsequent 
normalisation and increase in T2 reflect the reduction or normalisation of the 
oxygen extraction fraction (OEF) due to a decline in the cerebral metabolic rate of 
oxygen (CMRO2) (Calamante et al., 1999).  
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By including T2 ratios from early time points in the analysis, the sensitivity levels 
of T2 reported in this study are unlikely to be representative of the performance of 
the T2 ratio in patients. To date, a decrease in T2 due to ischaemia has not been 
captured in patients. Duchaussoy et al. (2019) were the first to quantify T2 
relaxation time ratios in hyperacute ischaemic patients as early as 30 minutes from 
symptom onset. None of the patients had a T2 ratio below one, but several within 
the first 90 minutes had a ratio of one or close to it. Even so, a decline in T2 would 
not be problematic for onset time estimation, as it would suggest that the patient 
is within the 4.5 hour treatment window for thrombolysis (Rogers, McGarry et al., 
2014). In support, patients without hyperintensities in T2w FLAIR images were 
found to be within three hours of symptom onset (Thomalla et al., 2009). Thus, 
the low sensitivity reported here should not discourage investigation of the T2 ratio 
as a method for stroke timing in patients.  
 
The sensitivity was zero for ADC and very low for T2w image intensity ratios 
(McGarry et al., 2016b). In clinical acute stroke cases, ADC was deemed to carry 
no timing information, but rather serve as an early MRI index of ischaemia per se 
(Burgess & Kidwell, 2011; Kauppinen, 2014). Similarly, the low sensitivity of T2w 
image intensities was reported clinically (Ebinger et al., 2010; Wouters et al., 2014). 
Thus, ADC or T2w image intensity ratios can be regarded as poor indices for stroke 
timing, but instead are important for stroke diagnosis (McGarry et al., 2016b). The 
low sensitivity of the T1 relaxation time compared to the other relaxation-based 
parameters is likely due to the more gradual changes in T1 over time (McGarry et 
al., 2016a), illustrated by the gradual slope and low correlation coefficient in Figure 
5.3. In contrast to T2, which increases rapidly following the initial shortening 
(Gröhn et al., 2000; Jokivarsi et al., 2010), the T1 relaxation time has a two-phase 
response to ischaemia (McGarry et al. 2016a), where T1 increases rapidly within 
the first 25 minutes post occlusion, followed by a more gradual change (Calamante 
et al., 1999). This two-phase response and subtle changes in T1 may make it less 
suitable for onset time estimation in clinics.   
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To conclude, from the multiple qMRI parameters studied here, Voverlap f2, and the 
T2 image intensity ratio quantified in the ADC defined ischaemic region provide 
the most accurate estimates of stroke onset time. The current preclinical data 
encourage investigation into qMRI indices based on absolute relaxation times (not 
weighted images), including image intensity ratios and distributions within the 
ischaemic region, as surrogates for stroke timing in clinical settings. A common 
concern regarding qMRI for stroke timing in clinical settings is the long scan times 
required for multi-echo T2 and inversion recovery T1, which increases the possibility 
of motion-induced artefacts and would delay treatment. However, methods for fast 
T1 and T2 relaxation time mapping is now possible in clinically available systems. 
With the advent of magnetic resonance fingerprinting (Ma et al., 2013, Chapter 3 
Section 3.7.3), which provides many quantitative MR results simultaneously, the 
future of qMRI for clinical use is promising (McGarry et al. 2016a, 2016b). 
 
Overall, the results of this Chapter suggest that qMRI parameters involving image 
intensity ratios of the T2 relaxation time, as well as the distribution of T2 relaxation 
times are informative of stroke onset time in rats. These results, therefore, warrant 
an investigation into the ability of these parameters for estimating onset time in 
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Translation of preclinical 
findings to clinical presentations 
of hyperacute ischaemic stroke  
 
The overarching goal of the preclinical MRI study in Chapter 5 was to investigate 
the potential utility of qMRI parameters for estimating stroke onset time, under 
controlled conditions, in an experiment that would be difficult and unethical to 
emulate in patients. A comprehensive study that investigates all possible qMRI 
parameters at multiple time points after ischaemia onset would not have been 
possible in patients due to the time-critical nature of treating hyperacute stroke 
patients and their vulnerable clinical state.  Additionally, the pathophysiology of 
cerebral ischaemia is highly variable as it is influenced by several factors such as 
the anatomical location, cause and severity of the ischaemia (i.e. degree of drop in 
local CBF), the presence of pre-existing systemic disease(s), and the age, body 
temperature, and arterial blood profiles of the patient (Macrae, 1992). These factors 
can be controlled in rats, but in a patient study, would introduce variability into 
the data that could confound statistical evaluation (Macrae, 1992). Use of the 
intraluminal thread model to induce middle cerebral artery occlusion (MCAo) 
ensured consistent location, size and severity of ischaemia across rats (Longa et al., 
1989) in the vascular territory that is most commonly affected in patients (Mohr 
et al., 1986). The potential confound of pre-existing diseases was also avoided by 





studying young rats, and the core temperature, breathing rate, and arterial blood 
gases were monitored.  
 
Rats are considered suitable subjects for studying ischaemia because the 
cerebrovascular anatomy is similar to that of a human, including the presence of a 
circle of Willis (Durukan & Tatlisumak, 2007; Tamura et al., 1981). However, there 
are also fundamental differences in the physiology and anatomy of the rat and 
human brain that limit how far results from rats are translatable to humans 
(Macrae, 1992). The most notable difference is that the rat brain is 86% grey matter 
(GM), whereas the human brain is approximately half GM and half white matter 
(WM) (Zhang & Sejnowski, 2000). Therefore, the conclusions drawn from studies 
of rat models of ischaemia are regarded as only representative of GM. 
 
Although the ischaemic cascade in GM and WM is similar as both start with the 
exhaustion of ATP followed by the loss of ion homeostasis (Macrae, 1992), it is 
unlikely that the same mechanisms damage these tissue types because of their 
extremely different compositions (Goldberg & Ransom, 2003). For example, GM 
has more neuronal cell bodies, and synapses than WM (Goldberg et al., 1987) and 
WM has no synapses, more axons and glia (Goldberg & Ransom, 2003). GM has 
twice the metabolic rate of WM (Clarke & Sokolof, 1999; Nishizaki et al., 1988) 
and up to three times the CBF and CBV requirements than WM has (Helenius et 
al., 2003; Simon et al., 2005). As discussed in Chapter 5, GM also has higher CBF 
thresholds for ischaemia (Bristow et al., 2005; Chen et al., 2019) and a faster 
decrease in anoxic depolarisation (Kumura et al., 1999). Ischaemic lesions have also 
been shown to extend preferentially within WM of patients (Berner et al., 2016). 
Replicating the ischaemic damage seen in WM of humans has not been 
straightforward in animal studies, and where it has been successful the methods 
used are not considered representative of how ischaemia is induced in the human 
brain (Sozmen et al., 2012). 
 





Given the differences between rats and humans outlined above, preclinical findings 
cannot be relied on for deciding which methods to use in the clinic but can be used 
to inform the design of pilot studies in patients, which will ultimately inform the 
design of larger-scale clinical studies. Chapter 5 and the previous preclinical and 
clinical MRI studies of stroke timing referenced in Chapter 4 (Section 4.4), informed 
the design of the pilot studies in the following chapters of this thesis. The overall 
goal of the pilot studies in Chapter 7 and Chapter 8 was to explore potential 
relationships between T2 based MRI parameters and time from stroke onset in 
hyperacute ischaemic stroke patients, with the view to generating specific 
hypotheses that could be investigated in future patient studies.  
 
The focus was specifically on T2 based qMRI parameters due to the encouraging 
results of T2 relaxation times in Chapter 5 and previous preclinical studies 
(Jokivarsi et al., 2010; McGarry et al., 2016a, 2016b; Rogers, McGarry et al., 2014) 
as well as the clinical study by Siemonsen et al. (2009). Although DWI and T2w 
signal intensities did not perform well for estimating stroke onset time in Chapter 
5, these were also included in the study in Chapter 7, because of the considerable 
attention they have received in the clinical stroke timing literature (e.g., see 
Wouters et al., 2014 and Etherton et al., 2018 for reviews). T2 based parameters 
were also considered the most feasible for the acute stroke setting as DWI and T2w 
imaging (without and without FLAIR) are already part of stroke protocols, for the 
respective identification and assessment of ischaemic regions (Mair & Wardlaw 
2014). These sequences can be run in a few minutes, and most clinical MRI scanners 
also produce T2 relaxation time maps from the weighted images at no extra time 
cost if a multi-echo T2 sequence is used.   
 
The T1 relaxation time was not included in the pilot studies because it showed poor 
performance in rats in Chapter 5, and as discussed, the two-phase response to 
ischaemia could make it less suitable for stroke timing than T2. Additionally, 
quantifying T1 using the inversion recovery approach (outlined in Chapter 4, 
Section 4.2.3) requires long repetition times (TR), which make it unsuitable for 





emergency clinical settings (Deoni et al., 2003; Pykett et al., 1983). We previously 
trialled quantifying T1 relaxation times using the DESPOT1 (Deoni et al., 2003) 
methods for fast T1 mapping (McGarry, 2015) which involves averaging T1 
weighted images acquired at two or more flip angles, with a short and constant 
TR. However, we were unable to accurately and consistently measure T1 in the 
human brain using a similar approach in the Philips Achieva platform (McGarry, 
2015) due to difficulties selecting the correct flip angles, and in-homogeneities in 
the B1 field (Deoni et al., 2008). 
 
The MRI protocol for the patient studies of Chapter 7 and Chapter 8, therefore 
included: 
- A multi b-value DWI sequence for visually locating ischaemic tissue and for 
quantifying DWI image intensities.  
- The trace of diffusion tensor, to quantify ADC and generate ischaemic 
volumes of interest (VOI). 
- Multi-echo T2 for quantification of T2w image intensities and computation 
of T2 relaxation time maps. T2w images also enabled tissue to be segmented 
into GM and WM for separate analysis in Chapter 8.  
- 3D T1w to register all other images to and to ensure that the same region 
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T2 relaxation-based MRI signals may identify acute ischaemic stroke patients with 
an unknown symptom onset time that are within the 4.5 hour time-window for 
intravenous (IV) thrombolytic therapy. This pilot study compared the ability of 
visual and quantitative MRI based stroke timing methods in a cohort of hyperacute 
ischaemic stroke patients.  
 
Thirty-five patients underwent 3T MRI (< 9 hours symptom onset). Diffusion-
weighted (DWI), apparent diffusion coefficient (ADC), T1 weighted (T1w), T2 
weighted (T2w) and T2 relaxation time (T2), images were acquired from all 35 
patients. T2 weighted FLAIR (FLAIR) images were acquired for 17 of these 
patients (sub-cohort). Image intensity ratios of the average intensities in ischaemic 
and non-ischaemic reference regions were calculated for ADC, DWI, T2w, T2 
relaxation, and FLAIR images and optimal image intensity ratio cut-offs were 
determined. DWI and FLAIR images were assessed visually for DWI/FLAIR 
mismatch.  
 
The T2 relaxation time image intensity ratio was the only parameter that correlated 
significantly with time from symptom onset (r = 0.49, p = 0.003), had a significant 
area under the ROC curve (AUC = 0.77, p < .0001) and an optimal cut-off (T2 
ratio = 1.072) that accurately differentiated between patients within (< 1.072) and 
beyond (> 1.072) the 4.5 hour treatment window without compromising sensitivity 
(0.74) and specificity (0.74). There was a trade-off between sensitivity and 
specificity for ADC, DWI and T2w image intensity ratios. Multiple logistic 
regression revealed no benefit of combining ADC, DWI, T2w, and T2 ratios. In the 
sub-cohort of patients with the additional FLAIR scans, areas under the precision-
recall-gain curve (AUPRG) and F1 scores showed that the T2 relaxation time ratio 
(AUPRG = 0.60, F1 = 0.73) performed considerably better than the FLAIR ratio 
(AUPRG = 0.39, F1 = 0.57) and the visual DWI/FLAIR mismatch (F1 = 0.25). 
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It was concluded that when exploiting T2 MRI in ischaemic stroke, quantification 
of the T2 relaxation time should be the preferred method because it is more adept 
at predicting whether a patient is within the IV thrombolysis treatment window 
than the alternatives considered here. The use of the quantified parameter also 
eliminates the presence of unwanted contributions to the signal that often affect 
weighted signal intensities. The T2 relaxation time is, therefore, a controllable MRI 
variable, which may provide a more reliable stroke timer.    
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Unknown time of symptom onset due to wake-up stroke or lack of witness is a 
common contraindication for reperfusion therapies for ischaemic stroke (Etherton 
et al., 2018). Intraarterial administration of thrombolytic agents is considered safe 
within six hours of onset but is not routine (Berkhemer et al., 2015) and patients 
with large vessel occlusion (LVO) can now be considered for mechanical 
thrombectomy if symptom onset was within the last 24 hours (Nogueira et al., 
2018; Powers et al., 2018). For the many patients without LVO, intravenous (IV) 
rtPA is the only alternative. The current European licensing limit for IV rtPA is 
4.5 hours (Fiehler et al.,2016; Powers et al., 2018) as the administration of IV rtpa 
after this time point is associated with increased risk of haemorrhage (Hacke et al., 
2008) Multiparametric MRI reveals pathophysiological changes in the ischaemic 
brain parenchyma, enabling diagnosis, insight into the extent of on-going tissue 
damage, and inference of stroke duration (for a comprehensive review see 
Kauppinen, 2014). MRI may, therefore, aid treatment stratification of ischaemic 
stroke patients with unknown symptom onset time by identifying patients that (a) 
are likely to be within the 4.5 hour IV rtPA treatment window or (b) have sufficient 
viable tissue that would suggest they may benefit from reperfusion therapy 
regardless of onset time (Biggs et al., 2019; Etherton et al., 2018). This study 
focused on imaging methods aimed at achieving (a).  
 
MRI contrasts, including diffusion-weighted imaging (DWI) or the parametric 
measure of diffusion, the apparent diffusion coefficient (ADC), are extremely 
sensitive to ischaemia.  Studies using rodent models showed DWI signals increase 
and ADC values decrease sharply within minutes of ischaemia onset at the same 
cerebral blood flow (CBF) threshold for catastrophic energy failure (Busza et al., 
1992; Gröhn et al., 2000). Regions with low ADC, therefore, reflect tissue 
undergoing cytotoxic oedema and the associated cellular changes (Kauppinen, 
2014). The wide dynamic range of ADC provides an excellent contrast to the non-
ischaemic brain, and so is useful for diagnosing ischaemia and localising affected 
brain tissue (Burgess & Kidwell, 2011; Kauppinen, 2014). However, ADC values in 
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patients remain consistently low for several days after the insult (Schlaug et al., 
1997), making it an unsuitable parameter for stroke timing. Preclinical studies have 
shown that the T1 and T2 relaxation times that contribute to the signal of weighted 
images typically acquired in the clinic, such as DWI, T2 weighted (T2w) and T2w 
FLAIR, also change early during ischaemia but, compared to ADC, changes are 
small (Kauppinen, 2014). T1 and T2 relaxation times have been shown to have 
linear time dependency in rat stroke models (Chapter 5, Jokivarsi et al., 2010; 
McGarry et al., 2016a, 2016b) and, for T2 this has been translated to human stroke 
(Damion, Knight, McGarry et al., 2019; Duchaussoy et al., 2019; Siemonsen et al., 
2009), suggesting quantification of T2 may be a suitable method for stroke timing. 
 
As outlined in Chapter 4, the T2 relaxation-based signal changes that occur in DWI 
and FLAIR images after stroke have also been exploited for stroke timing using 
visual (Thomalla et al., 2011) and quantitative methods (e.g., Song et al., 2012). 
For both approaches, if the signal in the ischaemic region in the FLAIR image 
(identified by DWI or ADC) is deemed not to be hyperintense, it is likely that the 
patient is within the 4.5 hour treatment window and thus potentially eligible for 
rtPA.  For the visual DWI/FLAIR mismatch approach (see Chapter 4, Section 
4.4.2), the presence of a mismatch where ischaemia is visible on DWI but not 
FLAIR scans indicates patient eligibility (Thomalla et al., 2011). For the 
quantitative approach, eligibility is determined by whether the ratio of image 
intensity values between ischaemic and non-ischaemic reference regions is below a 
specific optimal cut-off (e.g., Song et al., 2012, Chapter 4). This approach has been 
studied using image intensities from ADC, DWI, T2w, FLAIR and T2 relaxation 
images in animal models of ischaemia (Chapter 5, McGarry et al., 2016b, Xu et al., 
2014) and ischaemic stroke patients (Knight, Damion, McGarry et al., 2019; Madai 
et al., 2016; Song et al., 2012; Wouters et al., 2018) but the overall performance of 
these parameters has not been directly compared in hyperacute stroke patients.   
 
The recent results of the ‘WAKE-UP’ stroke trial (Thomalla et al., 2018) in which 
patients with DWI/FLAIR mismatch treated with IV rtPA showed an 11.5% 
Chapter 7 | A pilot study comparing T2 relaxation-based MRI stroke timing methods in 




increased favourable outcome compared to placebo, have provided further impetus 
for investigating the clinical benefit and application of MRI for timing the ischaemic 
stroke. Potential stroke timing methods must be able to successfully discriminate 
between patients within and beyond the 4.5 hour rtPA time-window. High 
sensitivity is essential to identify as many patients as possible that are eligible for 
rtPA, and high specificity is also imperative in order to avoid potentially harmful 
treatment. In this pilot study (McGarry et al., 2020), the performance of 
quantitative and visual MRI based stroke timing methods derived from the same 
cohort of hyperacute ischaemic stroke patients was compared. The focus was on 
image intensity ratios of ADC, DWI, T2w, T2 relaxation and FLAIR images, and 
the DWI/FLAIR mismatch.   
 
Chapter 7 | A pilot study comparing T2 relaxation-based MRI stroke timing methods in 





Chapter 7 | A pilot study comparing T2 relaxation-based MRI stroke timing methods in 






Patients were recruited from North Bristol NHS Trust Frenchay and Southmead 
Hospitals (Bristol), Queen Elizabeth University Hospital (Glasgow) and University 
of Oxford Radcliffe Department of Medicine’s Acute Vascular Imaging Centre 
(Oxford). Time of witnessed symptom onset, National Institute Health Stroke Scale 
(NIHSS), and the attending physician’s stroke classification according to the 
Oxford Community Stroke Project Classification (Bamford et al., 1991) were 
recorded on admission. Before enrolment, all patients received NCCT scans and 
were treated according to the standard-of-care protocol, including administration 
of IV rtPA if eligible. Thrombectomy was not offered at any site.  
 
Patients, or their legal representative, provided informed consent. Enrolled patients 
had MRI scans within nine hours of symptom onset. Exclusion criteria after 
enrolment included: withdrawal from involvement in the study after initial consent, 
early termination of scan due to claustrophobia, unclear diagnosis, uncertainty 
regarding symptom onset time and error in scan protocol. Imaging related exclusion 
criteria included: no evident ischaemia on ADC images, movement artefacts, 
evidence of bilateral stroke, bias field problems in weighted images and presence of 
extensive white matter hyperintensities (WMH) on T2w images (see Figure 7.1 for 
example). It was important to remove these imaging factors from the dataset as 
the non-ischaemic tissue would provide an unreliable estimate of pre-ischaemic MR 
values. Exclusion of patients according to the above criteria was agreed upon by 
three raters with experience in MRI and stroke (RD, RAK, BLM). WMHs, or 
leukoaraiosis, are visible as white spots on T2w images of the brain (Wardlaw et 
al., 2015). These hyperintensities are presumed to have a vascular origin and are 
common in older subjects and patients with stroke and dementia (Wardlaw et al., 
2015). WMHs were considered extensive if both parenchymal and periventricular 
WMHs were present. An example of an excluded case is shown in Figure 7.1.  
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The study received ethical approval from the South West Frenchay Research Ethics 
Committee (ref 13/SW/0256), Scotland A REC (ref 16/SS/0223) and UK National 
Research Ethics Service committees (refs 12/SC/0292 and 13/SC/0362) for 
participants in Bristol, Oxford and Glasgow, respectively. Ethical approval allowed 
patients to be in the scanner for up to 20 minutes at Bristol and up to 30 minutes 
at Oxford and Glasgow. The total scan time allowed included set up of the patient 
and localisers as well as the MRI protocol. The study was carried out in accordance 
with the Declaration of Helsinki.  
 
Figure 7.1 Example of a T2 weighted 
image with extensive white matter 
hyperintensities., indicated by the yellow 
arrows. 
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All sites used a 3T MRI scanner with a 32-channel head coil (Bristol: Philips 
Achieva, Glasgow: Siemens Magnetom Prisma, Oxford: Siemens Magnetom Verio). 
The MRI protocol detailed in Table 7.1 included: multi b-value diffusion for 
computation of diffusion-weighted and ADC images, multi-echo T2 for computation 
of T2 relaxation and T2w images, and 3D T1w images for anatomical reference and 
registration. The approved scan time at Oxford and Glasgow enabled the 
acquisition of T2w FLAIR as well.  
 
7.3.3 Image processing and analysis 
Image processing and analysis steps are illustrated in Figure 7.2 and are described 
in detail below. These methods were developed and implemented by Knight, 
Damion, McGarry et al., (2019) and Damion, Knight, McGarry et al., (2019) and 
programs used included MATLAB release 2016b (The MathWorks, Inc., Natick, 
MA, US), FSL (FMRIB, Oxford, UK), MANGO version 4.1 (Research Imaging 
Institute, UT Health Science Center, San Antonio, USA) and SPM12 (Wellcome 
Trust Centre for Neuroimaging).  
 
Image registration  
To ensure correct alignment between voxels across all images and that the midline 
of the brain was consistently defined, for each patient, T1w, ADC, DWI, T2w, T2 
relaxation and FLAIR images were brain extracted using FSL BET (Smith, 2002) 
and registered to the same space. This involved non-linear registration of the ADC 
images to the T2w image space using FSL FNIRT via the diffusion S0 image and 
the echo summed T2w image. If T1w images were available, the T2w image space 
was linearly registered (six-degrees of freedom) to the T1w image space, which was 
subsequently registered to the MNI frame at 1mm3 isotropic resolution using FSL 
FLIRT (Jenkinson & Smith, 2001). Where T1w images were not available, the T2w 
Chapter 7 | A pilot study comparing T2 relaxation-based MRI stroke timing methods in 




image space was, instead, directly registered (linearly) to the MNI frame at 1 mm3 
isotropic resolution. All images were then linearly registered to the MNI frame using 
the registration maps (or combination of) generated by previous stages.  The 
quality of co-registration across all image types was assessed visually by two 
independent assessors using SPM12. All images were deemed to be acceptably co-
registered. 
 
Image computation  
For diffusion data using three orthogonal diffusion-sensitising gradients at a 
common b-value, orientation independent ADC images were calculated using: 
𝐴𝐷𝐶 =	− ln(𝑆A𝑆g𝑆h /𝑆#h)/3𝑏 
Where 𝑆# is the signal without diffusion weighting, 𝑏 is the b-value and 𝑆A, 𝑆g, 𝑆h 
are signal intensities at the three orthogonal directions.  
 
For diffusion-weighted data with 20 independent diffusion-gradient directions (𝑏 = 
1000 mm2 s-1) and three b = 0 images, ADC values were obtained from mean 
diffusivity maps, which were computed using FSL DTIFIT. Effective diffusion-
weighted images were created for 𝑏 = 1000 mm2/s using the registered S0 and ADC 
images via:	 
𝐷𝑊𝐼 = 𝑆#𝑒()A###	×	<9=) 
 
Echo-summed T2w images were computed by summing all echoes of the TE series, 
followed by bias correction using FSL FAST (Zhang et al., 2001). Calculation of 
T2 relaxation images involved fitting a mono-exponential decay on a voxel-wise 
basis (described in more detail in Chapter 3, Section 3.7.2).  
.   
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Identification of ischaemic tissue 
The definition of ischaemic voxels was those with ADC values > 0.2 – 0.4 µm2/ms 
and < 0.55 – 0.6 µm2/ms as well as ADC values less than one half-width half-
maximum from the median ADC of non-ischaemic tissue (Knight, Damion, 
McGarry et al. 2019). Limits of T2 > 30 ms and < 200 ms were also applied to 
reduce CSF contribution (Knight, Damion, McGarry et al. 2019). These criteria 
were used to create binary masks to define ischaemic volumes of interest (VOI).  
 
To ensure that all ischaemic regions were correctly identified by this automatic 
procedure, the location and size of the binary masks in relation to the hypointense 
regions on the ADC images were visually inspected by Dr Michael Knight and Dr 
Robin Damion. In some cases, the binary masks included small clusters of random 
voxels that were not close to the ischaemic region (due to spurious signals). In such 
cases, the masks were refined by removing all but the largest contiguous cluster, or 
clusters, in the cases where there was more than one ischaemic region (Knight, 
Damion, McGarry et al., 2019). The smallest acceptable cluster size was a user-
defined parameter, which was set on a case by case basis (Knight, Damion, 
McGarry et al., 2019). 
 
Selection of non-ischaemic reference VOIs required reflecting the ischaemic VOI 
about the midline of axial slices (medial/lateral), applying the above T2 limits and 
manually editing if CSF was visible within the VOI. VOIs with visible CSF 
containing volumes were evident as hyperintense regions near the ventricles, which 
was further confirmed by clear tails present in histograms of the signal distribution 
within the VOI. In such cases, VOIs were manually refined using the MANGO 
multi-image analysis GUI, which enables the areas corresponding to the histogram 
tails to be automatically selected and deleted from the VOI.     
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Computation of image intensity ratios 
To approximate changes in image intensities due to ischaemia, image intensity 
ratios were calculated for each patient and image type, which involved dividing the 
mean value in the ischaemic VOI by the mean value in the non-ischaemic reference 
VOI. Pre-ratio values were in milliseconds (ms) for T2 relaxation images, µm2/ ms 
for ADC, and signal intensities (SI, which as explained in Chapter 3, Section 3.7.1 
are the arbitrary numbers that represent the signal strength) for weighted images 
(DWI, T2w, FLAIR).  The purpose of computing ratios instead of using hemispheric 
differences in mean values (as per Siemonsen et al., 2009) was to reduce concerns 
that may arise from differences in pulse sequences, structures and parameters 
between imaging sites.   
 
Visual DWI/FLAIR mismatch  
Four independent raters with experience in stroke MRI assessed DWI and FLAIR 
images. Raters were blinded to clinical details and asked to identify cases showing 
a match (visible hyperintensities in the same region on DWI and FLAIR), a 
mismatch (visible hyperintensity on DWI, not FLAIR) or cases they were uncertain 
about (no response) For an example of match and mismatch cases see Figure 4.10 
(Chapter 4, Section 4.4.2). Raters viewed and windowed the images according to 
personal preference. An arbitrator with over 25 years of experience in stroke MRI 
assessed images where there was uncertainty or disagreement between raters. Final 
classification as match or mismatch was based on majority classification, or the 
arbitrator’s adjudication when there was a 2-2 split in opinion. 
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7.3.4 Statistical analysis 
Data from all 35 patients and the sub-cohort of the 17 patients with the additional 
FLAIR scans were analysed separately. This separation was to allow for a fair 
comparison of the performance of FLAIR with other MRI classifiers.  Statistical 
analysis was carried out using GraphPad Prism version 8.02 (GraphPad Software, 
La Jolla California USA), MedCalc Statistical Software version 19.0.5 (MedCalc 
Software bvba, Ostend, Belgium) and MATLAB release 2019a (The MathWorks, 
Inc., Natick, MA, US).  
 
Data were assessed for normality using the Shapiro-Wilk test (Shapiro & Wilk, 
1965). The difference between the average ADC values in the ischaemic VOI 
between thrombolysed and non-thrombolysed patients was assessed using unpaired 
t-tests. The relationships of image intensity ratios with time from symptom onset 
were assessed using Pearson’s correlations for normally distributed data and 
Spearman’s and Kendall’s correlations for non-normal data. Randolph’s free-
marginal Fleiss Kappa calculator (Randolph, 2005, 2008) was used to measure the 
agreement between the four DWI/FLAIR mismatch raters. All statistical tests were 
two-tailed with a significance level of p < 0.05. 95% confidence intervals (CI) were 
calculated as ± 1.96 * the standard error (SE) unless otherwise stated. The 
performance of MRI classifiers was compared using measures of accuracy (accuracy, 
sensitivity/recall, specificity), correctness (positive and negative predictive values), 
and probability (logistic regression) (described in Appendix A). 
 
All patients 
For a visual indication of the overall performance of MRI classifiers, Receiver 
Operating Characteristic (ROC) curves were plotted. For a numerical indication of 
overall performance, areas under the ROC curves (AUC) were calculated and 
statistically compared using non-parametric methods that control for multiple 
comparisons (DeLong et al., 1988). Optimal image intensity ratio cut-offs were 
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derived by the maximum Youden J Index, which identifies the cut-off that 
minimises misclassification by giving equal weight to sensitivity and specificity 
(Youden, 1950). Accuracy, sensitivity, specificity, positive predictive value (PPV) 
and negative predictive values (NPV) associated with these cut-offs were also 
calculated. 
 
For further insight into the predictive performance of MRI classifiers, a logistic 
regression analysis using MATLAB’s Classification Learner app was also 
performed. Predictive generalised linear models were produced for individual image 
intensity ratios (i.e., ADC ratio, DWI ratio, T2w ratio, T2 relaxation time ratio 
separately) as well as a combination of all of the image intensity ratios. Predictive 
generalised linear models took the form of:  
 
 U = a + b1c1 + b2c2 + b3c3 + b4c4 ...      
 
Where, U  is the predicted log odds of the patient being within the treatment 
window (U = 1 for onset time < 270 minutes, U  = 0 for onset time > 270 minutes), 
a is the estimated intercept, b1  is the estimated regression coefficient, c1...n  are the 
predictors (e.g. image intensity ratio of ADC, DWI, T2w, T2) (Peng et al., 2002). 








Where the closer P is to 1, the higher the probability that the patient is within the 
4.5 hour treatment window.  
 
Chapter 7 | A pilot study comparing T2 relaxation-based MRI stroke timing methods in 




For a visual indication of the predictive power of the models, probability plots for 
each qMRI parameter (i.e., ADC ratio, DWI ratio, T2w ratio, T2 relaxation time 
ratio) were generated. This involved calculating the probability of each patient 
being within the thrombolysis treatment window (P) and plotting these 
probabilities against the image intensity ratio of each patient, to produce the 
curves, shown in Figure 7.6 of the Results (where the x-axis is the image intensity 
ratio of the individual patient, and the y-axis is the estimated P). P for each patient 
was calculated by solving the probability equation above using the coefficients of 
the generalised linear models from the logistic regression (shown in Table 7.3 of the 
Results Section) and the image intensity ratio obtained from the individual patient.  
For comparison, the true classification of each patient (Y = 1 indicates within the 
treatment window, and Y = 0 indicates beyond the treatment window) was also 
plotted against the image intensity ratio (X-axis), to give two parallel lines that 
correspond to the dichotomous outcomes (Figure 7.6 of the Results Section).    
 
The overall performance of the models was evaluated by comparing the significance 
of the chi-squared statistic (c2) and comparing the Akaike information criterion 
(AIC) values (Akaike, 1974) corrected for sample size (AICc, see Appendix A), 
where a low AICc indicates a high-quality model (Symonds & Moussalli, 2011). For 
the combined model, the significance level of the t-statistic associated with each of 
the estimated coefficients (b) was used to assess the extent of the contribution of 
each parameter to the model.  
 
Sub-cohort with FLAIR MRI 
Different methods of evaluation were applied to the sub-cohort of patients with the 
additional FLAIR scans due to the imbalance in class sizes (n = 5 with onset times 
less than 4.5 hours, n = 12 with onset times greater than 4.5 hours). In datasets 
where there is a class imbalance, traditional ROC curves and AUCs are not 
recommended as they place more weight on the larger class and portray an overly 
optimistic view of overall performance (Berrar & Flach, 2012; Davis & Goadrich, 
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2006). Instead, in cases where there is low prevalence in the positive compared to 
the negative class (i.e., five patients within the treatment window in this study) it 
has been recommended to use performance metrics such as precision/PPV and 
recall/sensitivity, which do not use the true negative contingency class in their 
definitions (Berrar & Flach, 2012; Davis & Goadrich, 2006; Ozenne et al., 2015). 
Flach and Kull’s (2015) precision-recall-gain (PRG) approach performs well in 
class-imbalanced data sets while maintaining the benefits associated with ROC 
analysis, and so this method was used instead of traditional precision-recall 
approaches (Davis & Goadrich, 2006) and ROC analysis (see Flach & Kull, 2015 
and Appendix A).  
 
For a visual indication of the overall performance of MRI classifiers, precision-
recall-gain curves (PRG) were plotted and for a numerical indication, areas under 
the PRG curves (AUPRG) were calculated using open-source MATLAB software 
(see http://people.cs.bris.ac.uk/~flach/PRGcurves//). An AUPRG of zero 
indicates a trivial (random) classifier, and positive and negative AUPRGs indicate 
more and less optimal classifiers, respectively. In order to compare the performance 
of image intensity ratios with the visual DWI/FLAIR mismatch, F1 scores 
(Rijsbergen, 1979) were calculated for the DWI/FLAIR mismatch and image 
intensity ratio cut-offs. The F1 score gives equal weighting to the importance of 
precision and recall and is considered an appropriate evaluation measure for 
imbalanced data sets (Bekkar & Djemaa, 2013). For each parameter, the image 
intensity ratio with the highest F1 score was chosen for comparison.  
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Sixty-eight patients were enrolled in the study.  Thirty were not included in the 
final analysis due to: bilateral stroke (n = 4), extensive WMHs (n =2) for which 
the mirror-reference approach cannot be applied, no clear ischaemia on ADC scans 
(n = 11), uncertainty over stroke diagnosis (n = 3 ), movement artefacts (n = 1), 
ADC or T2 not acquired (n = 4 ), vague onset time (n = 3), MRI declined after 
consent (n = 1) and the early termination of scanning due to claustrophobia (n = 
1). 
 
A summary of the clinical and imaging characteristics of all 35 patients and the 
sub-cohort of 17 patients with FLAIR scans are shown in Table 7.2. On average, 
the MRI protocol lasted eight minutes at Bristol, 14 minutes at Glasgow and seven 
minutes at Oxford. Results for Shapiro-Wilk tests, Pearson’s, Spearman’s and 
Kendall’s correlations are given in Appendix B (Table B1). Mean ADC values 
(µm2/ms) in ischaemic and non-ischaemic-reference VOIs were consistent with 
previous reports in patients (Sener, 2001). There was no difference between average 
ADC values in ischaemic VOIs between thrombolysed and non-thrombolysed 
patients, for all 35 patients  (thrombolysed mean = 0.50, SD = 0.05 vs non-
thrombolysed mean = 0.54, SD = 0.05, t(33) = 2.02, p = 0.052) and the sub-cohort 
with FLAIR scans (thrombolysed mean = 0.49, SD = 0.06 vs non-thrombolysed 
mean = 0.54 SD = 0.02, t(15) = 1.35, p = 0.197) 
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Patients, n (%): 35 17 
Female, n (%): 13 (37.1 %) 3 (17.6%) 
Age, median (min - max): 68 (31 - 85) 67 (49 - 85) 




























Left hemisphere, n (%): 16 (45.7%) 9 (52.9%) 
Thrombolysis: 
Patients received rtPA, n (%) 
Median time from onset to rtPA, hours:mins (min-max) 
Median time from rtPA to MRI, hours:mins (min-max) 
 
26 (74.3%) 
2:05 (1:02 - 3:55) 
3:37 (0:29 - 7:18) 
 
14 (82.4%) 
2:32 (1:05 - 3:55) 
4:20 (1:10 - 7:18) 
Time from onset to MRI: 
All patients, median hours:mins (min-max) 
0 – £ 4.5 hours:  
patients, n (%) 
median hours:mins (min-max) 
> 4.5 – £ 9.5 hours: 
patients, n (%) 
median hours:mins (min-max) 
5:34 (2: 25 - 9:29) 
- 
16 (45.7%) 
3:22 (2:25 – 4:25) 
- 
19 (54.3%) 
6:55 (5:08 – 9:29)  
6:46 (2:28 - 9:29) 
- 
5 (29.4%) 
3:00 (2:28 – 3:10) 
- 
12 (70.6%) 
6:59 (5:34 – 9:29)  
VOI characteristics: 
Median ADC defined ischaemic volume, mL (min-max) 
Median ischaemic ADC, µm2/ms (min-max) 
Median non-ischaemic ADC, µm2/ms (min-max) 
1.99 (0.04 - 54.6) 
0.53 (0.39 - 0.58) 
0.77 (0.36 - 1.00) 
5.50 (0.11 – 25.01) 
0.51 (0.39 - 0.58) 
0.79 (0.69 - 0.89) 
Note. rtPA = recombinant tissue plasminogen activator. *Scores on the National Institutes of Health Stroke Scale 
(NIHSS) range from 0 - 42, higher scores indicate greater deficit. †Strokes classified according to the Oxford Stroke 
Classification Scale (Bamford et al., 1991). LACS = Lacunar, PACS= Partial Anterior Circulation, POCS = 
Posterior Circulation, TACS = Total Anterior Circulation. VOI = volume of interest. ADC = apparent diffusion 
coefficient. mL = millilitres, ms = milliseconds.  
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7.4.1 All 35 patients 
The T2 relaxation time intensity ratio was the only parameter that correlated 
significantly with time from symptom onset (Figure 7.3). All correlation coefficients 
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Safe to treat and estimated unsafe (FN) Unsafe to treat and estimated safe (FP)
Unsafe to treat and estimated unsafe (TN) 
A. ADC B. DWI










Time from symptom onset (minutes)
rs = 0.22, p = 0.201
rs = 0.15, p = 0.395r = - 0.07, p = 0.708
> 0.536
< 1.074 < 1.072
< 1.494
4.5 hours 4.5 hours
4.5 hours 4.5 hours
Figure 7.3 Relationship of image intensity ratios with time from symptom onset for A. 
ADC, B. DWI, C. T2w and D. the T2 relaxation time. Correlation coefficients and p values 
are shown for each parameter. Pearson’s correlation coefficients (r) are shown for ADC and 
T2 as they were normally distributed. Spearman's rank correlation coefficients (rs) are shown 
for DWI and T2w as they were not normally distributed. Horizontal dashed lines represent 
optimal image intensity ratio cut-offs identified by the maximum Youden J index, which 
are labelled to the right of each Figure. Vertical solid lines represent the 4.5 hour 
thrombolysis treatment-window cut-off. Data points represent individual patients and are 
colour-coded according to the classification instructed by the optimal image intensity ratios. 
Green indicates a true positive case (TP), blue indicates a true negative case (TN), purple 
indicates a false negative case (FN) and red indicates a false positive case (FP). Data is 
from all 35 patients. 
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The T2 relaxation time image intensity ratio also showed the highest overall ability 
at distinguishing between patients scanned before and after 4.5 hours as the ROC 
curve was closer to the top left-hand corner of the ROC graph, and it was the only 
parameter with a significantly high AUC (Figure 7.4). There was no statistical 
difference between the AUCs of any of the parameters (statistics shown in 



























T2 = 0.77 (0.60 - 0.91), p < 0.001
T2w = 0.66 (0.48 - 0.81), p = 0.084








ADC = 0.55 (0.37 - 0.72), p = 0.645
Figure 7.4 ROC curves showing the overall ability of image intensity ratios for 
distinguishing between ischaemic stroke patients scanned before or after 4.5 hours from 
symptom onset. Lines closer to the grey dashed 0.5 reference line indicates parameters 
with poor overall ability. The closer the line to the top left-hand corner of the ROC 
graph, the higher the overall ability. AUC and p values are displayed for each MRI 
parameter with 95% binomial exact confidence intervals in brackets. An AUC with p > 
0.05 indicates an AUC that does not significantly differ from an AUC of 0.5 and therefore 
performs no better than chance. Results are from all 35 patients. 
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Figure 7.5 shows accuracy, sensitivity and specificity values for optimal image 
intensity ratio cut-offs. As seen, the T2 relaxation time ratio had the highest 
accuracy, and the sensitivity and specificity levels were high and comparable. For 
ADC, DWI and T2w there was a trade-off, where most patients within the 
thrombolysis time-window were correctly identified (high sensitivity) but at the 
expense of falsely regarding many patients beyond the time-window as within it 
(low specificity). With these optimal image intensity-ratio cut-offs, PPVs were 
calculated for T2 (70.59% CI: 51.79 – 84.28), ADC (50.0% CI: 45.15 - 54.85), DWI 
(59.09 % CI: 45.97 – 71.03), and T2w (57.14% CI: 43.43 – 69.84), and indicate that 
the T2 ratio has the highest probability of correctly predicting whether a patient 
that is identified by this parameter as being within the treatment window, is 
actually within the window. Except for ADC, where NPV = 100%, NPVs were 
comparable for DWI (76.92% CI = 52.46 – 86.6), T2w (71.43% CI = 49.16 – 86.6) 
and T2 (77.78% CI = 58.97 – 89.50). The performance of image intensity ratio cut-
offs is further illustrated in Figure 7.3, which shows how patients were classified 
when cut-offs were applied. 
 
 
Figure 7.5 Accuracy, sensitivity and specificity of optimal image intensity ratio cut-offs 
identified by the maximum Youden J index. For each parameter, the first bar represents 
the accuracy, the second represents sensitivity, and the third represents specificity. 
Corresponding values are labelled above the error bars, which represent the 95% confidence 
intervals.  Results are from all 35 patients. 
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Derived from logistic regressions, Figure 7.6 depicts that the probability that a 
patient is within the treatment window is higher when the DWI, T2w and T2 ratios 
are smaller and that the T2 relaxation time ratio offers the highest probability (up 
to 90%). As the ADC values decrease during ischaemia, higher ADC ratios indicate 
a higher probability of being within the treatment window. However, of those plots 
displayed in Figure 7.6, the results of the regressions indicate that only the T2 
relaxation time and the T2w ratios were significant predictors of whether the 
patient was within the treatment window (Table 7.3).  
 
Table 7.3 also shows that the combined model involving all four image intensity 
ratios significantly predicted the probability of a patient being within the treatment 
window, but not to the same extent as the single-parameter regressions on the T2w 
ratio and, in particular, the T2 relaxation time ratio. Closer examination of the 
contribution of each parameter in the combined model (p values, Table 7.3) shows 
that the intercept was the only significant contributor to the model and that the 
T2 ratio, though not significant, had the most dominant contribution (p = 0.068). 
Overall, the T2 relaxation time ratio only model was the best predictor of whether 
a patient was within or beyond the treatment window and compared to other 
models, it was the most significant and had the lowest AICc.     
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Figure 7.6 Probability plots for A. ADC, B. DWI, C. T2w, and D. T2 relaxation time 
image intensity ratios, derived from all 35 patients. The curves are the logistic fits that 
model the probability of a patient being within the 4.5 hour thrombolysis treatment window 
(y-axis) as a function of the image intensity ratio (x-axis). Dots represent image intensity 
ratios of individual patients that are within (U = 1) or beyond (U = 0) the treatment 
window. 
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Table 7.3 Information for the logistic regression analysis. 
 
    Overall model evaluation 
Model b (SE) t-
statistic 
p c2 df p AIC 
ADC    0.24 33 0.626 52.03 
ADC ratio 1.79 (3.68) 0.49 0.627 - - - - 
Intercept -1.34(2.43) -0.55 0.582 - - - - 
        
DWI    2.76 33 0.097 49.50 
DWI ratio -2.44(1.61) -1.51 0.130 - - - - 
Intercept 3.34 (2.33) 1.44 0.150 - - - - 
        
T2w - - - 5.38 33 0.020* 46.88 
T2w ratio -10.05 (5.29) -1.90 0.057 - - - - 
Intercept 10.514 (5.58) 1.88 0.060 - - - - 
        
T2    8.41 33 0.004* 43.85 
T2 ratio -17.13 (7.09) -2.42 0.016* - - - - 
Intercept 18.3 (7.64) 2.39 0.017* - - - - 
        
Combined    9.75 30 0.045* 48.52 
Intercept 22.05 (10.23) 2.15 0.031* - - - - 
ADC ratio -0.07 (5.90) -0.01 0.990 - - - - 
DWI ratio 0.72 (3.52) 0.21 0.837 - - - - 
T2w ratio -7.57 (8.78) -0.86 0.389 - - - - 
T2 ratio  -14.05 (7.69) -1.83 0.068 - - - - 
Note. b is the estimated coefficient of the ratio or intercept, SE is the estimated standard 
error of b, t-statistic = b divided by the SE, p is the significance level, * indicates p < .05, c2   
is the chi-squared statistic, df = degrees of freedom, AIC = Akaike information criterion. 
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7.4.2 Sub-cohort with FLAIR MRI 
The agreement between raters of the DWI/FLAIR mismatch was intermediate to 
good, with a free marginal Fleiss’ kappa value of 0.59 (CI = 0.36 – 0.82), and 72.8% 
agreement (Randolph, 2005). All image intensity ratios did not correlate 
significantly with time from symptom onset (Appendix B Table B1), likely due to 
the small number of patients in the sub-cohort (Table 7.2). Figure 7.7 shows the 
PRG curves and associated AUPRGs. The AUPRGs were highest for the T2 
relaxation time ratio and DWI ratio, suggesting both parameters have good overall 
ability at identifying patients within the thrombolysis treatment window. However, 
the T2 relaxation time curve was closest to the top right-hand corner of the graph, 
possibly suggesting a superior ability to the T2w ratio. The AUPRGs were lowest 
for the T2w and FLAIR ratios, demonstrating poor overall ability. Superior 
performance of T2 relaxation compared to other parameters was also reflected by 
the F1 score which was highest for the T2 relaxation time ratio (0.73, CI = 0.52 - 
0.94), lower for the ADC (0.59, CI = 0.35 – 0.82), DWI (0.67, CI = 0.44 – 0.89), 
T2w (0.59, CI = 0.35 - 0.82) and FLAIR (0.57 CI = 0.34 – 0.81) ratios, and very 
low for the DWI/FLAIR mismatch (0.25, CI = 0.15 – 0.35).  
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A. ADC B. DWI
C. T2w D. T2
E. FLAIR
AUPRG
A.  ADC = 0.56 (0.32 - 0.80)
B.  DWI = 0.69 (0.47 - 0.91)
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Figure 7.7 Precision-recall-gain (PRG) curves and areas under the PRG (AUPRG) curves 
from the sub-cohort of patients with additional FLAIR scans. The y-axis shows precision-
gain, and the x-axis shows recall-gain values. Lines closest to the top right of the graph 
indicate parameters with high overall ability to identify patients scanned before 4.5 hours. 
An AUPRG of zero indicates a trivial classifier, and positive and negative AUPRGs indicate 
more and less optimal classifiers, respectively. AUPRG values are given, with 95% 
confidence intervals in brackets. 
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In this study, the overall performance of quantitative and visual MRI based 
methods for estimating stroke onset time, in the same cohort of hyperacute stroke 
patients was compared (McGarry et al., 2020). The T2 relaxation time ratio 
outperformed ADC, DWI, T2w, FLAIR image intensity ratios and the visual 
DWI/FLAIR mismatch, and combining ADC, DWI, T2w and T2 ratios showed no 
benefit. Results, therefore, suggest that the acquisition of T2 relaxation times, with 
ADC for identification of the ischaemic region, may be sufficient for estimating 
stroke onset time (McGarry et al., 2020).   
 
The results of this study support recent conclusions drawn from preclinical 
(Chapter 5, McGarry et al., 2016a; Rogers, McGarry et al., 2014) and clinical 
studies (Damion, Knight, McGarry et al., 2019; Duchaussoy et al., 2019) that the 
T2 relaxation time detects brain ischaemia and estimates onset time more 
accurately than MRI parameters derived from weighted images (McGarry et al., 
2020). Studies in rat models of ischaemia reported strong relationships of the T2 
relaxation with time from stroke onset (Chapter 5, McGarry et al., 2016a, 2016b) 
and that onset time estimates made with T2 had a lower margin of error than when 
intensities of weighted images were used (McGarry et al., 2016a; Norton et al., 
2017; Rogers, McGarry et al., 2014). The T2 relaxation time also demonstrated 
higher overall ability at differentiating between scans performed before and after 
three hours from ischaemia onset in rat models (Chapter 5, McGarry et al., 2016b). 
 
As will be discussed further in the General Discussion of this thesis (Chapter 9), 
this study adds to knowledge in stroke timing literature by providing the first direct 
comparison of the performance of the parametric approach to qMRI (i.e., ADC and 
the T2 relaxation time) as a method for stroke timing with commonly researched 
timing methods based on the signals in weighted images (i.e., the DWI/FLAIR 
mismatch, DWI ratio, T2w ratio, FLAIR ratio). Previous to this study, there had 
been a range of clinical studies on the performance of individual MRI based stroke 
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timing, for example, separate studies on DWI/FLAIR mismatch (e.g., Aoki et al., 
2010; Thomalla et al., 2011, 2018), the DWI image intensity ratio (e. g., Chen et 
al., 2019; Emeriau et al., 2016; Wouters et al., 2018), the FLAIR image intensity 
ratio (e.g., Song et al., 2012; Wouters et al., 2016) and the T2 relaxation time ratio 
(e.g., Duchaussoy et al., 2019; Damion, Knight, McGarry et al., 2019; Knight, 
Damion, McGarry et al., 2019; Siemonsen et al., 2009). There had also been studies 
comparing one or more approaches, for example, the performance of the visual 
based DWI/FLAIR mismatch versus the performance of signal intensity ratios 
represented in weighted images (e.g., Cheng et al., 2013; Emeraiu et al., 2016; 
Madai et al., 2016; Petkova et al., 2010) and the strength of the correlation of 
FLAIR image intensity ratio compared to the T2 relaxation time ratio (Duchaussoy 
et al., 2019). Thus, before this study, it was not clear which MRI stroke timing 
method should be studied further. As a result of this study, it is now clear that the 
T2 relaxation time requires further study as a stroke timing parameters. 
 
Patient studies have shown the T2 relaxation time to have a strong linear 
relationship with time from symptom onset and high overall ability at 
distinguishing between patients within and beyond the thrombolysis time-window 
(Duchaussoy et al., 2019; Knight, Damion, McGarry et al., 2019; Siemonsen et al., 
2009). In this study, the AUC of the T2 relaxation time ratio shows that 77% of 
the time a randomly selected patient scanned within 4.5 hours of symptom onset 
had a lower T2 than a randomly selected patient scanned at a time later than 4.5 
hours. Similarly, previous patient studies have reported 76% using hemispheric 
differences in T2 relaxation times at 1.5T for a three hour time-window (Siemonsen 
et al., 2009), and at 3T for a 4.5 hour time-window, 71% using the T2 change 
(difference) and 81% using a user-independent technique to quantify T2 changes 
(Knight, Damion, McGarry et al., 2019).  
 
The potential utility of FLAIR imaging for estimating onset time has received 
considerable attention within the stroke imaging literature (e.g., see Etherton et 
al., 2018 for review) but has only recently been directly compared to the T2 
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relaxation time (Duchaussoy et al., 2019). Results by Duchaussoy et al. (2019) and 
from this study, suggest that the T2 relaxation time will provide a more accurate 
estimation of stroke onset time than FLAIR-based approaches. Duchaussoy et al. 
(2019) reported a stronger relationship for T2 relaxation with time from symptom 
onset compared to FLAIR image intensities (T2: r = 0.65 vs FLAIR: r = 0.18) in a 
cohort of stroke patients scanned within 4.5 hours of symptom onset. Here these 
findings were extended by showing that the stronger relationship with time also 
applies when scans performed up to nine hours from symptom onset are considered 
(all patients: r = 0.49(T2); sub-cohort: r = 0.35(T2), rs = 0.25(FLAIR). This 
extension across a longer time frame is important because it is well recognised that 
the signal of FLAIR images does not increase much within the first 4.5 hours of 
symptom onset (the premise of the DWI/FLAIR mismatch approach). Therefore, 
the low correlation of FLAIR with time reported by Duchaussoy et al. (2019) could 
just be representative of the limited time frame for which FLAIR was measured. 
Furthermore, although in early 2020, the licencing limit for rtPA is still 4.5 hours, 
as IA rtPA and mechanical thrombectomy start to become more routine practice 
in hospitals, there will be greater need to identify patients within six hours of 
symptom onset for IA rtPA. (Berkhemer et al., 2015) and between six and 24 hours 
for thrombectomy (Nogueira et al., 2018; Powers et al., 2018). 
 
In further support of previous research, in the sub-cohort of patients with additional 
FLAIR scans, the T2 relaxation time ratio demonstrated a much higher overall 
ability than the FLAIR ratio at identifying patients scanned within the 
thrombolysis treatment window. The ability of the FLAIR ratio and the 
DWI/FLAIR mismatch approach was comparatively weak, which is in accordance 
with previous studies that have reported low sensitivity of FLAIR-based methods 
(e.g., Ebinger et al., 2010; and see Wouters et al., 2014 and Etherton et al., 2018 
for reviews). The changes in T2 relaxation that occur during early ischaemia reflect 
the radical changes in water dynamics caused by anoxic depolarisation, whereby 
water is shifted from the extracellular to intracellular compartment, followed by 
the time-dependent breakdown of intracellular macromolecules (Knight, McGarry 
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et al., 2016). The same pathophysiological factors that cause changes in T2 
relaxation therefore also contribute to the signal of images with a T2 weighted 
component, which will explain why other patient studies have reported a 
relationship for DWI and FLAIR image intensities with time from symptom onset 
(e.g., Chen et al., 2019; Wouters et al., 2018).  
 
It is likely that the relationships of the DWI ratio and FLAIR ratios with time 
from symptom onset were not detected in this study because it was not powered 
to detect a relationship in these specific parameters. Wouters et al. (2018) reported 
a moderate correlation of the FLAIR ratio with time from symptom onset (r = 0.4, 
p < 0.01) in a clinical cohort scanned in the same time frame as the present study 
(within nine hours of symptom onset).  Based on Wouters et al.’s (2018) r value, a 
priori power analysis (see Appendix A for the power analysis output) showed that 
to be able to detect the same strong relationships with 90% probability and p < 
0.05, at least 61 FLAIR scans within nine hours of onset would be required. 
Whereas, based on Siemonsen et al.’s (2009) correlation of T2 differences (r = 0.5, 
within six hours of onset) and the present study’s correlation of the T2 image 
intensity ratio (r = 0.5 within 9 hours of onset), to be able to detect a relationship 
of T2 with time,  with 90% probability and p < 0.05, at least 37 patients would be 
required. This power analysis suggests the present study, which had 35 patients, 
was powered to detect the relationship with T2 over time, but not FLAIR and 
further indicates T2 is a more robust parameter for onset time estimation, as it is 
a more easily detectable qMRI parameter. 
 
Despite the complexity of contributions to the measured T2 relaxation time, being 
a single quantitative parameter, it is a more accurate measure of stroke onset time 
(and, possibly, of pathophysiological changes in ischaemia) than image intensities 
from weighted images which are also influenced by other factors such as proton-
density, T1 relaxation, pulse sequence parameters, and inhomogeneities in B0 and 
B1. The increase in T1 relaxation during ischaemia would decrease the T2w and 
FLAIR signals in ischaemic regions unless the images are acquired with very long 
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TR (>10000 ms at 3T) (McGarry et al., 2016a), which may explain why T2w and 
FLAIR ratios did not increase significantly in this study. Bias field problems are 
particularly problematic in weighted images and would result in a 
misrepresentation of the change in MR signals due to ischaemia. The benefit of 
quantifying the T2 relaxation time is that in computing the T2 images, sources of 
error described above are removed. Thus, using T2 relaxation instead of weighted 
images for stroke timing utilises the dependence of T2 on ischaemia while removing 
confounding factors, making it a potentially more reliable stroke timer.  
 
This study has some limitations that require consideration. Firstly, it was a pilot 
study with a modestly sized unselected cohort of people with stroke symptoms, 
consisting of strokes of varying size and severity, that occurred in different vascular 
territories and tissue types. Recent results suggest the time dependency of T2 during 
the first nine hours of stroke does not differ between grey and white matter 
(Damion, Knight, McGarry et al., 2019) but it is currently unclear whether this is 
true for different vascular territories. A previous study found the size of the 
ischaemic region to be a mediating factor in the relationship of DWI image intensity 
ratios with time from onset (Madai et al., 2016). It is, therefore, possible that the 
wide range of ischaemic regions sizes included in this study introduced some 
variability in the data, which could underlie the weak correlations of some of the 
parameters. Other clinical variables, which could not be accounted for in this study, 
may also affect the relationship of image intensity ratios over time. For example, 
collateral status has been shown to influence the relationship of FLAIR image 
intensities with time from symptom onset (Wouters et al., 2016).  
 
Secondly, due to the clinical nature of the study, the majority of MRI scans were 
acquired after thrombolysis was administered (74.3% all patients and 82.4% in sub-
cohort), which is not representative of patients with an unknown onset time. 
Nevertheless, it is unlikely that rtPA will have had a significant impact on T2 values 
within the ischaemic region as the average ADC values in ischaemic VOIs of the 
thrombolysed patients were not significantly different to the low ADC values of 
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non-thrombolysed patients. Preclinical data suggests that if the ADC remains low 
following reperfusion, T2 continues to increase with time (Kettunen et al.., 2002). 
Additionally, a recent patient study showed rtPA does not alter net water uptake 
in the ischaemic region (Broocks et al., 2020) and so by extension, T2, which also 
reflects net water uptake, should not be altered.  Furthermore, in a recent analysis 
of the patient cohort studied here, the size of ADC defined ischaemic VOIs 
increased in 11 out of 19 thrombolysed patients between the initial (< 9 hours 
onset) and follow-up scans (24+ hours), suggesting that ADC remained low long 
after rtPA, and thus rtPA would have had minimal or no effect on T2 in the 
ischaemic region (Damion, Knight, McGarry et al., 2019). However, to truly 
support this point, more information about blood flow would be needed.   
 
Given the above limitations, further investigation in a larger patient cohort is 
required. Such a study would enable more FLAIR scans so that the FLAIR image 
intensity ratio and DWI/FLAIR mismatch can be compared fully with other 
parameters. Additional scans should be acquired that offer information on collateral 
status to determine the effects of thrombolysis, and whether it mediates the 
relationship of other MR parameters with time from onset. A more extensive study 
would also allow separation of data analysis into different vascular territories and 
the size of ischaemic tissue and should involve validation of results in an unseen 
test data set.  
 
In conclusion, this study suggests that the T2 relaxation time is the most accurate 
and reliable measure for estimating stroke onset time and that relying on weighted 
images as a method for stroke timing may be problematic. It also suggests that 
quantifying ADC for identification of ischaemic tissue and quantifying T2 for onset 
time estimation will be sufficient, and other parameters are not needed.  In terms 
of clinical practice and feasibility, quantifying ADC and T2 relaxation times for 
onset time estimation requires minimal image processing. The MRI protocol 
adopted here is based on commonly available pulse sequences provided by all MRI 
vendors. Diffusion and multi-echo T2 are quick and easy to acquire (~ 5 minutes 
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maximum, in total, in this study), and most scanners automatically produce ADC 
and T2 relaxation time images.  
 
With the advent of magnetic resonance fingerprinting (MRF) (Ma et al., 2013; 
Chapter 3 Section 3.7.3) under-sampled image acquisition of both ADC and T2 
parameters could result in even shorter acquisition times, which is imperative in 
emergencies such as ischaemic stroke where ‘time is brain’ (Saver, 2006). The 
clinical feasibility of using MRF for the assessment of hyperacute stroke patients 
has recently been demonstrated, where 2D T1 and FLAIR images and T1 and T2 
relaxation time maps were acquired simultaneously within four minutes and 24 
seconds (Duchaussoy et al., 2019). It typically takes about one minute to acquire a 
full NCCT head scan but given all the extra information that can be obtained with 
MRF, the extra three to four minutes would be a worthwhile trade-off. The post-
processing steps used in this Chapter were exploratory and not designed for a 
clinical setting. However fast and automatic delineation of ischaemic regions on 
ADC images is already widely available (e.g., Straka et al., 2010) and at the 
University of Bristol, we have recently proposed a user-independent method for 
quantifying the impact of stroke on the human brain which has the potential to be 
easily automated for a clinical setting (Knight, Damion, McGarry et al., 2019).  
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The results of the previous chapters in this thesis suggest that quantifying the 
change in the T2 relaxation time due to ischaemia can provide an estimate of stroke 
onset time. However, the methods considered are dependent on non-ischaemic 
voxels as a reference for pre-ischaemic T2 values, which may be problematic due to 
inherently varying T2 relaxation times across the brain and common neurological 
co-morbidities in stroke patients. Studies in rats suggest the distribution of T2 
relaxation times within the ADC defined ischaemic region is informative of stroke 
onset time (e.g., Chapter 5, McGarry et al., 2016a; Rogers, McGarry et al., 2014) 
and so a reference-independent method based on the T2 distribution has been 
suggested as a potential proxy for stroke timing (Norton et al., 2017). This study 
examined the distribution of T2 relaxation times within ischaemic regions of 
hyperacute ischaemic stroke patients. The goal was to establish which, if any, 
distributional parameters have a relationship with time from stroke onset and 
could, therefore, provide a means to develop a reference-independent timing tool 
for human stroke.  
 
ADC and T2 relaxation time data from 23 ischaemic stroke patients, with onset 
time less than nine hours and low ADC defined ischaemic region greater than 0.5 
ml were analysed. Ischaemic and non-ischaemic volumes of interest (VOI) were 
segmented into grey matter (GM) and white matter (WM) VOIs and analysed 
separately. Probability distributions that best described the empirical distribution 
of T2 relaxation times within the VOIs were identified. For each patient and VOI 
type, the parameters of the probability distributions were estimated and used to 
design linear regression models. Linear regression models incorporating the 
standard deviation (SD) of T2 and the reference-dependent T2 image intensity ratio, 
were also created for comparison. All regressors were trained and tested using leave 
one out cross-validation (LOOCV).  
 
For whole ischaemic regions, the reference-dependent T2 image intensity ratio was 
the only variable that had a relationship with time from symptom onset. The 
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reference-dependent and reference-independent regressors were not significant for 
ischaemic WM. Significant regression models for GM included a second-order 
polynomial with parameters of the Burr type X11 distribution as predictor variables 
(reference-independent) and a multiple linear regression model with the T2 mean, 
SD and image intensity ratio as predictor variables (reference-dependent). Overall 
results suggest, that reference-independent distributional parameters in GM may 
be informative of stroke onset time in patients and that the reference-dependent 
approach applied to the whole ADC defined ischaemic region is more accurate and 
may, therefore, be more suitable for clinical settings.  
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Quantitative MRI (qMRI) could be used to identify ischaemic stroke patients with 
an unknown onset time that are within the treatment time window for 
thrombolysis. As described in Chapter 4 (Section 4.4), patient eligibility may be 
determined in a binary fashion, where a patient is deemed to be within the 4.5 hour 
treatment window if the measured qMRI parameter (e.g., image intensity ratio or 
the f2 parameter defined in Chapter 5) is below a certain threshold (applied in 
Chapters 5 and 7) or if the predictive probability is high (applied in Chapter 7).  
Alternatively, the amount of time that has passed since stroke onset can be 
estimated by inserting the measured qMRI parameter into a linear regression model 
(e.g., Jokivarsi et al., 2010; McGarry et al., 2016a; Norton et al., 2017; Rogers, 
McGarry et al., 2014). For both approaches, results of previous research 
(Duchaussoy et al., 2019; McGarry et al., 2016a, 2016b; Rogers, McGarry et al., 
2014; Siemonsen et al., 2009) and Chapters 5 and 7 suggest that compared to 
methods that rely on intensities of weighted images, the T2 relaxation time is a 
more robust MRI variable, which may provide a more reliable stroke timer. 
 
Despite the T2 relaxation time showing superior ability to the other MRI 
parameters considered in this thesis, the ability to estimate stroke onset time was 
not perfect, and there is still room for improvement. For example, in Chapter 7, 
the optimal T2 relaxation time cut-off was the most accurate at differentiating 
between patients scanned before and after 4.5 hours from symptom onset, but the 
accuracy of 75% meant 25% of patients were still misclassified. As discussed in 
Chapter 7, several factors may contribute to errors in estimates of onset time, 
including vascular territory, size of the ischaemic region, collateral status, clinical 
characteristics, and common neurological co-morbidities in aged stroke patients.  
 
As described in Chapter 4 (Section 4.4) the standard approach for estimating stroke 
onset time using the T2 relaxation time typically involves estimating the change in 
T2 due to ischaemia by using the non-ischaemic voxels in the mirror-reference 
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region as an indication of pre-ischaemic or ‘normal’ T2 values (e.g., Chapter 5; 
Chapter 7; McGarry et al., 2016a, 2016b; Siemonsen et al., 2009; Song et al., 2012). 
However, an accurate estimate of pre-ischaemic T2 will be challenging to obtain 
due to lack of perfect anatomical symmetry between hemispheres and inherently 
varying relaxation times across the brain (Knight, McCann, Tsivos, Coulthard et 
al., 2016; Wansapura et al., 1999). T2 relaxation anisotropy, where the measured 
T2 depends on the positioning of the patients head relative to the applied magnetic 
field, is likely to be another source of error, especially in WM (Knight et al., 2015). 
As these variations in T2 are larger than the changes caused by ischaemia, the 
increase in T2 due to ischaemia cannot be calculated with certainty, which will 
contribute to errors in estimates of stroke onset time (Knight, Damion, McGarry 
et al., 2019; Norton et al., 2017). Even in rat models of ischaemia, where, 
structurally, the brain is relatively homogenous consisting mainly of grey matter 
(GM) (Zhang & Sejnowski, 2000), Norton et al. (2017) found the placement of the 
mirror-reference region influenced the overall precision of onset time estimates in 
rats, resulting in larger uncertainties in stroke timing than have been reported 
previously (e.g., McGarry et al., 2016a; Rogers, McGarry et al., 2014).  
 
Preclinical studies in rats point to the possibility that the distribution of relaxation 
times within ADC defined ischaemic regions, which can be considered an indicator 
of the heterogeneity of tissue state, is more informative of stroke onset time than 
the change in average T2 relaxation time (e.g., Chapter 5; McGarry et al., 2016a, 
2016b; Rogers, McGarry et al., 2014). In Chapter 5 (McGarry et al. 2016b), the 
distributional parameters f1, f2 and Voverlap, which represent the volume of tissue 
with high relaxation times relative to the size of the ADC defined ischaemic region 
demonstrated better overall ability at distinguishing between scans performed 
before and after three hours from ischaemia onset than image intensity ratios.  
Rogers, McGarry et al. (2014) also found that by quantifying the spatial 
distribution of significantly elevated T2 relaxation times within the ischaemic 
region, an estimate of 4.5 hours since ischaemia onset had an uncertainty of ± 26 
minutes, compared to ± 35 minutes when using the change in T2. However, as with 
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the reference-dependent approach, these studies also relied on the non-ischaemic 
mirror-reference voxels to determine which voxels were comparatively ‘high’ in the 
ischaemic region  
 
Norton et al. (2017) developed a stroke timing method in rats that avoids the need 
for a non-ischaemic reference by exploiting the information of the empirical 
distributions of T2 within ADC defined ischaemic regions.  This method involved 
finding a probability distribution that best described the empirical distribution of 
the T2 relaxation time within the ischaemic region and using the parameters 
associated with the probability distribution to design linear regression models that 
could be used to estimate stroke onset time (Norton et al., 2017). A third-order 
polynomial regression model with parameters of the log-logistic probability 
distribution as predictive variables was a significant predictor of time since MCAo 
(Norton et al., 2017). This reference-independent regressor provided more accurate 
estimates of stroke onset time than the reference-dependent approach (Norton et 
al., 2017). A third-order polynomial includes squared and cubed terms of the 
predictive variables used in the linear model, which accounts for nonlinear 
relationships in the data (James et al., 2013). Norton et al.’s (2017) study, therefore, 
suggests distribution based qMRI parameters are related to onset time, but unlike 
the image intensity ratios studied in Chapter 5 and Chapter 7, this relationship is 
not necessarily linear.  
 
Madai et al. (2016) suggested another reference-independent approach for 
estimating stroke onset time, which involved quantifying the standard deviation 
(SD) of diffusion weighted image intensities within the DWI bright ischaemic 
region. Using this method, ischaemic stroke patients scanned before and after 4.5 
hours of symptom onset were identified with 85% accuracy. The explanation for 
this result was similar to the explanation given for f2 in Chapter 5. The DWI SD 
is a reflection of heterogeneity of ischaemic tissue, where, in the earlier hours, the 
DWI SD is large as the ischaemic region contains a combination of voxels with 
bright and duller signals indicating infarcted and normal tissue respectively (Madai 
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et al., 2016). As the ischaemic region progresses to infarction, the number of bright 
voxels relative to the number of duller voxels increase, therefore lowering the SD 
(Madai et al., 2016). Given that the T2 relaxation time contributes to the signal of 
DWI, and in the previous Chapters T2 was more informative of stroke onset time 
than DWI, the T2 SD could also be informative of stroke onset time. Motivated by 
the encouraging results of distribution-based methods for estimating onset time 
discussed above, this study examined the distribution of T2 relaxation times within 
the ischaemic tissue of hyperacute ischaemic stroke patients. The primary aims 
were to: 
a) Identify the probability distributions that best describe the distribution of T2 
relaxation times within the whole ADC defined ischaemic region as well as 
ischaemic regions segmented into GM and WM tissue types. As much of the 
T2 distribution-based work for onset time estimation has been conducted in 
rats (e.g., McGarry et al., 2016a, 2016b, 2017; Norton et al., 2017.) GM and 
WM were studied separately because human GM is closer to the cell 
composition of the rat brain (Zhang & Sejnowski, 2000). Also, as discussed in 
Chapter 6 the evolution of ischaemic injury differs between tissue types due to 
differences in structure, metabolism, haemodynamics and electrophysiology 
(Berner et al., 2016; Kumura et al., 1999).  
b) For whole, GM only and WM only ischaemic regions, create linear regression 
models using the estimated parameters of the probability distributions 
identified in a) as well as the T2 SD as variables, to determine which, if any, 
aspects of the T2 distribution, have a relationship with time from symptom 
onset.  
c) Compare the performance of the distribution-based reference-independent 
regression models created in b), with linear regression models based on the 
reference-dependent T2 image intensity ratio.  
The ultimate goal was to study whether T2 distributional parameters could provide 
a means to develop distribution-based reference-independent timing tools for 
human stroke.  
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  Methods 
8.3.1 Patient recruitment and MRI protocol 
The MRI data from the 35 patients in Chapter 7 were also used in this study. 
Therefore, details regarding recruitment, ethics, MRI protocol, image computation 
and identification of ischaemic regions, are also applicable here. 
 
8.3.2 Image processing 
Volumes of interest  
The steps involved in creating ischaemic volumes of interest (VOI) encompassing 
the whole ischaemic region, ischaemic GM only and ischaemic WM only, are 
illustrated in Figure 8.1 and are described in detail in the Figure caption.  To 
summarise, as outlined in the methods of Chapter 7, ischaemic volumes of interest 
(VOI) were generated using ADC and relaxation time limits according to methods 
given by Knight, McGarry et al. (2016) (Figure 8.1-part A). Non-ischaemic VOIs 
were created as described in Chapter 7, by reflecting the ischaemic VOIs about the 
sagittal midline (see Figure 7.2, in Chapter 7) and applying the same T2 limits to 
minimise CSF contribution.  
 
In order to analyse GM and WM within the ischaemic region separately, the 
ischaemic and non-ischaemic VOIs were further segmented into GM and WM VOIs 
by subtracting GM and WM masks from the ischaemic and non-ischaemic VOIs 
(Figure 8.1). This process involved computing GM and WM binary masks from the 
echo summed T2w images according to methods given by Damion, Knight, 
McGarry et al. (2019). The segmentation process involved running FSL FAST 
(FMRIB’s Automated Segmentation Tool, Zhang et al., 2001) on the echo summed 
T2w images and specifying four tissue types for segmentation (GM, WM, CSF, 
spurious tissue, Figure 8.1-partB). The T2w images were used for tissue type 
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segmentation because as outlined in Chapter 4 (Section 4.2.2), T2w images are 
insensitive to early ischaemia, and so appear as they would before ischaemia onset. 
This pre-ischaemic representation of MR signals means the ability of FAST to 
differentiate between tissue types would not be impacted by ischaemia and so 
resulting masks (Figure 8.1-part C) should correctly represent GM and WM 
regions. The T1w subcortical segmentation aspect of Damion, Knight, McGarry et 
al.'s (2019) segmentation procedure was not applied in this study as it had not 
been developed at the time of data analysis.  
 
Once the separate GM and WM masks were produced (Figure 8.1-part C), 
ischaemic WM VOIs were created by subtracting the GM mask from the ischaemic 
VOI (Figure 8.1-part D), and the ischaemic GM VOIs were created by subtracting 
the WM mask from the ischaemic VOI (Figure 8.- part E). VOIs were then applied 
to the T2 relaxation time maps to extract distributional information of the T2 
relaxation time within ischaemic GM and ischaemic WM, respectively (Figure 8.1-
part D). To generate non-ischaemic VOIs for GM and WM, the same procedure 
was followed but applied to the non-ischaemic VOIs that were generated in Chapter 
7. The GM and WM segmentation masks and the GM and WM ischaemic and non-
ischaemic VOIs were visually inspected to ensure they were accurately segmented 
and correctly placed. Figure 8.2 shows examples of the contiguous VOIs from three 
patients. 
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Figure 8.1 Illustration of the procedure followed to produce VOIs containing ischaemic WM 
only and ischaemic GM only. he ischaemic VOIs (represented as red) were generated using 
the methods described in Chapter 7 where ischaemic voxels were defined as those with ADC 
values > 0.2 – 0.4 µm2/ms and < 0.55 – 0.6 µm2/ ms,  ADC values less than one half-width 
half-maximum from the median ADC of non-ischaemic tissue, and  T2 > 30 ms and < 200 
ms. 
A. FSL FAST (FMRIB’s Automatic Segmentation Tool) was applied to T2w images to 
produce binary masks for four tissue types. Where the darkest grey represents CSF, 
the middle shade of grey represents GM, the lightest grey represents WM, and white 
indicates spurious signals. T2w images were used because they are insensitive to early 
ischaemia, and so provide an indication of the pre-ischaemic brain.  
B. The tissue type masks produced from FSL FAST were separated, and only the GM 
and WM masks were used for the rest of the analysis. 
C. Ischaemic VOIs containing only WM were created by subtracting the GM binary 
masks from the ischaemic VOI binary mask, to produce a separate WM ischaemic VOI 
(represented as yellow).  
D. Ischaemic VOIs containing only GM were created by subtracting the WM binary 
masks from the ischaemic VOI binary mask, to produce a separate GM ischaemic VOI 
(represented as orange).  
E. The ischaemic GM VOI and ischaemic WM VOI could then be loaded on to T2 
relaxation time maps, to extract T2 information within ischaemic GM and ischaemic 
WM respectively. 
To generate non-ischaemic VOIs for GM and WM, the same procedure was followed 
but applied to the non-ischaemic VOIs that were generated in Chapter 7.  
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Whole ischaemic VOI GM ischaemic VOI WM ischaemic VOI
GM non-ischaemic VOI WM non-ischaemic VOIWhole non-ischaemic VOI
Figure 8.2 Examples of contiguous VOIs containing the whole ischaemic region, only GM 
and only WM, from three patients with different onset times. VOIs are overlaid on the T2 
relaxation time maps. A. 69-year-old female patient with right total anterior circulation 
stroke (TACS), thrombolysed, NIHSS on admission = 21, time from symptom onset to 
MRI = 184 minutes, scanned at the Bristol site. B. 71-year-old male patient with right 
partial anterior circulation stroke (PACS), thrombolysed, NIHSS on admission = 7, time 
from symptom onset to MRI = 334 minutes, scanned at the Glasgow site. C. 64-year-old 
male patient with right TACS, thrombolysed, NIHSS on admission = 9, time from 
symptom onset to MRI = 452 minutes, scanned at the Glasgow site. 
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8.3.3 Data selection  
To ensure VOIs contained enough voxels to model the distribution of T2 relaxation 
times, only VOIs greater than 0.5 mm3 were included in the analysis. Patients were 
also excluded if the T2 MRI data did not cover the whole ischaemic region. This 
was sometimes the case for patients scanned at Bristol, as due to the shorter time 
allowed for scanning, radiographers applied the multi-echo T2 sequence only to 
regions affected by ischaemia (identified by DWI) rather than the whole brain. 
Total slice coverage was limited to 32 slices, which sometimes did not cover the 
whole ischaemic region. This was not considered a problem for quantifying image 
intensity ratios in Chapter 7 as average T2 relaxation times could still be extracted. 
However, an ischaemic VOI covering only part of the ischaemic region on T2 maps 
could distort the estimates of the T2 distribution parameters. As the leave-one-out 
cross-validation (LOOCV) technique used to train and test the regression models 
is sensitive to outliers (James et al., 2013), the distribution of onset times within 
the datasets was also assessed using box and whisker plots and patients with 
outlying onset times were not included in the analysis.    
 
8.3.4 Data analysis 
Identification of probability distributions  
Methods for investigating the relationship of T2 distributions with time from stroke 
onset were carried out as closely to Norton et al.'s (2017) methods as possible. 
MATLAB scripts, which called upon the 'fitmethis' script available for free 
download(https://uk.mathworks.com/matlabcentral/fileexchange/40167-
fitmethis) and the MATLAB release 2016b Statistics and Distribution toolbox and 
Distribution Fitting App, were created to identify which probability distributions 
best described the empirical distributions of T2 relaxation times within the 
ischaemic VOIs.  
 
Chapter 8 | An investigation of reference-independent stroke timing using the T2 relaxation 




To summarise, for each patient, the scripts created histograms of the T2 relaxation 
times within the whole, GM and WM ischaemic VOIs, which were area normalised 
to represent the probability densities. All distributions available in the MATLAB 
statistics and distribution toolbox (see Appendix C for list) were then fitted to the 
data by maximum likelihood estimation and compared with the empirical T2 
distributions. For each patient and VOI type, the three probability distributions 
with the lowest Akaike information criteria scores (AIC) (Akaike, 1974) indicating 
a good fit, were recorded (see Appendix A for an explanation of AIC). To keep the 
analysis as simple and clear as possible, rather than investigating all potential 
probability distributions, across patients, the two most commonly identified 
probability distributions were chosen as those that best described the distribution 
of T2 relaxation times within the whole, GM and WM ischaemic VOIs.  
 
Training and testing linear regression models   
The parameters of the best fitting probability distributions were estimated for each 
patient and VOI type, via maximum likelihood estimation and used collectively to 
estimate the coefficients of linear regression models as well as second and third-
order polynomial regression models. With no validation cohort available, leave one 
out cross-validation (LOOCV) was used to determine, train and test the regression 
models using the MATLAB release 2019a Regression Learner app. LOOCV involves 
iteratively separating the data into a training set containing the data from all 
patients, but one, and a test set, containing the data of the remaining patient, until 
each patient data set has served as a test set (James et al., 2013). For each iteration 
or 'fold' of the LOOCV, the root mean square error (RMSE) with respect to the 
actual onset time, was calculated.  
 
Linear regression models that included individual parameters of the probability 
distributions such as shape, scale and location, as well as the T2 mean and SD, 
were also created to examine whether these individually had a relationship with 
time from symptom onset. For comparison, reference-dependent linear regression 
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models were also created for each VOI type, which included the T2 image intensity 
ratio as a predictive variable. As described in Chapter 7 and illustrated in Figure 
7.2, the computation of image intensity ratios involved dividing the mean T2 
relaxation time of the ischaemic VOI by the mean T2 relaxation time of the non-
ischaemic VOI.  
 
The relationship of the T2 distributional parameters with the size of the ADC 
defined ischaemic region (number of voxels within the VOI) was also assessed using 
Pearson’s and Spearman’s correlations for normal and non-normally distributed 
data. Normality was determined by significant Shapiro -Wilk results (p < .05). As 
the T2 data at each time point were obtained from different patients, and therefore 
ischaemic regions of different sizes, this stage of the analysis was to determine 
whether the size of the ischaemic region would be a potential confound in any 
relationship of distributional parameters with time from symptom onset.   
 
Model evaluation  
The performance of regression models was evaluated by a) the significance and size 
of the R2, b) the size of the AICc corrected for sample size (AICc), where the model 
with the lowest AICc indicates a better quality model relative to the other models 
from the same data set (Symonds & Moussalli, 2011) and c), calculating the average 
RMSE across folds of the LOOCV to indicate how well the model would perform 
when applied to new data. The RMSE is the uncertainty of the onset time estimates 
in minutes (±).   
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Following the exclusion criteria outlined in the Methods section (Section 8.3), a 
total of 23 patients were included in the analyses. Of those excluded, nine patients 
had ischaemic VOIs less than < 0.5 mm3, two were identified as outliers with onset 
times of 568 and 569 minutes, and the T2 maps of one patient did not cover the 
whole ischaemic region. Ten of the remaining patients had GM VOIs less than 
0.5mm3 so were not included in GM analysis, and two had WM VOIs less 0.5 mm3, 
so were not included in the WM analysis. Table 8.1 shows the clinical and imaging 
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 Whole lesion  
(full cohort) 
GM 
 (sub cohort) 
WM 
(sub cohort) 
Patients, n (% full cohort): 23 (100%) 13 (56.5%) 21 (91.3%) 
Female, n (%): 8 (34.8%) 4 (30.8%) 6 (42.9%) 
Age in years  67 (31 – 85) 67 (31 – 81) 67 (31 -82) 
NIHSS*  7 (1 – 21) 9 (1 – 21) 7 (1 - 21) 
















    




















    
Left hemisphere, n (%): 10 (43.5%) 6 (46.2%) 10 (47.6%) 
Thrombolysis: 
Patients received rtPA, n (%) 
Time from onset to rtPA 
Time from rtPA to MRI 
 
19 (82.6%) 
2:00 (1:02 - 3:54) 
3:53 (0:29 - 5:53) 
 
12 (92.3%) 
1:13 (1:02 - 3:54) 
4:15 (0:38 - 5:53) 
 
17 (81.1%) 
2:00 (1:02 - 3:54) 
4:27 (0:29 - 5:53) 
    
Time from onset to MRI: 5:34 (2:25 - 7:51) 6:46 (2:28 - 7:51) 5:38 (2:25 - 7:51) 
    
VOI characteristics: 
 ADC defined ischaemic volume (mL) 
 % ischaemic GM  
 % ischaemic WM  
 
6.87 (0.59 - 32.44) 
23.12 (0 - 75) 
75.11 (21.77 - 100) 
 
 
5.54 (0.58 - 12.48) 
38.47 (12.77 - 75) 
58.60 (21.77 -87.19) 
 
3.21 (0.62 - 19.49) 
23.12 (0 - 75) 
75.11 (21.77 - 100) 
Note. Values given are medians with minimum and maximum values in brackets. n = 
number. rtPA = recombinant tissue plasminogen activator. *Scores on the National 
Institutes of Health Stroke Scale (NIHSS) range from 0 - 42, higher scores indicate 
greater deficit. †Strokes are classified according to the Oxford Stroke Classification 
Scale (Bamford et al., 1991). LACS = Lacunar, PACS= Partial Anterior Circulation, 
POCS = Posterior Circulation, TACS = Total Anterior Circulation. Times are in 
hours and minutes (hours: minutes). VOI = volume of interest. ADC = apparent 
diffusion coefficient. mL = millilitres, ms = milliseconds. % GM and % WM are the 
percentage of the respective tissue types with the whole ADC defined ischaemic region. 
Table 8.1 Clinical and imaging characteristics of patients included in the analysis of the 
whole ADC defined ischaemic region, ischaemic GM and WM VOIs. 
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8.4.1 T2 Distributions 
The fitted probability distributions over plots of the empirical distributions of T2 
relaxation times within whole ischaemic VOIs, GM ischaemic VOIs and WM 
ischaemic VOIs are shown in Figures 8.3, 8.4 and 8.5 respectively. Histograms of 
T2 relaxation times within the non-ischaemic VOIs are shown for comparison.  To 
give a representation of the distributions at regular time intervals, the distributions 
shown in the Figures are from separate patients, with time from symptom onset 
closest to the nearest hour. In some instances, there was only one patient scanned 
close to the hourly interval (whole ischaemic VOI: six and eight hours, GM VOI: 
two, four, five and hours, WM VOI: two hours, five hours, six hours, eight hours) 
and in other cases, no patients were scanned within the specific hourly interval 
(WM VOI: six hours). The shapes of the distributions were inspected for each 
patient and VOI type, including the ones that are not shown in the Figures.  The 
distributions shown in the Figures are representative of the other patients scanned 
within that time frame. Cases that appeared to show a different distribution to the 
other were included in the Figures, and these are highlighted in the Results (Section 
8.4.2). 
 
Within the whole dataset, there were two patients with data from all three VOI 
types where the size of the GM and VOIs relative to each other were comparable. 
The fitted probability distributions over plots of the empirical distributions of the 
relaxation times within whole, GM and WM ischaemic VOIs of these patients are 
shown in Figure 8.6. There were no patients scanned at three hours for which the 
GM and WM VOIs were similar sizes and so are the same patients shown in Figure 
8.2. The patient scans shown in Figure 8.6 are also the same patients shown in 
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Whole ischaemic VOIs 
The T2 distributions within whole ischaemic VOIs were best described by the 
Generalised Extreme Value (GEV) (Mathworks 2019a; McFadden, 1978) and Burr 
type X11 (Mathworks 2019b; Rodriguez, 1977) probability distributions (Figure 
8.3. and Figure 8.6- parts A, D, G). Of the 23 VOIs analysed, 15 had GEV in the 
top three distributions, and 15 had Burr in the top three distributions. Of these, 
seven had both GEV and Burr in the top three, six were Burr only, and eight were 
GEV only. 
 The three-parameter GEV probability distribution takes the form of: 



















Where 𝑘, µ and σ denote the shape, location and scale parameters. 
 
The three-parameter Burr type X11 probability distribution takes the form of:  










		𝑤ℎ𝑒𝑟𝑒	𝑥 > 0, 𝛼 > 0, 𝑐 > 0, 𝑘 > 0. 
Where α is the scale parameter, and c and k are the shape parameters.  
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Figure 8.3 Fitted generalised extreme value (GEV) and Burr type X11 probability 
distributions over histograms of empirical T2 relaxation times within whole ischaemic 
VOIs. Each histogram is from a different patient, and plots are grouped according to 
time from symptom onset, rounded to the nearest hour. In each plot, histograms of the 
T2 relaxation times in the non-ischaemic contralateral VOI are shown for comparison. 
Scan site, percentage of grey matter (GM) and white matter (WM) within the ADC 
defined ischaemic region and stroke type are shown. The x axis is the T2 relaxation time 
in ms (20 – 220 ms) and the y axis is the probability density (0 - 0.1). 
 
A. 68-year-old male patient with right partial anterior circulation stroke (PACS), not 
thrombolysed, NIHSS on admission = 11, time from symptom onset to MRI = 148 
minutes, scanned at Glasgow. 
 
B. 82-year-old male with left total anterior circulation stroke (TACS), thrombolysed, 
NIHSS on admission = 19, time from symptom onset to MRI = 145 minutes, scanned 
at Oxford.  
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C. 54-year-old female with Lacunar Stroke (LACS), thrombolysed, NIHSS on admission = 
2, scanned at Bristol.  
 
D. 81-year-old male with right TACS, thrombolysed, NIHSS on admission = 8, time from 
symptom onset to MRI = 185 minutes, scanned at Oxford.  
 
E. 63-year-old female with right TACS, thrombolysed, NIHSS on admission = 17, time 
from symptom onset to MRI = 235 minutes, scanned at Bristol.  
 
F. 66-year-old male with left PACS, thrombolysed, NIHSS on admission = 3, time from 
symptom onset to MRI = 265 minutes, scanned at Bristol.  
 
G. 71-year-old male with left PACS, thrombolysed, NIHSS on admission = 7, time from 
symptom onset to MRI = 334 minutes, scanned at Glasgow.  
 
H. 80-year-old male with right posterior circulation stroke (POCS), thrombolysed, NIHSS 
on admission = 5, time from symptom onset = 338 minutes, scanned at Bristol. 
 
I. 76-year-old male with left PACS, thrombolysed, NIHSS on admission = 2, time from 
symptom onset to MRI = 361 minutes, scanned at Glasgow.  
 
J. 56-year-old male with left PACS, thrombolysed, NIHSS on admission = 10, time from 
symptom onset to MRI = 410 minutes, scanned at Oxford.  
 
K. 45-year-old male with right TACS, thrombolysed, NIHSS on admission = 18, time from 
symptom onset to MRI = 415 minutes, scanned at Bristol.  
 
L. 31-year-old female with left POCS, thrombolysed, NIHSS on admission = 2, time from 
symptom onset to MRI = 471 minutes, scanned at Bristol. 
 
 
Ischaemic GM VOIs 
The T2 distributions within ischaemic GM VOIs were also best described by the 
GEV and Burr type X11 probability distributions (Figure 8.4 and Figure 8.6-parts 
B, E, H). Of the 13 GM VOIs analysed, 12 had GEV in the top three distributions, 
and six had Burr in the top three distributions. Six VOIs were described by both 
Burr and GEV; six were described by GEV only, two of which did not fit Burr at 
all so could not be used to train the Burr based regressors.  
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Figure 8.4 Fitted generalised extreme value (GEV) and Burr type X11 probability distributions over 
histograms of empirical T2 relaxation times within ischaemic grey matter (GM) VOIs. Each histogram 
is from a different patient, and plots are grouped according to time from symptom onset, rounded to 
the nearest hour. There were no patients in the GM group scanned six hours from symptom onset. 
Scan site and stroke type are shown. In each plot, histograms of the T2 relaxation times in the non-
ischaemic contralateral VOI are shown for comparison. The x axis is the T2 relaxation time in 
ms (20 – 220 ms) and the y axis is the probability density (0 - 0.1). 
A. 68-year-old male with right partial anterior circulation stroke (PACS), not 
thrombolysed, NIHSS on admission = 11, time from symptom onset to MRI = 148 minutes, 
scanned at Glasgow. 
 
B. 69-year-old female with right total anterior circulation stroke (TACS), thrombolysed, 
NIHSS on admission = 21, time from symptom onset to MRI = 184 minutes, scanned at 
Bristol.  
 
C. 81-year-old male with right TACS, thrombolysed, NIHSS on admission = 8, time from 
symptom onset to MRI = 185 minutes, scanned at Oxford. 
 
D. 63-year-old female with right TACS, thrombolysed, NIHSS on admission = 17, time 
from symptom onset to MRI = 235 minutes, scanned at Bristol. 
 
E. 71-year-old male with left PACS, thromblysed, NIHSS on admission = 7, time from 
symptom onset to MRI = 334 minutes, scanned at Glasgow.  
 
F. 59-year-old male with left PACS, thrombolysed, NIHSS on admission = 13, time from 
symptom onset to MRI = 409 minutes, scanned at Glasgow. 
 
G. 45-year-old male with right TACS, thrombolysed, NIHSS on admission = 18, time from 
symptom onset to MRI = 415 minutes, scanned at Bristol.  
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Ischaemic WM VOIs 
The T2 distributions within ischaemic WM VOIs were best described by the GEV 
and log-logistic (Fisk, 1961; Mathworks, 2019c) probability distributions (Figure 
8.5 and Figure 8.6-part C, F, I). Of the 21 WM VOIs included in the analysis, 12 
had GEV in the top three distributions, nine had log-logistic in the top three, two 
VOIs fitted both distributions, and two did not fit either. The two-parameter log-
logistic probability distribution takes the form of:  
 













Where µ denotes the log-median value and σ denotes the distributional shape.  
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Figure 8.5 Fitted generalised extreme value (GEV) and log-logistic probability distributions 
over histograms of empirical T2 relaxation times within ischaemic white matter (WM) 
VOIs. Each histogram is from a different patient, and plots are grouped according to time 
from symptom onset, rounded to the nearest hour. There were no patients in the GM group 
scanned six hours from symptom onset. Scan site and stroke type are shown. In each plot, 
histograms of the T2 relaxation times in the non-ischaemic contralateral VOI are shown for 
comparison. The x axis is the T2 relaxation time in ms (20 – 220 ms) and the y axis is the 
probability density (0 - 0.1). 
 
A. 82-year-old male with left total anterior circulation stroke (TACS), thrombolysed, 
NIHSS on admission = 19, time from symptom onset to MRI = 145 minutes, scanned at 
Oxford.  
 
B. 49-year-old male with right lacunar stroke (LACS), not thrombolysed, NIHSS on 






Chapter 8 | An investigation of reference-independent stroke timing using the T2 relaxation 




C. 81-year-old male with right TACS, thrombolysed, NIHSS on admission = 8, time from 
symptom onset = 185 minutes, scanned at Oxford.  
 
D. 63-year-old female with right TACS, thrombolysed, NIHSS on admission = 17, time 
from symptom onset to MRI = 235 minutes, scanned at Bristol.  
 
E. 66-year-old male with left partial anterior circulation stroke (PACS), thrombolysed, 
NIHSS on admission = 3, time from symptom onset to MRI = 265 minutes, scanned at 
Bristol.  
 
F. 65-year-old female with left PACS, not thrombolysed, NIHSS on admission = 3, time 
from symptom onset to MRI = 261 minutes, scanned at Bristol.  
 
G. 80-year-old male with right posterior circulation stroke (POCS), thrombolysed, NIHSS 
on admission = 5, time from symptom onset to MRI = 338 minutes, scanned at Bristol. 
 
H. 76-year-old male with left PACS, thrombolysed, NIHSS on admission = 2, time from 
symptom onset to MRI = 361 minutes, scanned at Glasgow.  
 
I. 45-year-old male with right TACS, thrombolysed, NIHSS on admission = 18, time from 
symptom onset to MRI = 415 minutes, scanned at Bristol.  
 
J. 53-year-old male with right LACS, not thrombolysed, NIHSS on admission = 1, time 
from symptom onset to MRI = 422 minutes, scanned at Bristol.  
 
K. 31-year-old female with left POCS, thrombolysed, NIHSS on admission = 2, time from 
symptom onset to MRI = 471 minutes, scanned at Bristol. 
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8.4.2 Observations from the probability distributions   
The following observations were made from the histograms shown in Figures 8.3, 
8.4, 8.5 and 8.6. What these observations may mean and why they are interesting 
are considered in the Discussion of this Chapter.  
- For all VOI types, the T2 distributions display a right shift over time, 
showing more voxels with longer T2 relaxation times in the later hours of 
ischaemia.  
- In Figure 8.6, there is a bimodal distribution of T2 relaxation times within 
ischaemic VOIs of the patient scanned at approximately three hours from 
symptom onset (Figure 8.6-parts A, B and C, and Figure 8.4-part B ), and 
the patient scanned at approximately five and a half hours from symptom 
onset (Figure 8.6-parts D, E and F and Figure 8.4-part E). The bimodal 
distribution is not present in the patient scanned at the later time from 
symptom onset (Figure 8.6-parts G, H and I), or any of the other patients 
in the study dataset.  
- The T2 values within VOIs of Bristol patients are shorter than the T2 values 
within VOIs of the patients scanned at Glasgow and Oxford. 
 
Figure 8.6 (shown on the left-hand side). Fitted probability distributions over histograms 
of empirical T2 relaxation times within ischaemic whole (A, D, G), GM (B, E,H) and WM 
(C,F I) VOIs from three example patients (also in Figure 8.2) scanned at different times 
after symptom onset (to the nearest half hour). Histograms of T2 relaxation times within 
the non-ischaemic VOIs are shown for comparison. A. B. and C. are from a 69-year-old 
female patient with right total anterior circulation stroke (TACS), thrombolysed, NIHSS 
on admission = 21, time from symptom onset to MRI = 184 minutes, scanned at the Bristol 
site, ischaemic VOI = 17% GM, 83% WM. D. E. and F. are from a 71-year-old male 
patient with right partial anterior circulation stroke (PACS), thrombolysed, NIHSS on 
admission = 7, time from symptom onset to MRI = 334 minutes, scanned at the Glasgow 
site, ischaemic VOI = 41% GM, 59% WM. G. H. and I. are from a 64-year-old male 
patient with right TACS, thrombolysed, NIHSS on admission = 9, time from symptom 
onset to MRI = 452 minutes, scanned at the Glasgow site, ischaemic VOI = 37% GM, 63% 
WM. The T2 distributions within the non-ischaemic reference VOIs are shown for 
comparison. The x axis is the T2 relaxation time in ms (20 – 220 ms) and the y axis is the 
probability density (0 - 0.1). 
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8.4.3 Linear regression models 
The linear regression results for whole ischaemic VOIs, ischaemic GM VOIs and 
ischaemic WM VOIs are given in Tables 8.2, 8.3, and 8.4, respectively. Figure 8.7 
illustrates the predictive abilities of the distribution-based reference-independent 
regressors and the reference-dependent regressors. Correlational analyses showed 
no relationship between VOI size and any of the T2 parameters studied in the 
regression models, for whole ischaemic VOIs, GM VOIs and WM VOIs (see 
Appendix C, Table 1C for Shapiro Wilk, Spearman’s and Pearson’s Correlations 
results). It was therefore concluded that the size of the ADC defined ischaemic 
region was not a confounding factor in the regression results.  
 
To summarise the results, which are described in more detail below, overall, GM 
was the only VOI type for which the T2 distributional parameters showed a 
relationship with time from symptom onset. Reference-dependent models 
incorporating the T2 ratio were the most accurate models for estimating onset time 
in GM and whole ischaemic VOIs. None of the reference-dependent and reference-
independent regressors for WM were significant.  
 
Whole ischaemic region regression models 
Reference-independent regression models which incorporated parameters of the 
GEV and Burr type X11 probability distributions, or the T2 SD, as predictive 
variables were not significant. Therefore, T2 distributional parameters within the 
whole ischaemic VOIs were not related to time from symptom onset. The reference-
dependent T2 image intensity ratio was the only parameter studied that showed a 
relationship with time from symptom onset. The linear regression model with the 
T2 image intensity ratio as the predictive variable outperformed all of the whole 
ischaemic VOI  based regressors as the R2 was moderate and highly significant (R2 
= 0.39, p = 0.001), it had the lowest AICc value (275.49) and one of the lowest 
average RMSE across LOOCV folds (± 92 minutes). The regression equation was:   
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Stroke onset time (minutes) » (1052.3 ± 285.3)rT2 ischaemic- (828.1 ± 308.5) 
Where rT2 ischaemic is the T2 relaxation time image intensity ratio obtained from the 
whole ischaemic and whole non-ischaemic VOIs.   
A four-parameter linear regression model incorporating the T2 ratio, mean T2, T2 
SD and one constant term was also significant with a high R2 and significance level 
(R2 = 0.49, p = 0.008), a low AICc value (278.62) and low average RMSE (± 91 
minutes). However, upon further investigation, the constant term and T2 ratio were 
the only significant variables in the model (p < 0.05), showing that the T2 ratio 
was the only variable that was related to onset time.  
 
GM regression models  
Reference-independent regression models with parameters associated with the GEV 
and Burr type X11 probability distributions as predictive variables were not 
significant. However, including a quadratic term into the Burr distribution-based 
regression model, improved the fit, and produced a significant seven-parameter 
second-order polynomial regression model (including one constant term) with a 
high R2 of 0.95, and average RMSE of  ± 121 minutes. All variables significantly 
contributed to the model (p < 0.001). The equation for the regression model was:  
Stroke onset time (minutes) »  
- (572.9 ± 242.9)aGMT2 - (79.3 ± 25.4)cGMT2  + (96.1 ± 15.1)kGMT2  - (572.9 ± 
242.9)a GMT22 + (0.368 ± 0.115)cGMT22 - (1.9 ± 0.32)kGMT22+ (2932.9 ± 1288.9) 
 
Where  aGMT2, cGMT2, and kGMT2 are the estimated scale, first shape and second 
shape Burr type X11 distributional parameters for T2 within ischaemic GM.   
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A linear regression model incorporating the reference-dependent T2 ratio as the sole 
predictive variable was also significant (R2 = 0.32, p = 0.043, average RMSE = 
±106 minutes, AICc = 159.21). Where,  
Stroke onset time (minutes) »  
Stroke onset time (minutes) » (884.3 ± 386.0)rT2 GM - (828.1 ± 308.5) 
Where rT2 GM is the T2 relaxation time image intensity ratio obtained from the 
ischaemic and non-ischaemic GM VOIs.   
 
However, including the T2 mean and T2 SD in addition to the T2 ratio, produced 
a significant model (p = 0.024) that, compared to the T2 ratio in isolation, had 
with a higher R2 (0.63), lower RMSE (± 94 minutes) and comparable AICc (159.02). 
All variables significantly contributed to the model (p < .001). The equation for 
the regression model was:  
Stroke onset time (minutes) »  
(751.3 ± 319.8) rT2 GM+ (5.01 ± 1.9) MT2 ischaemicGM -  
(18.8 ± 7.2)SDT2 ischaemicGM - (730 ± 331.2) 
 
Where rT2 GM is the T2 ratio of the GM VOIs, MT2 ischaemicGM is the mean T2 
relaxation time within the ischaemic GM VOI, and SDT2 ischamicGM is the T2SD of 
the ischaemic GM VOI.  
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Figure 8.7 Reported symptom onset time vs estimated time of stroke onset plots 
illustrating the performance of T2 based reference-independent and reference-dependent 
regression models for whole ischaemic (A., B., C.), GM (E., F., G.) and WM (H., I., 
J.) VOIs. 
A. Whole VOI reference-independent regressor with parameters of the GEV probability 
distribution as variables.  
 
B. Whole VOI reference-independent regressor with the parameters of the Burr type 
X11 probability distribution as variables.  
 
C. Whole VOI reference-dependent regressor with the T2 ratio as the predictive variable.  
 
D. GM VOI reference-independent regressor with parameters of the GEV probability 
distribution as predictive variables.  
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E. GM VOI reference-independent second-order polynomial with the parameters of the 
Burr type X11 probability distribution as variables.  
 
F. GM VOI reference-dependent regressor with the T2 ratio, mean T2 and T2 SD as 
variables.  
 
G. WM VOI reference-independent regressor with parameters of the GEV probability 
distribution as variables. 
 
H. WM VOI reference-independent regressor, with the parameters of the log-logistic 
probability distribution as variables. 
 
I. WM VOI reference-dependent regressor with the T2 ratio as the predictive variable. 
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The study examined the distributions of T2 relaxation times within ADC defined 
ischaemic regions of hyperacute ischaemic stroke patients. The aim was to 
determine whether characteristics of the T2 distributions would correlate with 
stroke onset time and therefore provide a means to develop reference-independent 
timing tools for human stroke. GM was the only tissue type for which distributional 
parameters demonstrated a relationship with time from symptom onset.  Despite 
concerns over finding an accurate non-ischaemic reference in the contralateral 
hemisphere, the simple reference-dependent T2 image intensity ratio from the whole 
ischaemic VOI provided the most accurate estimates of stroke onset time.  
 
The finding that distributional parameters within GM VOIs showed a significant 
relationship with time from symptom onset is consistent with Norton et al.’s (2017) 
results in rat models of ischaemia, where ischaemic regions were almost exclusively 
GM.  Norton et al. (2017) found a third-order polynomial regression model with 
the T2 location (µ) and scale (s) parameters associated with the log-logistic 
probability distribution as variables, was significantly related to time from 
ischaemia onset. In the present study, a second-order polynomial regressor 
including the T2 scale (c, k) and shape (a) parameters associated with the Burr 
type X11 probability distribution as variables, was significantly related to time 
from symptom onset. The squared (this study) and cubed (Norton et al., 2017) 
variables included in the regressors from both studies, suggests that, at least for 
GM, the relationship between T2 distribution-based parameters and time from 
symptom onset is not necessarily linear.  
 
Interestingly, Siemonsen et al. (2009) also reported a quadratic trend of hemispheric 
differences in the T2 relaxation time in ischaemic regions containing both GM and 
WM in ischaemic stroke patients. Accordingly, the mathematical cytotoxic oedema 
dissociation model (CED model), which describes the combined spatiotemporal 
progression of ADC and T2 in rat cerebral ischaemia predicts a nonlinear 
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development of the T2 distribution in early time points where the width of the T2 
distribution is initially narrow, then becomes broader and longer than average, 
before narrowing again (Knight, McGarry et al., 2016). It is assumed that this 
change in distribution reflects the gradual change of oedema states in the ischaemic 
region, as not all voxels are equally affected by ischaemia (Knight, McGarry et al., 
2016).  
 
The initially narrow distribution shows that most of the voxels within the ischaemic 
region have similar ‘normal’ T2 relaxation times because at this stage water content 
has not changed (i.e., cytotoxic oedema). The broader distribution that follows 
reflects the transition to the ionic oedema and vasogenic oedema states, where total 
water content, and therefore T2, begins to increase. As the development of ionic 
and vasogenic oedema is gradual and will happen at different rates within the 
ischaemic tissue, some voxels will have very long T2 relaxation times reflecting 
increased water content (vasogenic oedema), some will have long T2 relaxation 
times but longer than normal (reflecting more subtle water uptake from ionic 
oedema), or normal, pre ischaemic relaxation times (reflecting cytotoxic oedema). 
The eventual re-narrowing of the T2 distribution in the later hours of ischaemia 
reflects the final state of vasogenic oedema, where all voxels within the ischaemic 
region have increased water content, and so the majority of voxels have similarly 
long T2 relaxation times. Thus, the relationship of T2 based parameters with time 
from stroke onset may be more complex and dynamic than first assumed. It is 
difficult to determine from the dataset in this study whether the transition of the 
T2 distribution described above (from narrow to broad to narrow again) also applies 
to patients because the ischaemic VOIs differed considerably in size and location. 
However, it is worth investigating other potential nonlinear fits to the data when 
investigating T2 based methods for stroke onset time estimation.  
 
The GEV and log-logistic probability distributions provided the best fit to the T2 
distributions within ischaemic WM of patients, but parameters associated with 
these distributions showed no relationship with time from symptom onset. The time 
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dependency of GM, but not WM distributional parameters, could be due to 
inherent functional and structural differences between the tissue types. For 
example, imaging studies of patients suggest WM is generally more resistant to 
ischaemia, as WM tended to contain more 'at risk' tissue than GM even at later 
time points (Falcao et al., 2004; Koga et al., 2005). WM has half the metabolic 
demands of GM (Helenius et al., 2003; Simon et al., 2005) and up to one-third of 
the CBF and CBV requirements that GM has (Clarke & Sokolof, 1999; Nishizaki 
et al., 1988). Thus, lack of oxygen will be less detrimental to WM, resulting in 
slower progression to irreversible infarction than GM (Matute et al., 2013).  
Consequently, changes in the heterogeneity of the ischaemic region and therefore 
T2 distributional parameters, may not be pronounced enough with the first six 
hours to demonstrate a relationship with time. The six hour time period studied 
here may also explain why the WM T2 image intensity ratio was not a significant 
predictor of stroke onset time but was in a previous study with a larger cohort of 
strokes scanned within nine and a half hours of onset (Damion, Knight, McGarry 
et al., 2019).   
 
Additionally, WM is structurally more complicated than GM, and so damage and 
stress are likely to alter its magnetic environment in a different way to GM (Knight, 
McCann, Tsivos, Coulthard, et al., 2016). For example, WM contains fibre tracts, 
for which the T2 relaxation time is directionally dependent, termed ‘T2 anisotropy' 
(Knight et al., 2015). Longer T2 in the head-foot direction and WM corticospinal 
tracts and shorter T2 in the anterior thalamic radius of elderly participants has also 
been observed (Knight, McCann, Tsivos, Coulthard, et al., 2016). Given this 
variation, it is likely that the T2 distribution within WM differs depending on 
anatomy and may, therefore, explain why T2 distributions were not related to onset 
time in this study as the regressors were trained on T2 data from strokes occurring 
in different territories. A study with a larger cohort would enable ischaemic regions 
in different anatomical regions to be studied separately. 
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Aside from containing only ischaemic GM, another difference between previous 
studies investigating the T2 distributions over time (e.g., Chapter 5; McGarry et 
al., 2016a; Norton et al., 2017) is that that the majority of patients received 
thrombolysis (Chapter 7, Section 7.4, Table 7.1) whereas the rats in the previous 
studies were not thrombolysed. As discussed in Chapter 7, it is unlikely that 
thrombolysis affected the average T2 over time as the formation of ischaemic brain 
oedema is not affected by rtPA (Broocks et al., 2019). Siemonsen et al. (2012) also 
found no difference between T2 values in ischaemic growth regions and surviving 
tissue regions in thrombolysed and non-thrombolysed patients. However, it is not 
clear how thrombolysis would affect distributional parameters. The location and 
scale parameters of the log-logistic distribution changed with time from stroke onset 
in GM of non-reperfused rats (Norton et al., 2017), but thrombolysis could be 
responsible for these parameters not changing in WM, especially as thrombolysis is 
more effective in WM than GM (Tisserand et al., 2014).  
 
The hypothesis that the SD of T2 within the ADC defined ischaemic region would 
provide timing information in acute stroke patients was based on Madai et al.'s 
(2016) finding that the SD of DWI image intensities differentiated between patients 
within and beyond the thrombolysis treatment window with high accuracy. 
However, this hypothesis was not supported in the present study. The relationship 
of the DWI SD, but not T2 SD, with time from symptom onset, could be because 
the DWI signal eliminates signal from mobile species such as water and is, therefore, 
less likely to be influenced by CSF than T2 relaxometry maps. The DWI signal 
intensity would, therefore, be also sensitive to changes in the T2 distribution caused 
by ischaemia.   
 
Furthermore, although in Chapter 7 it was concluded that a range of confounding 
factors that influence intensities of weighted images contribute to errors in onset 
time estimates, it may be that when examining the heterogeneity of the ischaemic 
region, these factors are beneficial. The DWI signal is essentially the composite of 
the ADC and the T2 relaxation time, and therefore, the signal reflects a 
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combination of cytotoxic oedema (ADC) and vasogenic oedema (T2). The DWI 
image intensity ratio is not ideal for estimating onset time because the decrease in 
ADC counteracts the increase in T2, causing a weak relationship with time. Also, 
Madai et al. (2016) found the ADC SD and T2w FLAIR SD studied separately, did 
not predict onset time, suggesting it is something about the combination of ADC 
and T2 that makes DWI unique for reflecting changes in the heterogeneity of 
ischaemic tissue. The change in the DWI SD overtime may be similar to f2, 
reflecting the change in T2 relative to the change in ADC. It was beyond the scope 
of this study to examine the distribution of DWI signal intensities in relation to 
stroke onset time, but this should be investigated in future. 
 
There are a few limitations to this study, related to having a small data set that 
imposed restrictions on the analysis and inference of results. Firstly, in the absence 
of a test dataset to validate the regression models, LOOCV was applied to estimate 
how well they could potentially perform with new data (James et al., 2013). 
LOOCV is useful for small datasets as it means all of the available data is used to 
train the model, and therefore benefits from low bias (James et al., 2013). However, 
because the performance of the model is only tested on one dataset, LOOCV is 
sensitive to fluctuations in the data, which can result in a high variance in the 
estimates of the model's prediction accuracy (James et al. 2013; Varoquax, 2018). 
Therefore, estimates of the overall performance of the regression models given by 
the average RMSEs provide an initial indication of the ability to estimate onset 
time but should not be considered conclusive.   
 
Secondly, Norton et al.’s (2017) reference-independent approach to stroke timing 
required finding the probability distribution that ‘best described’ the empirical 
distributions of T2 relaxation times within ADC defined ischaemic regions.  In the 
current study, ‘best described’ was operationally defined as the two probability 
distributions that commonly had the lowest AIC values across patients. Therefore, 
the identified probability distributions did not fit the empirical T2 distributions of 
all of the patients. For example, in the WM VOI dataset, some VOIs fitted the 
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Burr type X11 probability distribution only, some, the GEV distribution only, some 
fitted both and a few fitted neither. Therefore, including data in the GEV based 
regression model, that did not have a good fit to the GEV probability distribution, 
could have contributed to higher uncertainties in onset time estimates. The fact 
that a singular distributional model did not fit the T2 distribution of all ischaemic 
VOIs in the same group could also reflect the more complex structure of the human 
brain compared to the rat brain.  
 
Further to the point above, the present study was conducted on the assumption 
that the distributions of relaxation times within ischaemic regions would be 
unimodal, as this was observed previously in rat models of ischaemia (Knight, 
McGarry et al. 2016; Norton et al. 2017). However, a bimodal distribution was 
observed in the ischaemic VOIs of two patients in this study (Figure 8.6- parts A, 
B, C, E and F). This observation raises two interesting possibilities. Firstly, the 
presence of a bimodal T2 distribution may be indicative of onset time, as bimodality 
was present in the earlier scan times (3 hours and 5.5 hours) and not in the later 
scan time (7.5 hours). However, a bimodal distribution was not present in the data 
of the other patients. It is not clear why these particular patients had bimodal 
distributions, but a larger dataset would help clarify this. 
 
Secondly, although the rest of the dataset did not contain a bimodal distribution, 
the two cases in Figure 8.6 highlight the possibility that T2 distributional 
information within the ischaemic region is not necessarily reducible to a unimodal 
distribution. Therefore, in future studies, before deciding on which distributional 
models and associated parameters best describe the T2 distribution, the probability 
distributions of T2 for each patient should first be tested for multi-modality. One 
approach would be to use the Müller and Sawitzi (1991) excess-mass test which 
indicates the presence of a mode where the excess of the probability mass is 
concentrated. In cases where a multi-modal distribution is present, the appropriate 
models to be tested for fitting can be selected.  
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An additional limitation is that the multi-echo T2 pulse sequences and parameters 
needed for computation of T2 relaxometry maps differed between sites. The only 
multi-echo T2 sequence available on the Philips scanner in Bristol was a gradient 
and spin-echo sequence (GRASE), which involves alternating 180-degree RF pulses 
and gradient pulses to generate multiple echoes (Caruthers et al., 1998; Elster 
1993). The resulting signal is therefore influenced by both T2 relaxation due to the 
spin-echo component, as well as T2* due to the gradient-echo component (Caruthers 
et al., 1998; Elster 1993). Whereas the only multi-echo T2 sequence available on 
the Siemens scanners at Glasgow and Oxford was a turbo-spin-echo sequence 
(TSE), and so T2* did not contribute to signal. The contribution of T2* could have 
made the T2 results from Bristol noisier (Carneiro et al., 2006). 
 
Additionally, compared to GRASE, the TSE sequences involved longer TRs and 
fewer TEs with longer echo-spacing (Chapter 7, Section 7.3, Table 7.1), which 
produced inherently longer T2 values in ischaemic and non-ischaemic regions. The 
difference in the average T2 between sites is evident in Figure 8.6 where the peak 
of the T2 distributions of ischaemic and non-ischaemic VOIs are further to the right 
in the two patients from Glasgow (D, E, F and G, H, I) compared to the patient 
from Bristol (A, B, C). Quantifying T2 relaxation times is more reliable than 
quantifying intensities from weighted images because T2 relaxation times are 
reproducible across sites and repeated imaging sessions (Deoni et al., 2008), but 
only if the same T2 sequence is used. Thus, combining the T2 distribution data 
from the three sites could have mitigated any relationship between T2 distributional 
parameters and time from symptom onset. Separating the data according to the 
site would be an essential next step to determine whether pulse sequence 
parameters affect the T2 distribution. If so, a standardisation method that ensures 
T2 is sensible across all scans would be required. However, given that the purpose 
of quantifying image intensity ratios for the reference-dependent approach was to 
reduce concerns associated with different pulse sequences, quantifying the image 
intensity ratio for onset time estimation may be the more straightforward option. 
 
Chapter 8 | An investigation of reference-independent stroke timing using the T2 relaxation 




To conclude, this study suggests that T2 distributional parameters may be 
informative of onset time in strokes occurring in GM, but not in WM or strokes 
affecting both tissue types. The relationship of T2 distributional parameters with 
time from stroke onset was studied to determine whether the T2 distribution could 
provide a reference-independent means for onset time estimation. A reference-
independent approach would avoid sources of error associated with reference-
dependent methods for stroke timing. However, this study suggests that the 
distribution-based reference-independent approach has its own sources of error, 
such as sensitivity to tissue type, anatomical location and pulse sequences, that 
would limit its utility in a clinical setting. Considering these issues and that the T2 
image intensity ratio from the whole ischaemic VOI provided the most accurate 
estimate of stroke onset time, the reference-dependent approach may be more 
suitable for clinical settings.   
 
Sources of error associated with the reference-dependent approach are still a 
concern, but these could be addressed by improving methods for defining the 
reference volume. For example, Knight, Damion, McGarry et al. (2019) recently 
developed the user-independent, spherical reference approach, that exploits the 
insensitivity of T2w signal intensities to ischaemia to approximate pre-ischaemic T2 
relaxation times. In brief, the spherical reference approach involves measuring the 
mean T2 relaxation time of normal brain tissue in a reference sphere (of a given 
radius) centred around a voxel contralateral to the ischaemic region and measuring 
the T2w signal intensity value of a voxel in the ischaemic region. The pre-ischaemic 
reference T2 relaxation time is estimated by conditioning the mean T2 relaxation 
time by the T2w intensity value. This spherical-reference method was more accurate 
at estimating stroke onset time in patients than the standard mirror-reference 
approach (used in Chapters 5 and 7 and other studies, e.g., Siemonsen et al., 2009; 
Song et al., 2012), and for a more detailed explanation, the reader is referred to the 
paper published by Knight, Damion, McGarry et al. (2019).  
 
  







                      
General Discussion 
The aim was to explore the ability of time-based qMRI methods for estimating 
stroke onset time in preclinical models of ischaemia and hyperacute ischaemic 
stroke patients. The overall goal was to identify which, if any, parameter(/s) should 
be examined further in more extensive clinical studies. This Chapter begins by 
summarising the main conclusions and the questions that emerged from the three 
research chapters (Chapter 4, Chapter 6, Chapter 7). These summaries are then 
drawn together to form an overarching conclusion, followed by a discussion 
outlining the original contributions of this thesis. Conclusions are then discussed in 
the context of up-to-date stroke timing literature (up to February 2020) and how 
they support or complement the ongoing qMRI research efforts for alleviating the 
problem of unknown onset time issue in clinics. Limitations of the research studies 
in this thesis are subsequently addressed, and the Chapter ends with 
recommendations for further work.  
  




 Summary of the conclusions drawn from the research 
chapters 
 
Chapter 5 (preclinical study): The T2 relaxation time ratio and T2 
distributions estimate ischaemia onset time more accurately than 
image intensity ratios from weighted images in rat models of 
ischaemia  
Chapter 5 was a preclinical MRI study that investigated the accuracy, sensitivity 
and specificity of qMRI parameters in distinguishing between scans performed 
before and after three hours from ischaemia onset (McGarry et al., 2016b). The 
study enabled a direct and unambiguous comparison between qMRI parameters, 
under controlled conditions, without being compromised by the short MRI scan 
time for patients. The purpose was to identify the qMRI parameters that could also 
be used in patients and therefore inform the design of the pilot studies in Chapters 
7 and 8. The main conclusions drawn from the preclinical study were that qMRI 
indices based on the T2 relaxation time are more accurate, sensitive and specific 
than any quantitative parameters from weighted images and that the distributional 
information of the T2 relaxation times (f2) or distributional information of T1 and 
T2 combined (Voverlap) may be more informative of onset time than the relaxation 
time ratios. These conclusions support previous preclinical studies that showed 
relaxation-based qMRI parameters had smaller margins of error when used to 
estimate stroke onset time than qMRI parameters based on intensities of weighted 
images (McGarry et al., 2016a; Rogers, McGarry et al., 2014). An additional 
conclusion was that the T1 relaxation time ratio is unlikely to be suitable for stroke 
timing in clinics because it had low sensitivity, which is likely due to the more 
gradual, two-phase response to ischaemia (Calamante et al., 1999; Kettunen et al., 
2000). 
 




The questions that emerged from Chapter 5 were: a) whether the T2 relaxation 
time-based image intensity ratios based on the non-ischaemic reference would 
identify hyperacute ischaemic stroke patients scanned within or beyond the 4.5 
hour treatment window. b) whether distributional information of the T2 relaxation 
time within the ADC defined ischaemic region would also be informative of stroke 
onset time in patients. These questions were subsequently addressed in Chapters 7 
and 8. 
 
Chapter 7 (clinical study): The T2 relaxation time image intensity 
ratio is a more accurate and reliable indicator of time from 
symptom onset in hyperacute ischaemic stroke patients than 
image intensity ratios from weighted images. 
Chapter 7 was a pilot study of hyperacute ischaemic stroke patients, which 
compared the ability of visual and quantitative MRI methods for stroke timing. 
The T2 relaxation time was the only qMRI parameter that showed a significant 
linear relationship with time from symptom onset, had the highest ability at 
differentiating between scans performed within and beyond 4.5 hours of onset 
(without compromising sensitivity and specificity) and the highest probability of 
correctly predicting whether a patient was scanned within 4.5 hours. The predictive 
ability by MRI variables was not improved by including ADC, DWI, T2w and T2 
ratios in the same model, suggesting that acquiring ADC (for identification of 
ischaemic regions) and T2 (for onset time estimation) would be sufficient. T2 also 
demonstrated better ability at identifying patients within the treatment window 
compared to the visual DWI/FLAIR mismatch and the FLAIR image intensity 
ratio. This finding supports previous conclusions concerning the low sensitivity 
associated with FLAIR-based stroke timing methods (Ebinger et al., 2010; Etherton 
et al. 2018). 
 
In line with conclusions from Chapter 5, the main conclusion from Chapter 7 was 
that quantification of the T2 relaxation time is a more accurate method for stroke 




timing than quantification of intensities of weighted images. The main question 
that emerged from Chapter 7 was whether the results would be supported in a 
more extensive study, which would enable acquisition of more FLAIR scans and 
the potential influence of factors such as vascular territory and collateral flow (i.e., 
with additional angiography scans) to be studied.  
 
Chapter 8 (clinical study): T2 distributional parameters in 
ischaemic GM may be a reference-independent indicator of onset 
time, but the reference-dependent method may be more accurate 
and more applicable for patients.    
Chapter 8 was a pilot study of hyperacute ischaemic stroke patients that 
investigated which probability distributions best described the empirical 
distributions of T2 relaxation times within ADC defined whole, GM and WM 
ischaemic regions. Also, whether any of the distribution characteristics could 
potentially provide a reference-independent stroke timing tool for human stroke as 
has been suggested in a rat stroke model (Norton et al. 2017). The T2 in whole 
ischaemic regions and GM ischaemic regions was best described by the Burr type 
X11 and the generalised extreme value (GEV) probability distributions. The T2 in 
WM ischaemic regions was best described by the GEV and log-logistic 
distributions. However, the only distributional parameters that showed a 
relationship with time from symptom onset were the shape a and scale (c,k) 
parameters of the Burr type X11 probability distribution in GM, in the form of a 
second-order polynomial regression model.  
 
The main conclusions drawn from Chapter 8 were that T2 distributional parameters 
from GM, but not WM or whole ischaemic regions, may be informative of stroke 
onset time, but the relationship of GM T2 with time may not be linear. Tentatively, 
the ischaemic GM T2 distribution characteristics is a potential reference-
independent stroke timer. Additionally, the reference-dependent image intensity 
approach applied to the whole ischaemic region (used in Chapter 5 and Chapter 7) 




may be more suitable for clinical settings because it provided the most accurate 
estimate of stroke onset time. Also, the reference-independent distribution-based 
approach is likely to be influenced by tissue type, anatomical location and the MRI 
pulse sequences used to acquire T2 maps. The main question raised from Chapter 
8, for future work, was whether the lack of timing information of the T2 
distributional parameters in WM and whole ischaemic regions was due to a) the 
small sample sizes, b) inherent complexities of WM, c) combining distributions 
from different vascular territories, or d) the use of different multi-echo T2 pulse 
sequences (i.e. GRASE and TSE).  
 
 Main conclusion  
The collective results of the studies in this thesis strongly suggest that future 
imaging research efforts dedicated to reducing the problem of unknown onset time 
should focus on quantifying the T2 relaxation time within the ADC defined 
ischaemic region. This is because the T2 relaxation time was demonstrated to be a 
more reliable and accurate estimator of onset time than image intensities from 
weighted images in both rat models of ischaemia and hyperacute stroke patients.  
 
 Original contributions 
First direct comparisons of potential MRI stroke timers  
The studies in this thesis were the first of their kind. At the start of this PhD 
(2015), the T2 relaxation time as an estimator of stroke onset time was mainly the 
focus of preclinical research (e.g. Jokivarsi et al., 2010; McGarry et al., 2016a, 
2016b), and the study by Siemonsen et al. (2009) was the only published study 
that investigated T2 in hyperacute ischaemic stroke patients for the purpose of 
stroke timing. Much of the focus within the stroke timing literature was on the 
potential ability of the visual-based DWI/FLAIR mismatch (Thomalla et al., 2011), 




and quantification of the FLAIR image intensity ratio (e.g., Song et al., 2012; 
Petkova et al., 2010). With the exception of Wu et al. (2011), in 2015 (and even 
now in 2020), comprehensive, often-cited MRI stroke timing review papers have 
not mentioned T2 relaxometry as a potential method for onset time estimation (e.g., 
Biggs et al., 2019; Etherton et al., 2018; Huang et al., 2019; Kang et al., 2012; 
Wouters et al., 2014), despite the large amount of preclinical work indicating the 
potential utility of MR relaxometry in stroke timing (e.g., Calamante et al., 1999; 
Gröhn et al., 1998; Hoehn-berlage et al., 1995; Jokivarsi et al., 2010; Rogers, 
McGarry et al., 2014). Until the publication of McGarry et al. (2016b) (Chapter 
5), there had not been a direct comparison of DWI, ADC, T2w, and T2 ratios as 
qMRI stroke timers in rat models. Until now (Chapter 7) there has not been a 
direct comparison of all of these qMRI parameters with the FLAIR image intensity 
ratio and the DWI/FLAIR mismatch for stroke timing in patients. Also, the 
heterogeneity of T2 within ADC defined ischaemic regions had not been studied in 
hyperacute ischaemic stroke patients (Chapter 8), only in rats (Knight, McGarry 
et al., 2016; McGarry et al., 2016a; Rogers, McGarry et al., 2014; Norton et al., 
2017).  
 
Existing T2 based MRI stroke timing methods can be improved 
by parametrising T2 weighted MRI data  
The main conclusion of this thesis also suggests that the scientific community 
focused on improving stratification of stroke patients with unknown onset time to 
treatment, are on the right track using T2 based MR signal intensities represented 
in weighted images to estimate onset time ( i.e., DWI and T2w with/without 
FLAIR). However, the results also suggest that the ability of T2 based MRI data 
for estimating onset time can be improved by adopting the parametric approach to 
quantitative MRI (Chapter 3, Section 3.7.2). The studies here have demonstrated 
that by transforming weighted images to their parametric counterparts (i.e., DWI 
to ADC and T2w images to T2 relaxation time maps), ischaemia can be identified 
early-on and onset time can be estimated more reliably and accurately. The MR 
data that is represented in parametric maps (e.g., ADC values in ADC maps, and 




T2 relaxation times in T2 maps) are essentially a purer, more refined form of the 
signal intensities studied in the corresponding weighted images (e.g., DWI, T2w or 
T2w FLAIR) because they are not impacted by uncontrollable sources of variance 
(e.g., magnetic field inhomogeneities, T1 relaxation and PD). By taking this 
parametric approach, the recommended MRI stroke protocol incorporating DWI, 
T2w, T2w FLAIR and T2*w images (Mair & Wardlaw, 2014) can still be used at no 
extra scan time as DWI and ADC are always provided together in clinical practice, 
and most MRI scanners can automatically produce T2 maps from multi-echo T2 
sequences. It would also be possible to acquire all these images almost as quickly 
as it would take for a patient to have a NCCT scan if magnetic resonance 
fingerprinting, which involves the simultaneous acquisition of multiple parameters 
(Ma et al., 2013, see Chapter 3, Section 3.7.3), becomes a routine in clinical MRI 
scanners.  
 
Demonstration that preclinical MRI of stroke is translatable to 
clinical MRI of stroke 
The successful translation of preclinical MRI findings (Chapter 5; Jokivarsi et al., 
2010; McGarry et al., 2016a, 2016b; Rogers, McGarry et al., 2014; Norton et al., 
2017) to clinical presentations of hyperacute ischaemic stroke (Chapters 7 and 8) 
shows that MRI observations made in animal models of stroke are directly relevant 
to human stroke. This is because the MRI and data analysis techniques used in the 
rat (Chapter  5) and patient (Chapters 7 and 8) studies and the parallel research 
in patients at the University of Bristol (Damion, Knight, McGarry et al., 2019; 
Knight, Damion, McGarry et al., 2019) were all developed in preclinical projects 
(Knight, McGarry et al., 2016; McGarry et al., 2016a, 2016b, 2017; Norton et al., 
2017). This translation and other recent research (e.g., Bertoglio et al., 2017) 
demonstrates that preclinical MRI data are crucial guides for advancing clinical 
imaging to benefit patient management of stroke and other neurological conditions. 
This demonstrated translation, therefore, also justifies the use of animal models in 
future MRI research of common human diseases. 




First application of Precision-Recall-Gain analysis in MRI stroke 
timing research  
Another original contribution of this thesis is that the study in Chapter 7 (McGarry 
et al., 2020) raises awareness of the problem of class imbalance in MRI stroke 
timing research, and is the first study to apply Precision-Recall-Gain (Flach & 
Kull, 2015) as a more appropriate method of evaluation to address the problem. As 
discussed in Chapter 4, Section 4.4, the majority of clinical MRI stroke timing 
studies treat the problem of unknown onset time as a binary classification problem 
and evaluate the performance of different MRI based timing methods using ROC 
curves, the area under ROC curves and by calculating the accuracy, sensitivity and 
specificity. However, as highlighted in Chapter 8 (McGarry et al., 2020), these 
performance metrics are only appropriate if the class distribution is evenly weighted 
(i.e., a comparable number of patients within 4.5 hours and beyond 4.5 hours). If 
there are more patients in one class than the other (i.e., more scanned within the 
treatment window than beyond it) than the evaluation metrics will be biased 
toward the class with a higher number of patients.  
 
At the time of writing this Discussion (early 2020), out of all the MRI stroke timing 
studies that assessed the same MRI based methods that were studied in this thesis 
(DWI/FLAIR mismatch, FLAIR ratio, DWI ratio, ADC ratio), only one (Petkova 
et al., 2010) had an evenly weighted class distribution (63 scanned within three 
hours of onset, and 67 scanned after). Most studies included more patients within 
the treatment window than beyond (e.g., Emeriau et al., 2013, 2016; Madai et al., 
2016; Thomalla et al., 2011; Wouters et al., 2018) and others did not specify the 
class distribution (e.g., Cheng et al., 2013; Siemonsen et al., 2009). Authors of 
stroke timing studies have confidently reported evaluation metrics whilst being 
unaware of the impact of an imbalanced class distribution on these metrics and 
their resulting conclusions. For example, in a clinical study, Madai et al. (2016) 
reported high accuracy, sensitivity and specificity levels for DWI/FLAIR 
mismatch, the DWI ratio and FLAIR ratio, but these results were based on a 
dataset that had 63 patients within the 4.5 hour thrombolysis treatment window 




and 19 beyond it. Therefore, results would have overestimated the overall accuracy 
and sensitivity of these classifiers, giving an unrealistic representation of the ability 
to correctly identify patients within the rtPA treatment window. 
Overrepresentation of sensitivity is critical, because as discussed in Chapter 4, 
Section 4.4.2, it is one of the predominant limitations of the visual DWI/FLAIR 
mismatch.  
 
The class imbalance problem also applies to studies that examine the relationship 
of qMRI parameters with time from symptom onset. For example, Ebinger et al. 
(2010) reported no relationship between the FLAIR image intensity ratio and time 
from symptom onset; however, the cohort included 72 patients scanned within 4.5 
hours from symptom onset and 22 patients scanned after. It is already well 
established that T2w FLAIR signals image do not change much within the first 4.5 
hours (hence why DWI/FLAIR mismatch indicates patients within 4.5 hours), so 
if the majority of points in the correlation were from this early time point, it is not 
surprising there was no overall correlation. Similarly, Cheng et al. (2013) reported 
a strong relationship of the FLAIR image intensity ratio with time from symptom 
onset, but the majority of patients were scanned between four and 12 hours from 
symptom onset, which would have biased the strength of the correlation as the size 
of the FLAIR ratio would have been greater for a larger proportion of the dataset.   
 
In order to fully understand the ability of MRI based methods for timing the 
ischaemic stroke, this work encourages future stroke timing studies to either a) 
ensure that the dataset is comprised of an equal number of patients within and 
beyond the specified treatment window or b) to apply methods, such as precision-
recall-gain that can account for the class imbalance (Flach and Kull, 2015).   
 




 Relevance to stroke timing literature in early 2020 
Recently published MRI studies adopting supervised machine learning and 
unsupervised deep learning techniques for stroke onset time estimation (Ho et al., 
2019; Lee et al., 2020) are of particular relevance to the thesis results. Supervised 
machine learning involves developing algorithms that computers can use to extract 
patterns from existing data to generate predictive models that can be applied to 
new data (Kelleher & Tierney, 2018). Deep learning is a form of machine learning, 
that is unsupervised, where computers discover complex patterns in large data sets 
that would otherwise be unknown (Lundervold & Lundervold, 2019). The machine 
learning studies distinguished between patients scanned before and after 4.5 hours 
from symptom onset using MRI based descriptive (e.g., image intensities) and 
morphological features (e.g., the diameter of the ischaemic region) (Lee et al., 2020), 
as well as latent features identified via deep learning (Ho et al., 2019), as predictive 
variables. Lee et al. (2020) reported an AUC of 0.83, a sensitivity of 0.75 and 
specificity 0.83, whereas, with the addition of deep learning features, Ho et al. 
(2019) obtained an AUC of 0.77, sensitivity and specificity of 0.79.   
 
What is interesting about the above machine learning results is that 34 predictive 
features across three images types (FLAIR, ADC, DWI, b-value of 1000) (Lee et 
al., 2020) and 486 predictive features across four image types (DWI, ADC, FLAIR, 
PWI) (Ho et al., 2019) were required to achieve similar predictive ability to the 
one reported for the T2 relaxation time alone in Chapter 7 (AUC of 0.77, sensitivity 
of 0.75, specificity of 0.75). Thus, as discussed in Chapter 7, ADC and T2 alone are 
robust enough to estimate stroke onset time in a clinically applicable manner, 
without the support of additional predictive MRI variables. However, it is also 
worth considering that, given the poor performance of weighted images 
demonstrated in Chapters 5 and 6, if Lee et al. (2020) and Ho et al. (2019) ’s models 
including descriptive, morphological and deep features, can achieve such high levels 
of predictive ability using weighted images, perhaps similar models using T2 maps, 
will improve the ability of the T2 relaxation time as a stroke timer. 




The studies in this thesis were designed in accordance with thrombolysis guidelines 
for hyperacute ischaemic stroke patients with unknown onset time, where 
chronological time was (and still is) the main barrier to treating patients with 
unknown onset time with rtPA (Biggs et al., 2019; Powers et al., 2018). However, 
between the start and end of this PhD research project (2015 – 2019), there has 
been a move toward exploration of patient-specific, instead of guideline-based, 
stroke treatment. For example, in 2018, the European Union’s Horizon 2020 funded 
a four-year project, Precise 4Q (precise4q.eu), which is focused on developing 
predictive machine learning methods that would enable individualised stroke 
treatment, including using MRI parameters for treatment stratification of 
hyperacute stroke patients.  
 
Many authors (e.g., Etherton et al., 2018; Wang & Wang, 2019) are encouraging 
the use of imaging as a tissue clock (outlined in Chapter 1) for patient-specific 
treatment decisions due to the accumulating evidence that some patients benefit 
from reperfusion-based therapies after 4.5 hours (reviewed by Etherton et al., 2018; 
Wang and Wang, 2019). For example, the DAWN trial showed patients with large 
vessel occlusion, a clinical-core mismatch (significant clinical deficit, small infarct 
volume identified via perfusion CT or DWI), and onset time between six and 24 
hours, benefited from mechanical thrombectomy (Nogueira et al., 2018). The 
EXTEND trial (Ma et al., 2019) also showed patients with ischaemic stroke and 
salvageable brain tissue (identified via perfusion CT or MRI) that awoke with 
symptoms or whose time of symptom onset was between four and a half hours to 
nine hours, and received rtPA, were more likely to have no or minor neurological 
deficits than patients given a placebo. Thus, for some patients, penumbral tissue 
may exist longer than 4.5 hours after symptom onset.  
 
In the future, treatment guidelines for reperfusion therapies may shift from the 
chronological time-based to the patient-specific tissue-based approach (Etherton et 
al., 2019; Wang and Wang, 2019). Rather than relying on a uniform time window, 
clinicians would tailor treatment decisions according to the status of the individual 




patient’s brain (Demeestere et al., 2020). In this situation, ADC and T2 relaxation 
time MRI will remain highly relevant in clinics and will be extremely useful for 
stratification of acute ischaemic stroke patients to treatment. This is because, as 
suggested by Rogers, McGarry et al. (2014) and McGarry et al. (2016a), and 
discussed in Chapter 5, the combination of ADC and T2 also provides an 
opportunity to identify potentially salvageable tissue. Reduced ADC indicates 
cytotoxic oedema, and therefore potentially viable tissue, and elevated T2 in regions 
of reduced ADC represents tissue destined for infarction (Gröhn et al., 2000). 
Regardless of onset time if the low ADC region is more extensive than elevated T2, 
reperfusion therapy may reduce stroke lesion size (McGarry et al., 2016a; Rogers, 
McGarry et al., 2014). 
 
Inspired by the studies by Rogers, McGarry et al., (2014) and McGarry et al. 
(2016a) that produced images showing the spatial distributions of changes in 
relaxation times caused by ischaemia (e.g., Figure 5.1 in Chapter 5), the spherical 
reference approach (which was being developed during the period of this thesis), 
prepares images of the change in T2 relaxation time due to ischaemia in images 
from patients as well as providing a user-independent approach for estimating onset 
time (Knight, Damion, McGarry et al., 2019. Although the spherical reference 
approach needs validating, it would enable the benefits of ADC and the T2 
relaxation time for reducing the problem of unknown onset that were identified in 
this thesis to be studied in the context of the tissue clock approach to treatment 
stratification of acute ischaemic stroke patients.    
 
 Limitations 
The main limitations of the studies in Chapters 7 and 8 are the small patient sample 
sizes. The sample size for the preclinical study in Chapter 5 may sound small. 
However, the rats were genetically homogenous, and of the same sex and the 
experimental conditions, including the severity of ischaemia, was strictly controlled. 




These factors could not be controlled in the patients. The patient studies were 
conducted on MRI data from three UK hospitals, between the years 2014 and 2018 
and so data analysis was limited to the reality of what could feasibly be collected 
in hospitals where emergency MRI of hyperacute stroke patients was not necessarily 
a routine practice. Therefore, the studies were not designed to be powered to test 
a specific hypothesis; instead, the purpose was to explore which qMRI 
parameter(/s) should be examined in a larger-scale clinical study. 
 
The small patient sample also highlights a problem that is specific to imaging of 
hyperacute stroke patients in the UK. It took four years to scan 68 stroke patients 
by MRI, 38 of these with low ADC verified acute ischaemia. The majority of scans 
were acquired from the Queen Elizabeth Hospital in Glasgow, which is actively 
engaged in clinical research of stroke patients and is equipped with a research-
dedicated MRI system. Except for six scans from Oxford, which is also a clinical 
stroke facility, the rest of the scans were acquired at Southmead Hospital in Bristol, 
where emergency MRI is not routine, and the MRI scanner was located two floors 
above the accident and emergency department. Patients were only scanned if the 
MRI radiographers could fit the patient into the overbooked MRI schedule, and if 
the correct staff were available (i.e., clinicians and research nurses involved in the 
study and the porters to transport the patients to the MRI scanner).   
 
Unfortunately, the situation at Southmead Hospital is typical of most NHS 
hospitals, and although clinicians are most likely aware of the benefits of MRI for 
treatment stratification of acute stroke patients, they have to work with what is 
available. Therefore, it is recognised that although the thesis results are promising 
for improving the stratification of acute ischaemic stroke patients to treatment, 
MRI cannot solve the problem of unknown onset time alone. Other methods for 
when MRI is not available are needed. For example, recent studies indicate that it 
may now be possible to estimate stroke onset time using NCCT (in a similar way 
to the reference-dependent qMRI approaches) (Mair et al., 2017; Minnerup et al., 
2016). Studies quantifying the change in CT signal (Hounsfield units = HU) caused 




by ischaemia (Mair et al., 2017) and using the HUs to approximate the percentage 
water uptake (Minnerup et al., 2016), identified patients within 4.5 hours of 
symptom onset with high sensitivity and specificity. However, the insensitivity of 
NCCT to early ischaemia poses a substantial challenge for this approach, as the 
location of ischaemic tissue cannot be identified as easily as with ADC or DWI 
(Chalela et al., 2007; Fiebach et al., 2002).   
 
One of the main consequences of a low number of stroke patients scanned is that 
it is difficult to draw reliable and generalisable clinical conclusions (Varoquaux, 
2018). The studies in this thesis used predictive models to assess the ability of 
qMRI parameters to estimate stroke onset time. However, in order to draw reliable 
conclusions, a much larger sample size is required so that the data can be split into 
a training set to develop the models, and a test dataset to validate their 
performance (Lee et al., 2020; Varoquax, 2018). With no test data set available, 
leave one out cross-validation (LOOCV) was used in Chapter 8 to approximate 
how well the regression models would perform on new data. Although LOOCV is 
better than no validation, when applied to small data sets, cross-validation methods 
can strongly underestimate estimates of prediction accuracy (Varoquax, 2018). 
Varoquax (2018) estimated that in order to be 90% confident in the measures of 
prediction accuracies from cross-validation techniques in neuroimaging studies (e.g., 
average RMSE of ± minutes across folds in Chapter 8), at least 1000 samples would 
be needed. Therefore, with a sample size of 23 patients in Chapter 8, the estimated 
predictive accuracies reported should not be taken as definitive and only as an 
indication of which probability distribution best describes the T2 distribution and 
how well these distributional characteristics could potentially perform when 
estimating onset time. This point is especially important to consider for Chapters 
5 and 7 as validation methods were not used, and so the reported performance of 
the qMRI parameters will be biased toward the data set that the results are based 
on (James et al., 2013; Kelleher & Tierney, 2018).   
 




As highlighted in the discussions of Chapters 7 and 8, a further consequence of the 
small sample size was that it was not possible to account for all of the potential 
sources of variability, which may affect qMRI measurements and therefore 
estimates of onset time. For example, strokes that occurred in different vascular 
territories (PACS, LACS, TACS, LOCS) were grouped in the analysis. However, 
focal cerebral ischaemia is a highly variable disease state, and the 
pathophysiological effects, and the rate at which infarction spreads, will differ 
according to the vascular territory involved, due to differences in local blood supply 
and metabolism (Macrae et al., 1992; Wang & Wang, 2019). As qMRI parameters 
are sensitive to these pathophysiological changes, the differing rates could, in turn, 
influence the rate and extent of changes in MRI signals. Lumping MRI data from 
all vascular territories into the same analysis may, therefore, have confounded 
estimates of stroke onset time. Additionally, as suggested in Chapter 8, the T2 
distributions within ischaemic regions may also differ according to the vascular 
territory involved. The inclusion of lacunar infarcts (LACS 34%  in Chapter 7, and 
30% in Chapter 8), which are small infarcts in deep cerebral WM, basal ganglia, or 
the pons, could have been a particular source of error, as compared to cortical 
ischaemic strokes, lacunar strokes are thought to have different pathophysiological 
causes and consequences (Wardlaw, 2005). Basal ganglia regions also have higher 
iron concentrations, and so T2 relaxation times are inherently shorter than other 
regions (Schenker et al., 1993). 
 
An inherent limitation of stroke timing studies is that they are reliant on knowing 
the exact time of ischaemia onset. In rats, the exact time of ischaemia onset is 
precise, whereas, in patients, the time of the first symptoms is used to approximate 
the time of ischaemia onset. However, the CBF thresholds for loss of function and 
ischaemia are known to be different (Hossmann, 1989, 1994). Indeed, there could 
be a delay in the onset of symptoms after the ischaemic event, which may be 
common for lacunar strokes (Nakamura et al., 1999). Additionally, if multiple 
emboli and arterial branches were involved, there could have been multiple 
ischaemic events, for which the onset times would be different. Therefore, the time 




of symptom onset recorded for the patients in this study may not be representative 
of the time of the first ischaemic event, which could have introduced some 
variability into the data and explain why some patients were misclassified.   
 
Another limitation of the clinical studies in this thesis was the use of two different 
multi-echo pulse sequences for the computation of T2 maps and T2w images 
(GRASE in Bristol, TSE in Oxford and Glasgow). The advantage of the parametric 
approach to qMRI is that the measured values are repeatable and reproducible 
across sites, but that is providing the same pulse-sequence is used (Deoni et al., 
2008). For quantifying image intensity ratios combining data from GRASE and 
TSE sequences was not considered a problem because ratios are comparable. 
However as discussed in Chapter 8, given the contribution of T2* to the spin-echo 
from the GRASE sequence, combining data could have introduced variability into 
the T2 distribution data, making it difficult to draw any concrete conclusions.  
 
The use of two versions of multi-echo T2 pulse sequences in the clinical studies was 
not intended in the initial design of the study and was a result of combining data 
from a clinical MRI scanner with data from a research specific MRI scanner. The 
clinical study was designed to be conducted in Bristol only, and the only multi-
echo T2 sequence in the clinical package of the Bristol’s Philips MRI scanner was 
the GRASE sequence. For the purposes of estimating onset time, the use of GRASE 
and the small contribution of T2* to the spin-echo was seen as insignificant. 
However, due to difficulties with recruiting enough patients within the Dunhill 
Medical Trust funding time window (2014 – 2018), Oxford and Glasgow were 
included as additional sites into the study These sites had Siemens research 
scanners that did not have a GRASE equivalent, and so TSE was used. In future 
studies, it would not be difficult to ensure the same multi-echo sequence is used in 
scanners from different vendors. All MRI scanners can perform multi-echo TSE, 
and so it would be a matter of ensuring that the correct package is available at all 
sites before beginning the study.   




 Recommendations for further work  
Although this thesis demonstrated that T2 MRI relaxation times are more accurate 
than image intensity ratios for onset time estimation, the accuracies reported are 
still not high enough to confidently base treatment decisions on, as accuracy was 
77% in Chapter 7, and the smallest margins of error were ± 90 minutes in Chapter 
8. The following suggestions for future studies may help to improve the accuracy 
of T2 as a proxy for onset time. These suggestions are based on the questions that 
emerged from the research Chapters, the discussed limitations, and inspiration from 
research in other areas of clinical imaging. 
 
Studies focused on improving the detection of elevated T2 caused 
by ischaemia  
The potential utility and success of the T2 relaxation time in aiding treatment 
decisions of hyperacute ischaemic stroke patients and patients with other conditions 
is reliant on the ability to accurately measure T2 in the first place. Throughout this 
thesis, it has been argued that the benefit of quantifying T2 relaxation times, is 
that, unlike image intensities from weighted images, measuring relaxation times 
facilitates unbiased comparison between scans from the same and different patients 
in different sessions and scanners (Deoni et al., 2008; 2010; Tofts, 2005).  
Additionally, the extent of the change in T2 values caused by ischaemia is unlikely 
to be influenced by the pulse-sequences used (Damion, Knight, McGarry et al., 
2019; Knight, Damion, McGarry et al., 2019). However, as highlighted in Chapter 
8, the absolute T2 values will vary because of significant T2 anisotropy imposed by 
tissue microstructure (Knight et al., 2015; Knight, McCann, Tsivos, Dillon, et al., 
2016) as well as the use of different pulse sequences (e.g. T2 was shorter with 
GRASE than with TSE). These sources of variation are a potential cause for 
concern, as could result in errors when measuring T2, which could potentially 
confound estimates of onset time and the extent of high T2 within the ischaemic 
region. When quantifying T2 for clinical use, one needs to be confident that the 
observed changes in T2 are due to ischaemia and do not have biological and/or 




MRI technical basis. Thankfully, low ADC is a guidance for the presence of acute 
ischaemia.  
 
A test-retest study where a patient or a healthy elderly participant, is scanned 
multiple times with the same protocol with the same scanner, would enable the 
minimum and maximum variation in T2 between scans to be estimated (i.e., by 
calculating the coefficient of variation). Knowing the repeatability limits of T2 
relaxation times within healthy tissue and ischaemic tissue would enable one to 
determine the extent to which the measured T2 values can be classified as ‘normal’ 
or ‘elevated’ (Jansen et al., 2007). This estimate could then be included in 
predictive models for onset time estimation and accounted for when quantifying 
the extent of T2 change due to ischaemia. Similar methods have been adopted in 
clinical imaging research using relaxation times for identifying cartilage 
degeneration (e.g., Hannila et al., 2015; Williams et al., 2011) and breast cancer 
(e.g., Aliu et al., 2014). 
 
Another avenue for improving the measurement of the T2 relaxation time and thus 
improving the ability to detect T2 change due to ischaemia would be to invest in 
methods that increase the signal to noise ratio (SNR). For instance, by engineering 
improved hardware and pulse sequences and performing studies using ultra-high-
field MRI. Achieving a higher SNR enables imaging with smaller voxel sizes, and 
increased spatial resolution, which in turn results in increased sensitivity to changes 
in the signal caused by pathology (Filippi et al., 2014; Schindler et al., 2017). For 
example, studies at 7T and 8T detected more incidences of WM ischaemia than 
1.5T and 3T (Kangarlu et al., 2007; Mistry et al., 2011). Another example is in this 
thesis, as the overall accuracy of qMRI parameters was higher in the preclinical 
study in Chapter 5, compared to the patient study in Chapter 7. Aside from the 
more controlled conditions, the use of ultra-high-field scanners in the preclinical 
study (4.7T and 9.4T) compared to the clinical studies (3T) would likely have 
contributed to this higher accuracy. Therefore, studying T2 at ultra-high field could 
enable better detection of T2 changes caused by ischaemia and a clearer picture of 




the T2 heterogeneity within the ischaemic region, which could ultimately enable 
more accurate estimates of onset time. 
 
A study specifically investigating the T2 characteristics in white 
matter 
The clinical work in this thesis had the advantage of being informed by preclinical 
studies. It was clear from studies and Chapter 5 (McGarry et al., 2016b) and 
previous preclinical work (e.g., Jokivarsi et al., 2010; Rogers, McGarry et al., 2014) 
that the T2 relaxation time increases during ischaemia and so is also likely to be 
suitable for stroke timing in patients. Also, that the T2 distribution in ischaemic 
GM may be informative of onset time (Norton et al., 2017). These observations 
were supported in the clinical studies in Chapter 7 (McGarry et al., 2020) and 
Chapter 8. For the studies in this thesis, especially Chapter 8, there was not this 
advantage of supporting preclinical research on the T2 in WM specifically. This is 
because, as discussed in Chapter 6 and Chapter 8, WM ischaemia is difficult to 
induce in rats when there is so little WM available in the brain. WM also has 
different ischaemic pathology to GM, and as a tissue type, is structurally more 
complex. The T2 relaxation times have only been studied specifically in WM in 
acute ischaemic stroke patients by Damion, Knight, McGarry et al. (2019) who 
showed a relationship of the T2 relaxation time within WM specifically. There was 
no prior work indicating what to expect about the distribution of T2 relaxation 
times  The sample size for ischaemic WM in Chapter 8 was too small (n = 21) and 
too variable (i.e., WM ischaemic regions in multiple vascular territories and of 
different sizes) to draw a definitive conclusion regarding the lack of relationship 
between T2 distributional parameters and time from symptom onset that was 
observed. Thus, there is a need for further studies investigating the distributional 
parameters of WM specifically.  
 
Given that this thesis demonstrated that preclinical MRI of ischaemia is 
translatable to the clinical MRI of ischaemia, it would also be advantageous if 




preclinical work specifically into WM ischaemia was possible. However, as rodents 
are poor models for WM ischaemic pathology, higher species that have a similar 
composition of GM and WM to humans would be needed (Kauppinen, 2014). For 
example, others have successfully studied WM ischaemia in cats (e.g., Matsumiya 
et al., 1990), baboons (e.g., Bell et al., 1985) and dogs (e.g., Xu et al., 2014). 
However, there are several factors that suggest a preclinical study of higher species 
is not the optimal way forward. For example, in labs that study rodents, it is fairly 
easy and inexpensive to care and look after a large number of animals (Sommer, 
2007). However, this is not the case for higher-level species (Sommer, 2007). 
Therefore, unless there is a large research budget, there would not be much 
improvement on the small sample sizes in clinical studies such as Chapter 8. 
Additionally, because of the cognitive and emotional similarities to humans, there 
are also the important ethical contentions surrounding studying higher-level species 
to consider (Cook & Tymianski, 2012). The brains of higher-level species are also 
structurally and physiologically more complex than rodent brains, and so the 
variabilities that could be avoided by studying rodents (e.g., location, size, severity 
of ischaemia), are not necessarily avoidable when studying higher species, and the 
different methods for inducing ischaemia have their own complications (reviewed 
by Cook & Tymiansk, 2012).  
 
Another way to gain insight into the T2 distribution in WM is to study subcortical 
lacunar strokes (LACs) in patients. This is because, LACs only affect WM, 
specifically deep cerebral white matter, the basal ganglia, or pons, and are caused 
by the occlusion of a single small perforating artery supplying subcortical brain 
regions (Bamford, 1991; Wardlaw, 2005). LACs are caused by the occlusion of a 
single small perforating artery supplying subcortical brain regions (Bamford, 1991; 
Wardlaw, 2005). Thus, studying LACs in patients, would have the benefits of 
studying ischaemia in GM of rats, as one artery is occluded (i.e., the MCA in rats 
and a small perforating artery in patients) and due to the location that is affected, 
there is little blood supply from surrounding regions, thus controlling for the 
variability in the MRI data that could be induced by collateral blood supply (i.e., 




Wouters et al., 2016). LACs constitute one fifth of all strokes (Sudlow & Warlow, 
1997) and so it would be possible to obtain a large enough sample size (i.e., 39 
patients based on the power analysis in Chapter 7). Thus, studying patients with 
LACS would enable the distribution of T2 in WM to be studied in isolation and in 
a context that has some of the benefits of a preclinical study (i.e., control over 
sample size, affected region, collateral blood supply) but avoids the complications 
associated with conducting preclinical studies in higher-level species (Cook & 
Tymiansk, 2012).  
 
A more extensive, hypothesis-driven study 
The next step for investigating the ability of T2 for reducing the problem of 
unknown onset is to design and conduct a larger, more extensive study that is 
powered to directly test whether the T2 relaxation time is the more accurate and 
reliable method for estimating stroke onset time. Also, to address the questions 
that could not be addressed in this thesis, such as whether different vascular 
territories have different T2 distribution characteristics and whether thrombolysis 
influences onset time estimation. A more extensive study would also enable 
predictive models to be developed and tested on separate data sets to provide a 
more reliable indication of their ability to estimate stroke onset time.  
 
If funding, feasibility, and practicalities were not obstacles, a more extensive study 
could involve: 
- Acquiring enough data to be able to study T2 image intensity ratios and the 
distributions of T2 relaxation times in the ischaemic regions of different vascular 
territories separately. The power analysis conducted in Chapter 7 suggested 
that at least 37 patients would be needed to have 90% confidence in identifying 
a relationship with time from symptom onset. Therefore at least 37 patients of 
each stroke subtype would be required. Validation test-tests of a similar size 
per territory would also be acquired. As discussed earlier in this Chapter, 




studying lacunar strokes in isolation would enable further insight into the T2 
distribution of ischaemic WM.  
 
- Acquiring enough data to be able to compare sensitivity and specificity of the 
T2 relaxation time with the DWI/FLAIR mismatch and FLAIR image 
intensities, as due to the imbalanced dataset in Chapter 7, a comparison of 
specificity was not possible. According to the power calculations in Chapter 7, 
this would require data from at least 67 patients to be able to confidently 
identify a relationship of the FLAIR image intensity ratio with time from 
symptom onset. Again, a validation test set of a similar size would also be 
required.  
 
- The addition of a perfusion-weighted imaging (PWI) sequence to approximate 
the collateral status. Collateral status was previously shown to modify the 
relationship of the FLAIR image intensity ratio with time from symptom onset, 
where the relationship of FLAIR was less dependent on time from symptom 
onset in patients with good collateral flow than patients with poor collateral 
flow (Wouters et al., 2016). It would, therefore, be important to determine 
whether the same is true for the T2 relaxation time when assessing the ability 
of T2 to estimate stroke onset time. 
 
- The addition of sodium magnetic resonance spectroscopy (MRS) to the imaging 
protocol. Extensive clinical and preclinical studies suggest that MRS is more 
informative of tissue viability in acute ischaemic stroke than MRI (see Fagan, 
2012 for a review) because compared to hydrogen (studied in MRI) sodium is 
more immediately related to the ischaemic cascade due to the collapse of the 
ionic gradients. Regions with increased sodium are thought to reflect the 
irreversibly damaged core, whilst regions with normal or decreased sodium 
levels indicate hypoperfused potentially viable tissue (Fagan, 2012). MRS data 
could, therefore, be compared to regions of decreased ADC and elevated T2 to 




determine whether ADC and T2 could be informative of tissue status and thus 
be used to assist with the patient-specific tissue clock approach to the problem 
of unknown onset time. As has been argued throughout this thesis, 
parameterising MR signals is the key to obtaining more reliable information 
about pathophysiology in ischaemic stroke research. As MRS is parametric, 
MRS may overcome the difficulties that have been encountered when trying to 
approximate tissue viability with perfusion-weighted images mentioned in 
Chapter 1 (Dani et al., 2011; Demeestere et al., 2020; González et al., 2013). 
MRS may therefore be a more reliable indicator of the viability of tissue with 
regions of low ADC and high T2 than PWI. 
 
Adding MRS is the most ambitious aspect of this suggestion for future research 
as it would involve an MR research scanner with two tubes (one hydrogen and 
one sodium), broad transmit-receive coils, specialised radiofrequency coils and 
a specifically optimised pulse sequence (Fagan, 2012) that are not currently 
available in hospital scanners. However, MRF including spectroscopy, involving 
the simultaneous acquisition of sodium density images, PD weighted, T1 
relaxation time maps and T2 relaxation time maps, has recently been achieved 
(Yu et al., 2020), suggesting this proposed study may be possible in future.  
 
Machine learning   
At the International Society for Magnetic Resonance Imaging in Medicine 
(ISMRM) conference in May 2019 (Montreal, Canada), it was apparent that MRI 
research is moving toward use of artificial intelligence (AI) enabled precision 
medicine. AI-based MRI medical research involves using supervised and 
unsupervised machine learning methods to develop predictive models that could 
aid clinicians in their diagnoses and treatment decisions. The potential benefits of 
machine learning in medical imaging was recently demonstrated in breast cancer 
research (Yala et al., 2019). Predictive models which included latent texture and 
density information of mammograms (identified using deep learning algorithms) 




resulted in significantly higher accuracy for risk discrimination than genomic and 
clinical information alone (Yala et al., 2019). If such improvement can be achieved 
by applying deep learning to simple mammographic images, then it is likely that 
applying deep learning to multiparametric MRI data could be extremely beneficial 
when developing predictive models for many disease states, given that it already 
provides so much more information about different pathologies (Kuhl, 2019). 
Indeed, deep learning was shown to be beneficial in stroke timing research, as by 
including latent features extracted from PWI, the accuracy of identifying patients 
with 4.5 hours improved by 10% (Ho et al., 2019).  
 
Machine learning approaches, especially those involving deep learning, require 
extensive data sets (Lundervold & Lundervold, 2019) and so, if, or when the T2 
relaxation time is more routinely acquired, and enough T2 data from hyperacute 
ischaemic stroke patients is available, deep learning methods could be investigated 
for T2 based stroke timing. Deep learning algorithms may also offer further insights 
into the heterogeneity of T2 within the ischaemic region. In the future, if 
appropriately applied and understood, advanced machine learning techniques could 
help further unlock the currently untapped potential of quantitative relaxometric 
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Contextualised descriptions and definitions of 
performance metrics used  
Performance of MRI classifiers was assessed using measures that consider true 
positive (TP), false positive (FP), true negative (TN) and false negative (FN) rates, 
where TP and TN refer to the number of patients correctly identified as within or 
beyond the treatment window, respectively. FP and FN refer to the number of 
patients incorrectly identified as within or beyond the treatment window, 
respectively. The measures used, defined in the context of estimating stroke onset 
time of patients, are given below (Bekkar & Djemaa, 2013).  
 
Measures of accuracy 
- Accuracy: the overall ability of the classifier to differentiate between 
patients within and beyond the treatment window correctly 
(TP+TN/TP+TN+FP+FN).  
- Sensitivity/recall: the ratio of patients correctly identified as within the 
treatment window to all the patients that were within the treatment 
window (TP/TP+FN). Represents the ability of the classifier to identify 
patients within the treatment window correctly.  
- Specificity: the ratio of patients correctly identified as beyond the 
treatment window to all the patients that were beyond the treatment 
window (TN/TN+FP). Represents the ability of the classifier to identify 
patients beyond the treatment window correctly. 
 
Measures of correctness 
• Precision / positive predictive value (PPV): the ratio of patients 
correctly predicted to be within the treatment window to the total predicted 





probability that a patient with an image intensity ratio below the optimal 
cut-off (or above for ADC) is within the treatment window.  
• Negative predictive value (NPV): the ratio of patients correctly 
predicted to be beyond the treatment window to the total predicted to be 
beyond the treatment window (TN/TN+FN). Approximates the 
probability that a patient with an image intensity ratio above the optimal 
cut-off (or below for ADC) is beyond the treatment window. 
 
Performance metrics  
- Receiver operating characteristic (ROC) curves demonstrate the 
trade-off between sensitivity and specificity for every possible image 
intensity ratio cut-off. Classifiers with high discriminative ability have lines 
closest to the top left-hand corner of the ROC plot, and classifiers with 
random performance are close to the 0.5-area reference line, which is a 
straight diagonal line from (0,0) to (1,1) (Zweig & Campbell, 1993).  
 
- The area under the ROC (AUC) is a numerical indication of overall 
performance. An AUC of 0.5 indicates a classifier that performs no better 
than random guessing and an AUC of 1 indicates a perfect classifier (Hanley 
& McNeil, 1983). In the context of this study, the AUC is an estimate of 
the probability that a randomly selected scan before 4.5 hours will have an 
image intensity ratio lower (or higher for ADC) than the image intensity 
ratio of a randomly selected scan performed after 4.5 hours.  
 
- The Youden J Index (max[sensitivity + specificity – 1]) identifies the  
cut-off that minimises misclassification by giving equal weight to sensitivity 
and specificity and corresponds to the point on the ROC curve with a 
vertical distance furthest from the 0.5 reference line, where the summation 
of sensitivity and specificity are maximum (Habibzadeh, Habibzadeh, & 





Youden J index will, therefore, be the one that can be used to distinguish 
the highest number of patients within and beyond the treatment window.  
- Logistic Regression is used to describe and test hypotheses about the 
relationship between a categorical outcome variable, U  (e.g., within or 
beyond the treatment window) and one or more independent predictor 
variables (e.g., image intensity ratios) (Peng, Lee, & Ingersoll, 2002). The 
logistic model predicts the natural logarithm, U, of the ratio of the 
probability of an event happening (e.g., the patient is within the treatment 
window) to the probability of the event not happening (e.g., the patient is 
beyond the treatment window). The logistic model, therefore, takes the form 
of: 
U = a + b1c1 + b2c2 + b3c3 + b4c4 ....  
 
In the context of this study, U  is the predicted log-odds of the patient being 
within the treatment window (U = 1 for onset time < 270 minutes, U  = 0 
for onset time > 270 minutes) a is the estimated intercept, b1 is the 
estimated regression coefficient and c1...n are the predictor variables (e.g. 
image intensity ratio of ADC, DWI, T2w, T2). The probability of being 






- Akaike information criteria (AIC) (Akaike, 1973) is a measure of the 
quality of a model relative to other models in the same dataset and 
represents the amount of information lost by using the model (Symonds & 
Moussalli, 2011).  The most accurate model has the lowest AIC (Akaike, 
1973). The AIC is calculated using the number of fitted parameters, 
including the intercept in the model (𝑘), and the maximum likelihood 





𝐴𝐼𝐶 = −2 ln(𝐿) + 2𝑘. 
 
However, when 𝑘 and the sample size (𝑛) is less than 40, AIC corrected for 
sample size (AICc) is recommended (Symonds & Moussalli, 2011) and was 
thus used in this study. Where:  
 
𝐴𝐼𝐶 = 𝐴𝐼𝐶 +	
2𝑘(𝑘 + 1)
𝑛 − 𝑘 − 1
 
 
The lowest AIC the generalized linear model produced by the logistic 
regression analysis with the lowest AICc value represents the one that, in 
comparison to other models, best predicts whether a patient is within the 
thrombolysis treatment window.  
 
- Precision-recall-gain (PRG) methods developed by Flach and Kull 
(2015) is a more interpretable variation of the traditional precision-recall 
analysis. Precision-gain and recall-gain are linearized versions of precision 
(or PPV) and recall (or sensitivity) values. PRG methods have been shown 
to be an appropriate alternative to ROC analysis in class imbalanced data 
sets and overcome problems associated with traditional precision-recall 
analysis (see Flach & Kull, 2015). 
 
- The precision-recall-gain (PRG) curve provides a visual indication of 
overall performance by plotting precision-gain on the y-axis and recall-gain 
on the x-axis, ignoring negative gains.  Lines closest to the top right of the 
graph indicate parameters with high overall ability to identify patients 
scanned before 4.5 hours. 
 
- The area under the PRG curve (AUPRG) provides a numerical 





classifier and positive and negative AUPRGs indicate more and less optimal 
classifiers, respectively (Flach & Kull, 2015). There is no predefined limit 
as to what constitutes a high overall performance, but a higher AUPRG 
would indicate a classifier that performs better at identifying patients 
within the treatment window.  
 
- The F1 score (Rijsbergen, 1979) is considered an appropriate measure for 
evaluation of a class-imbalanced data set, where the higher the F1 score, the 
better the overall performance. (Bekkar & Djemaa, 2013). The F1 score gives 
equal weighting to the importance of precision and recall and is defined as 











Power analyses referenced in the Discussion of Chapter 7 
Apriori power analyses were conducted using G*Power (Faul et al., 2007). 
 
Power analysis for the FLAIR image intensity ratio: based on Wouters et 
al.’s (2016) report of relationship of the FLAIR ratio with time from symptom onset 
in patients scanned within nine hours (r = 0.4).  
 
Analysis: A priori: Compute required sample size  
Input:  Tail(s) = Two 
   Correlation ρ H1 =0.4 
   α err prob =0.05 
   Power (1-β err prob=0.9 
   Correlation ρ H0 =0 
Output:  Lower critical r =-0.2520938 
   Upper critical r =0.2520938 
   Total sample size =61 























Exact - Correlation: Bivariate normal model
Tail(s) = Two. Correlation ρ H0 = 0. α err prob = 0.05. Correlation ρ H1 = 0.4





Power analysis for the T2 relaxation time:  based on Siemonsen et al.’s (2009) 
report of relationship of hemispheric differences in T2 relaxation times with time 
from symptom onset in patients scanned within six hours of symptom onset (r = 
0.5) and the relationship of the T2 image intensity ratio with time from symptom 
onset in patients scanned within nine hours of symptom onset reported in McGarry 
et al. (2020) and Chapter 7 (r = 0.5). 
 
Analysis: A priori: Compute required sample size  
Input:  Tail(s) =Two 
   Correlation ρ H1 =0.5 
   α err prob =0.05 
   Power (1-β err prob) =0.9 
   Correlation ρ H0 =0 
Output:  Lower critical =-0.3245729 
   Upper critical r =0.3245729 
   Total sample size =37 
   Actual power =0.9011434 
 
  
















Exact - Correlation: Bivariate normal model
Tail(s) = Two. Correlation ρ H0 = 0. α err prob = 0.05. Correlation ρ H1 = 0.5
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ADC vs DWI 0.09 (0.09) -0.08 – 
0.26 
1.06 0.288 
ADC vs T2w 0.12 (0.14) -0.15 – 
0.38 
0.84 0.399 
ADC vs T2 0.22 (0.12) 0.00 – 
0.45 
1.92 0.055 
DWI vs T2w 0.02 (0.09) -0.15 – 
0.20 
0.26 0.794 
DWI vs T2 0.13 (0.11) -0.08 – 
0.34 
1.24 0.215 
T2w vs T2  0.11 (0.12) -0.10 – 
0.32 
1.01 0.313 
Note. AUC = area under the receiver operating characteristic (ROC) curve, 


































Distributions tested  
- Birnbaum Saunders 
- Burr Type X11 
- Extreme Value 
- Exponential  
- Gamma  
- Generalised Extreme Value  
- Generalised Pareto  



































Chapter 2, Figure 2.2. Schematic diagram illustrating the types of 
oedema during ischaemia.   
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